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ABSTRACT
Sickle Cell Disease (SCD) is a genetic disorder which affects hemoglobin and is
associated with high rates of neurologic and neurocognitive deficits. Recent studies have
indicated executive functioning (EF) as a common area of impairment for children
diagnosed with SCD; however, there is no consensus about which measures of executive
function are best to use in clinical practice or research. The purpose of the present
research is to assess the properties of a new executive function measure, the
“EXAMINER” to determine its utility with the SCD population. Thirty-two children
with SCD and 86 demographically-matched controls completed established cognitive
measures known to be sensitive to SCD-related neurocognitive deficits as well as
EXAMINER tasks of executive attention, set shifting, working memory, inhibition,
planning, and fluency. A statistical analysis compared performance on the attention, set
shifting, inhibition, planning, and fluency measures in the EXAMINER relative to
established measures (i.e., the verbal comprehension, processing speed, short term
memory measures in the Woodcock Johnson Tests of Cognitive Abilities III) to compare
reliability and validity. It was expected that the EXAMINER would show comparable
reliability and validity to the established measures using traditional definitions of these
constructs. In addition, examination of cultural validity was examined due to the high
preponderance of SCD among the African-American population. Statistical analysis
indicated support for internal consistency, convergent validity, cultural validity, and
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sensitivity of the EXAMINER, relative to traditional cognitive measures. Taken together,
these results suggest that the EXAMINER is a useful neuropsychological test for the
pediatric SCD population. Future research should focus on using more sophisticated scale
development approaches, including greater ethnic and economic diversity with norming
groups, and incorporating children in the statistical models to further establish strong
psychometric properties.
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CHAPTER I
INTRODUCTION
The identification of appropriate executive function (EF) measures for pediatric
sickle cell disease (SCD) is pivotal in understanding disease related impacts on cognitive
functioning. SCD is an autosomal recessive genetic blood disorder commonly found in
individuals with African, Mediterranean, Indian, and Middle Eastern heritage.
Approximately 1 in 11 African Americans in the United States (US) carry the sickle cell
trait and it is estimated that 1 in 500 African-Americans have SCD in the United States
(Charache, Lubin, & Reid, 1992).
SCD is a multi-systemic disease that ultimately impacts the biological integrity of
organs, especially the brain. Decrements associated with SCD brain effects have been
found in a wide range of cognitive areas that can be categorized as EF. EF is a broad
construct that incorporates a collection of interconnected cognitive processes responsible
for focused, goal oriented behavior (Gioia, Isquith, & Guy, 2001). Even when children
with SCD appear normal by magnetic resonance imaging (MRI) scan and on traditional
measures of cognition, such as Intelligence Quotient (IQ), cognitive functioning has been
found to be impaired (Steen, Fineberg-Buchner, Hankins, Weiss, Prifitera, & Mulhern,
2005; Schatz, Finke, Kellett, & Kramer, 2002; Wang et al., 2001). However, pediatric
SCD treatment studies have consistently utilized neurologic imaging technologies and
global measures of IQ to understand cognition, as opposed to modality specific
1

neuropsychological assessment (Schatz, Finke, Kellett, & Kramer, 2002).
Methodological issues associated with the measurement of cognitive functioning
are important several reasons, especially in this population. First, multi-center SCD
randomized clinical treatment trials have been halted by The National Heart Lung and
Blood (NHLB) for safety concerns associated with aparticipants completing
neuroimaging exams (Lee, Piomelli, Granger, Miller, Harkness, Brambilla, Adams,
2006). Second, neuroimaging exams may only capture structural lesions and
underestimate the full extent of neurocognitive deficits (Schatz, Brown, Pascual, Hsu,
DeBaun, 2001; Schatz, Finke, Kellett, & Kramer, 2002). In addition, the brain health of
children with SCD may be improved if measurement of the narrow abilities associated
with cognition were incorporated in pediatric SCD treatment studies. Pediatric SCD
treatment studies have excluded specific measures of cognitive ability performance from
their outcomes, in part due to inconsistent measurement practices in the research
literature. Deficits in children with SCD have been shown to impact general intellectual
ability, attention, language, visual-spatial abilities, short and long term memory, and
academic outcomes (Steen, Fineberg-Buchner, Hankins, Weiss, Prifitera, & Mulhern,
2005; Schatz, Finke, & Roberts, 2004; Schatz, Finke, Kellett, & Kramer, 2002). While
this distinct cognitive profile for pediatric SCD is apparent, there is a lack of standard
psychometric tools which evaluate these cognitive abilities across this body of literature.
Furthermore, within this literature, there is a wide assortment of neuropsychological
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measures which are used to investigate cognition partly due to the lack of systematic
evaluation of the measures themselves for use with the SCD population.
The development of a neuropsychological assessment battery focused on
executive functions that will meet or exceed the current established by cognitive
batteries, such as the Wechsler Intelligence Scales for Children (WISC) and the
Woodcock Johnson-III Tests of Cognitive Abilities (WJ-III), will help the field develop
more accurate measurement of disease impacts for children with pediatric SCD. The
issue of having well validated tools to measure executive functions for clinical research is
common across multiple neurologic conditions. The Executive Abilities: Methods and
Instruments for Neurobehavioral Evaluation and Research (EXAMINER) was
constructed to address this limitation. The overall goal for the development of the
EXAMINER was to reliably and validly assess domains of EF for clinical investigations
and clinical trials that were adaptable across a wide range of ages and disorders. The
purpose of the present investigation was to validate the psychometric integrity of the
EXAMINER for use in children with SCD.
Organization of Review
This study sought to integrate SCD research, SCD treatment, and EF literature to
propose utilization of a standard psychometric battery which will impact both science as
well as practice. The background information to set the stage for this study was
conducted in three separate sections. The first section provided background information
on SCD and SCD associated neurologic complications. Pediatric SCD studies examining
cognitive functioning in relation to neurologic disease and treatment were discussed. The
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concept of EF, construct conceptualization, and measurement in the context of clinical
outcomes and clinical decision making was reviewed in the second section.
The third section, of this document, assessed the current state of the science for
cognitive tools in pediatric SCD literature and identified the minimal standards that EF
measures should meet or exceed in order to become the new state of the art for clinical
outcome studies in SCD. In this section, an overall description of the measures that are
currently in use with this population is presented. Additionally, the psychometrics of
specific tests utilized with pediatric SCD are reviewed. Strengths and weaknesses
associated with the cognitive measures, used to-date, with the SCD population are also
described. Finally, general comments are offered about the current state of EF measures
within these existing studies.
Section I: Sickle Cell Disease
Nearly 50,000 Americans in the United States (US) have SCD and the majority of
these individuals are of African, Mediterranean, Indian, and Middle Eastern descent
(Edwards et al., 2005; McCrae & Lumley, 1998). It has been estimated that 1 out of 500
African Americans have a genetic variation of sickle cell disease (Charache, Lubin, &
Reid, 1992). SCD refers to a category of inherited blood disorders (McCrae and Lumley,
1998). SCD occurs when an individual inherits an S-type hemoglobin (sickle type
hemoglobin) gene along with another hemoglobin gene that does not code for A-type
hemoblobin (the most common form of hemoglobin). Hebbel, Mohandas, Embury, &
Hebbel (1994) describe four major genotypes of SCD: hemoglobin SS (HbSS),
hemoglobin SC, (HbSC), HbS-beta-zero-thalassemia (HBSβ0), and HbS-beta-plus
thalassemia (HBSβ+). Sickle Cell Anemia, hemoglobin SS, is the most severe form of the
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disease and affects 65% to 75% of people diagnosed with SCD in the US (Platt, Orkin,
Dover, Beardsley, Miller, Nathan, 1984).
Individuals with SCD produce abnormal hemoglobin, which is influenced by the
genetic genotype of the disease. When oxygen saturation in the blood drops below a
critical threshold the red blood cells (RBCs) outer membrane change from typical disklike, “donut” shape to a curved, elongated, “banana” or “sickle” shape. Rigid “sickled”
cells often lead to common complications associated with the disease, due to these cells
having reduced lifespan and poorer oxygen carrying capacity (Serjeant, 1997). Chronic
symptoms include unpredictable pain from vessel occlusion, anemia, increased fatigue,
splenic sequestration, lung functioning impairment, priapism, enuresis, growth delays,
increased risk of infection, tissue infarction, cerebral vascular disease (CVD), and acute
chest syndrome (Sickle Cell Disease Guideline Panel, 1993).
Chronic symptoms related to SCD have been found to directly and indirectly
impact cognitive ability through brain function. In particular, CVD and neurologic
dysfunctions related to blood vessel function have been found to increase the probability
of neurologic complication (Hillery & Panepinto, 2004). This damage is thought to occur
because “sickled” cells reduce oxygen delivery to the brain and also damage small and
large vessels in the brain (Huttenlocher, Mohr, Johns, et al. 1994). Silent stroke can be
evidenced on clinical MRI exams in areas such as the arteriole-capillary-venule beds,
such as found in white matter regions at the distal parts of the major cerebral arteries
(Adams, McKie, Hsu, Files, Vichinsky, et al., 1998). Overt stroke, which is evidenced
with clinical MRI exams and an observable neurologic event, can be present from the
internal carotids to the circle of Willis (DeBaun, Derdeyn, McKinstry, 2006). In children
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with SCD and overt stroke, decreased verbal intelligence quotient (VIQ), full-scale
intelligence quotient (FIQ), and narrower abilities such as freedom from distractibility,
attention, and other location-specific functions (e.g., motor skills contralateral to the
injury) have been demonstrated (Craft, Schatz, Glauser, Lee, DeBaun, 1993; Steen,
Emudianughe, Hankins, Wynn, et al., 2003). Less severe neurocognitive deficits, in
similar areas of cognitive ability as overt stroke, have been associated with silent stroke
in children with SCD (Armstrong, Thompson, Wang, Zimmerman, Pegelow, Miller, et
al., 1996; Bernaudin, Verlhac, Freard, Roudot-Thoraval, Benkerrou, et al., 2000).
Furthermore, deficits associated with FIQ, general cognitive ability, and attention-related
skills (e.g., short term memory and processing speed) have been shown for those with
SCD without identifiable brain injury on clinical MRI (Schatz et al., 2004). These deficits
have been demonstrated to not be related to general disease severity (e.g., hospitalization
rates, pain severity, anemia severity) and are above and beyond social risk factors for
poorer cognitive test scores (for review, see Schatz et al., 2002). In terms of functional
behavior, the broad and narrow cognitive processes affected by SCD are important as
inter-related processes which are responsible for purposeful, goal-directed behavior. This
is one of the definitions of EF (Gioia, Isquith, Guy, and Kenworthy, 2000).
SCD neurologic injury has been a focal point of treatment studies; however
assessing EF from a psychological perspective is uncommon in pediatric SCD treatment
studies. Many of these studies have not included cognitive measures due to contextual
and methodological considerations in the research associated with pediatric SCD and
cognition. Many pediatric hematology centers have limited access to psychology
resources. The use of cognitive tools has been inconsistent across clinical studies.
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Methodologically, in contrast to tools such as clinical/structural MRI exams for
identifying cerebral infarcts, there is not a gold standard assessment battery
recommended to measure cognitive deficits in this population. This limitation reduces the
use of cognitive abilities as a primary measure of treatment outcomes. The absence of
established, standard neuropsychological tests may also influence the results obtained for
children with SCD. The cognitive performance of children with SCD has often been
measured with tools idiosyncratic to each study, and many of which have varying
psychometric quality. Additionally, research studies which evaluate cognition in pediatric
SCD generally have small samples sizes, thus restraining the generalizability of findings
(Nikhar et al., 2011). Furthermore, pediatric SCD research methodology is varied in
nature which creates challenges in comparing findings across studies (e.g., different
control groups, different approaches to sampling, etc.). Although there are limitations
associated with pediatric SCD neuropsychological research, neuropsychological
assessment is generally viewed as valid and reliable with validity measures equaling or
exceeding those of medical tests, including neuroimaging (Matarazzo, 1990; Meyer,
Finn, Eyde, et al., 2001). Therefore, the inclusion of cognitive measures is important for
improved understanding of disease related mechanisms and treatments.
Overview of neurocognitive relationships in SCD
An examination of the existing literature on the cognitive effects of pediatric SCD
is essential for the understanding how to best select neuropsychological measures to
include in treatment studies. Stroke, silent infarct, and general disease status differentially
affect the severity of cognitive deficits. Additionally, the cognitive performance of
children has been shown to be impacted by location, size, and volume of neurologic
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tissue damaged by SCD morbidity (Watkins, Hewes, Connelly, Kendall, Kingsley,
Evans, Gadian, Vargha-Khadem, Kirkham, 1998). Compared to healthy children, stroke
risk has been shown to increase by 221-fold in pediatric SCD (King, Herron, McKinstry,
Bacak, Armstrong, White, and DeBaun, 2006). Overall, stroke has been shown to
negatively impact language ability, attention, working memory, processing speed, and
executive functioning on various neuropsychological tests (Steen et al., 2005; Schatz,
Finke, & Roberts, 2004; Schatz, Finke, Kellett, & Kramer, 2002; Noll et al., 2001; Schatz
et al., 2001). In addition, the SCD-related risk of silent cerebral infarct is 410-fold higher
versus peers without SCD (King, Herron, McKinstry, Bacak, Armstrong, White, and
DeBaun, 2006). Children diagnosed with SCD and silent cerebral infarcts generally
perform poorer in FIQ, VIQ, performance intelligence quotient (PIQ), language, memory,
academic achievement, attention, processing speed and motor coordination than children
with SCD and no MRI abnormality (Bernaudin et al., 2000; Schatz et al. 2001; Schatz &
Buzan, 2006; Steen et al. 2005). Furthermore, cognitive decrements have also been
demonstrated in children with SCD who have no history of brain abnormalities evidenced
on MRI (Schatz et al., 2002; Steen 2003; 2005). Overall, a wide range of psychological
domains such as general intellectual ability, attention, language, visual-spatial abilities,
short and long term memory, executive functioning, and academic outcomes have been
shown to be reduced in children diagnosed with SCD when compared to healthy peers
(Steen et al., 2005; Schatz, Finke, & Roberts, 2004; Schatz, Finke, Kellett, & Kramer,
2002).
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SCD Treatment Studies
Most pediatric SCD treatment studies provide a limited view of cognitive effects
associated with neurologic change from treatment therapies. Treatment studies
traditionally seek to alleviate complications associated with pediatric SCD by relieving
pain and managing overall disease related complications (Puffer, Schatz, Roberts, 2007).
Additionally, the primary focus of this body of literature is the prevention of secondary
neurologic injury after an initial brain insult has occurred, due to SCD complications
(Adams, Ohene-Frempong, Wang, 2001). Many pediatric SCD treatment studies which
utilize neuropsychological measures simply assess global IQ scores due to long-standing
data on the relationships between IQ and functional outcomes, such as the likelihood of
educational and vocational success. This methodology is flawed because measurement of
specific executive processes is more informative than broad cognitive performance to
understand SCD brain effects (Steen et al., 2003; Armstrong et al., 1996; Boni, Brown,
Davis, Hsu, & Hopkins, 2001; Knight, Singhal, Thomas, & Serjeant, 1995). Treatment
therapies also typically focus on the use of bone marrow transplantation (BMT), chronic
transfusion therapy (CTT), and Hydroxyurea (HU) to treat symptoms associated with
pediatric SCD.
At the present time, BMT is the only known curative therapy for SCD (Miller et
al., 2000; Walters et al., 1996). The therapy consists of destroying SCD bone marrow and
transplanting healthy bone marrow from a genetically-matched donor (Mehta, AfenyiAnnan, Byrns, & Lottenberg, 2006) Healthy bone marrow then produces normal
hemoglobin. Shenoy (2011) reports that BMT procedures are under-utilized in the SCD
population, referring to data that reveals that less than five hundred bone marrow
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transplantation procedures were reported in the Center for International Blood and
Marrow Transplant Research database. Although BMT is effective in curing SCD, the
Seattle collaborative study found no change in neurologic complications of patients with
SCD after BMT (Walters et al., 1997). This study investigated the effects of BMT in 22
children with a mean age of 9 year 9 months who had symptomatic SCD. MRI/MRA
findings suggested that 2 children evidenced new neurologic damage after BMT and
there was no change in the neurologic status for the remaining individuals in the sample.
The lack of effectiveness of BMT for neurologic outcomes may well be due to the timing
of BMT, which often occurs after extensive artery damage has already occurred.
Furthermore, we do not yet know the long term effects of BMT in pediatric SCD
(Walters et al., 2000). The gap in this literature suggests the importance of conducting
more comprehensive neurological assessment before and after BMT treatment. Including
neuropsychological measurement in treatment studies could provide more sensitive
assessment of neurologic status after treatment, that is not evident by brain imaging or IQ
scores alone.
CTT has been shown to be the most effective treatment in the prevention of
recurring vasoocclusive episodes for children with SCD (Piomelli et al., 1985; Pegelow et
al., 1995). These episodes occur when the circulation of blood vessels is obstructed by
“sickled” red blood cells, causing neurologic injuries. CTT prevents these episodes by
increasing brain oxygenation levels, suppressing HbS synthesis, and reducing hemolysis
(Raj et al., 2004). The Stroke Prevention Trial in Sickle Cell Anemia (STOP) was pivotal
in demonstrating the benefits of CTT for stroke risk in children with SCD. Findings
indicated that children who were screened with TCD and subsequently received CTT
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demonstrated less recurrence of overt stroke. This intervention also prevented first
episodes of stroke for children with abnormal cerebral blood flow (Adams, McKie, Hsu,
et al.1998). Likewise, Wilimas and associates (1980) used routine neuropsychologic
testing along with radiologic and electrophysiologic studies to evaluate children with
SCD and previous stroke who were treated with CTT for a 3 year period. Results
revealed that their WISC -Revised mean FIQ increased from 63.7 to 67.2 with use of
CCT. Presently, The Silent Infarct Multicenter Transfusion Trial is evaluating global IQ
in those receiving blood transfusion compared to a comparison group of participants
(study in progress). As noted by Schatz and associates (2002), use of broad scale IQ is
limiting when compared to information obtained from specific measurement of cognitive
functioning. More information about the treatment of CTT and cognitive effects could be
understood if studies of this nature included measurements of narrow cognitive ability
within the study design. Currently the literature lacks the data describing CTT and narrow
range cognitive abilities due to the omission of neuropsychological measurement for
these specific abilities. Without this information, treatment trials for SCD may miss
important information about selective effects of treatment (e.g., benefits to specific
cognitive abilities and associated neural systems) which could further inform brain
imaging variables to study. The inclusion of modality specific cognitive measures within
these studies could help to determine if the brain health benefits are global or specific
with CTT.
HU (hydroxycarbamide), is a novel and effective treatment which increases fetal
hemoglobin in patients with SCD, which inhibits the sickling of S-type hemoglobin. It
increases the amount of oxygen distributed in the body and thereby decreases the chances
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of vasoocclusion (Puffer, Schatz, Roberts, 2007). In a randomized control trial, HU was
shown to reduce the number of hospitalizations and make pain crises milder by
decreasing vasoocclusive complications and pulmonary tissue damage from acute chest
syndromes (Charache et al., 1995) Subsequent studies have further supported the health
benefits of HU therapy for the SCD population (Strouse et al., 2008; Lankron et al 2008).
To date there is only one study that investigates the effects of HU on cognition in SCD
(Puffer, Schatz, Roberts, 2007). This study examined 15 children with SCD on HU
therapy compared to 50 healthy peers, statistically controlling for social/demographic
factors in a retrospective, correlational design. Results indicated that children with SCD
on HU performed better on verbal comprehension, fluid reasoning, and general cognitive
ability tasks than control subjects. The findings from this study provide support for the
cognitive benefits of HU therapy in pediatric SCD. Additional prospective investigations
of HU and cognition should be conducted for more thorough understanding of treatment
effects.
Summary
SCD refers to a category of inherited blood disorders which affect an estimated 1
out of 500 African Americans in the US (Charache, Lubin, & Reid, 1992). SCD
complications can influence the neuropsychological functioning of the child. The cellular
dysfunction associated with SCD can lead to a wide range of insults to the brain
(Huttenlocher et al., 1984). This is evidenced by findings which suggest that the
neurologic risk of stroke for children with SCD is more than 200 times the general
population of healthy peers and the risk doubles for silent cerebral infarct (Early et al.,
1998). Findings indicate overt stroke and SCD result in decreased cognitive ability
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greater than silent stroke or SCD status (Steen et al., 2005; Schatz, Finke, & Roberts,
2004; Schatz, Finke, Kellett, & Kramer, 2002; Noll et al., 2001; Schatz et al., 2001).
Along with decreased cognitive functioning in patients with SCD and stroke, children
with SCD and silent cerebral infarcts show decrements in cognitive ability greater than
SCD status but less than SCD and overt stroke (Bernaudin, Verlhac, Freard, RoudotThoraval, Benkerrou, et al., 2000; Schatz et al., 2001; Schatz & Buzan, 2006; Steen et al.,
2005). Unfortunately cognitive deficits have also been found for children with SCD who
have no history of brain abnormalities evidenced on MRI (Schatz et al., 2002; Steen
2003; 2005). Further understanding these cognitive dysfunctions are important for
children with SCD because knowledge can help to identify disease related impacts as
well as to inform treatment intervention research.
Treatment therapies such as BMT, CTT, and HU therapies have all been shown to
significantly improve disease related effects of SCD (Walters et al., 1996; Adams et al.,
1998; Charache et al., 1995). Although some treatment studies have utilized brain
imaging to recognize neurologic treatment effects, only the Puffer and colleagues (2007)
study, to date, has included neuropsychological assessment measures which assess
narrow cognitive abilities. It is essential to add comprehensive neuropsychological
measures to these studies so that the impact of treatment therapies on specific EF is
understood. It is possible that treatments for SCD may differentially affect cognitive
processes such that there is improvement in some areas yet greater deficit in other
domains of EF. Furthermore, the absence of this information may cause treatment
interventions to lack necessary focus to target specific cognitive systems.
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Section II: Executive Function (EF)
Cognitive abilities such as those impacted in SCD are often described as EF. EF
has been described in many different manners throughout its evolution and currently has
no formal, broadly agreed upon definition. Historically, the EF concept largely grew out
of awareness that IQ tests failed to capture important, higher-level cognitive abilities for
everyday problem solving that could be seen in some individuals with neurologic disease.
These cases often involved injury to regions of the prefrontal cortex. The concept of EF
has often been used synonymously with the functions of prefrontal brain regions. More
recently, scientists have begun defining executive function as also including important
emotional processing and motivational/reward functions that influence judgment and
decision making (sometimes called “hot” EF); however, classically EF has focused on
“cold” cognitive processes involved in dealing with complex cognitive tasks. For this
review we will focus on “cold” EF.
Rabbitt (1997) described EF as a portrayal of a group of cognitive actions such as:
dealing with novelty, planning and implementing strategies for performance, monitoring
performance, using feedback to adjust future responding, vigilance, and inhibiting taskirrelevant information. EF has also been defined as the cognitive processes which control
and integrate component neurologic activities in support of adaptive behavior (WoodruffPak, 1997). Similarly, Zelazo and colleagues (1997) conceptualize EF as a
macrostructure with executive sub functions which work together to accomplish the
higher-order function of solving problems. For the purposes of this investigation, the EF
definition developed by Gioia, Isquith, and Guy (2001) will be used to describe these
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broad and narrow cognitive processes. Their definition describes EF as an umbrella
expression that incorporates a compilation of inter-related processes which are
responsible for purposeful, goal-directed behavior.
Theoretical models of EF are complex and have evolved greatly over the past 30
years. The following overview is meant to provide a sampling of the range of EF
theories, rather than an exhaustive account, which is beyond the scope of the current
review. In the early 1970s the EF concept emerged in the literature when Broadbent
developed one of the first theories invoking the concept of EF. He reported that there are
two separate mental processes, automatic and controlled (Shiffrin & Schneider, 1977).
Similarly, Baddeley proposed a working memory model which contained the term
"central executive" component of cognition (Baddeley & Hitch, 1974). After that, Posner
further elucidated on the EF concept using the term "cognitive control" and created the
foundation for much recent EF research (Posner & Synder, 1975). Posner theorized that
focused attention on specific aspects of the environment is controlled by a distinct
"executive" branch of the attentional system (Posner & Petersen, 1990). Additionally,
Lezak (1983) developed an EF definition by explaining EF as the dimension of human
behavior that deals with “how” behavior is expressed. It is also believed that the
prefrontal cortex of the brain may mediate many component EF abilities; however the
tasks controlled by these brain regions are numerous (Stuss et al., 2002). Stuss and
colleagues (2002) has elaborated on critical EF functions mediated by the prefontral
regions such as working memory, preparatory set, and inhibitory control, which he argues
sub-erve the goal of integrating behavior over time (e.g., maintaining goals over time,
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anticipating events). These classic theories led to the development of the current working
models of EF.
More recent theories of EF include the Top-Down Inhibitory Control Model,
Brown’s EF Model, Miyake’s “unity and diversity” theory, and the Anderson EF Model.
The Top-Down Inhibitory Control Model focuses on the inhibitory control mechanisms
involved in response control, memory, selective attention, theory of mind, and emotion
regulation as the central mechanism to EF (Anderson & Green, 2001; Tipper, 2001;
Stone & Gerrans, 2006). However, one of the main criticisms of this hypothesis is that it
excludes the possible impacts of bottom up inhibition (Aron, 2007). Brown’s model
focuses on distinct component areas of EF. The six clusters of cognitive function in the
Brown EF model includes activation, focus, effort, emotion, memory, and action are
explained as dynamic and shifting functions (Brown, 2005). These models also
emphasize domains of EF that often do not account well for EF, in an ecological sense.
Most everyday tasks involving EF require the use of several of these domains. Miyake’s
theory identifies three main component areas for EF (inhibition, working memory, set
shifting). However, Miyake theorizes that in tasks with functional significance all three
areas are required to work in concert; thus, EF measures should tap into all three of these
domains to be relevant to everyday behavior. Anderson’s model focused more on
integrating information from developmental and clinical literatures and identifies four
main areas of EF with component skills that make up each area. Each domain is believed
to be somewhat distinct (e.g., domains may be dissociated across different clinical
conditions), yet contains component skills that could be measured in isolation.
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Consequently, Anderson’s theory falls somewhere between Brown and Miyake’s models
in terms of emphasizing the unity versus the diversity of cognitive skills in EF.
Summary
The EF field has progressed in both definition and theory in the past three
decades. Currently there is not a standard definition of EF. However, the Gioia, Isquith,
and Guy (2001) description of EF was utilized for this review. This definition was used
because it allows for the study of component processes, which may inform us about the
function of component neural systems. In addition, this definition upholds the notion that
EF is critically important because of its role in adaptive behavior. Varied definitions of
EF and evolving theories have negatively impacted the creation of measurement tools.
Due to the wide ranging definitions and theories, EF tasks vary greatly in their format,
content, and measurement strategy. It has often been the case that any task sensitive to
prefrontal cortex injury will be described as an EF measure. A more detailed discussion
of EF tools will be presented next.
EF Measurement
The lack of a recognized definition of EF makes the accurate assessment of
cognitive abilities challenging. First, when invoking the EF construct, it is important to
state the conceptual approach one is using. Such definitional statements are often lacking
the literature. Many historically important measures of EF, such as the Wisconsin Card
Sorting Test and the Category Test involved complex, cognitively heterogeneous, novel
tasks. Although these measures are sensitive to brain dysfunction, these instruments often
do not do a good job of identifying distinct neural systems that are affected nor do they
perform well at identifying specific cognitive processes are affected by brain dysfunction.
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Specific EF abilities have been shown to be related to specific neural systems.
For example, the Wager and Smith (2003) meta-analysis found results indicated that that
different EF processes are associated with specific cerebral areas. For instance, they
found results which showed that the right inferior prefrontal cortex is frequently activated
when it is necessary to manipulate information to perform a dual task (i.e., divided
attention or shifting mental sets across tasks). Additionally, it was demonstrated that the
superior frontal cortex shows activation once information is presented that has to be
constantly restructured and when it is necessary that memory for temporal order is
sustained (i.e., working memory). Due to neurologic associations such as these, many
current approaches to identify EF capacities and processes use a task-based assessment of
specific processes that have distinct neural associates (Hughes & Graham, 2002).
Conceptually, this is consistent with the “diversity” approach of considering distinct,
component EF processes.
Contemporary EF Measurement
The present day EF measurement approach involves an analysis of test
psychometrics prior to administration, just as with any other psychological construct.
This allows for a more thorough understanding of examinee performance. Although this
may seem obvious to psychologists today, many neuropsychological tasks of EF were
developed from behavioral neurology assessment tasks that lacked strong psychometric
evaluation. Appropriate psychometric analysis includes an examination of considerations
of the task requirements (content coverage, practicality of the methods), reliability,
validity, and suitability of the standardized sample chosen to assess an individual (GrothMarnat, 2003). These considerations are of particular importance for the SCD population
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due to the uniqueness of disease related morbidity. Knowledge of test psychometrics aids
in the appropriate interpretation of performance, given the characteristics of the SCD
population and possible limitations of the measures.
Practicality of administration is an important assessment factor to examine prior
to test administration. Recognition of how the measure approaches the EF construct is
meaningful because the test may not be measuring one of the aspects of EF which are of
interest for this population (Haynes, Richard, & Kubany, 1995). In addition, the context
and manner in which the test is given is of particular importance. Differential ethnic
group status between the examiner and examinee has been shown to impact the
intellectual performance of children (Groth-Marnat, 1997; Sattler, 1992). Similarly
Terrell, Terrell, & Taylor, (1980) found results which suggest that African American
children obtained significantly higher scores on the WISC-R when administered the
measure by an examiner of a similar race. Performance can be affected by educational
attainment, as well. If the reading level of the test is higher than the subject’s ability,
scores may be adversely impacted.
Children with SCD often have poor education attainment and academic
achievement due to school absences which result in poorer reading scores than healthy
peers (Schatz et al., 2001; King et al., 2006). Additionally, test length may negatively
impact performance on neuropsychological measures due to examinee fatigue or
frustration, which may not be the constructs of interest (Groth-Marnat, 2003). Many
neuropsychological test batteries are extensive and require sustained attention over long
periods of time. The performance of children with SCD on these measures may be
especially impacted by test length because disease related deficits have been shown to
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impact sustained attention (White, Moinuddin, McKinstry, Noetzel, Armstrong, &
DeBaun, 2006; Schatz et al., 2001).
Another psychometric issue especially related to pediatric SCD is the adequacy of
the norm referenced comparative sample. Norm referenced developmental samples have
become the typical evaluation method for the performance of individuals on
neuropsychological measures (Sparrow et al., 2000). Norms in psychological assessment
are described as the mean and standard deviation score among a category of individuals
(McIntire & Miller, 2007). Individual test results are evaluated relative to psychometric
norms. Standardized norm-referenced measures with dissimilar demographics from SCD
characteristics may not adequately reflect performance in the pediatric SCD population.
Generally, the composition of normative groups is stratified by age and/or education level
(Cicchetti, 1994). Children with SCD may not meet usual age range expectations due to
disease related morbidity (Stevens et al., 1986; Zemel et al., 2007). Furthermore, most EF
tasks have restricted age/ability ranges in contrast to SCD treatment studies (Gaston et
al., 1986; Ballas et al., 2000). These studies often use broad age range convenience
samples, the implications of this dissonance are possible increases in errors related to
interpretation. Additionally, measurement precision is often not the same across different
ability levels (McIntire & Miller, 2007). Finally, test generalizability is limited to the
characteristics of the norm sample. Characteristics of the norm sample should be
investigated when compared to the examinee, particularly in the SCD population in part
because health status has been shown to affect test psychometric scores (Johnson, 2006).
The performance of SCD children should be interpreted with caution if the characteristics
of the SCD sample are extremely divergent from demographics of the normative sample.
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Methods of Isolating Specific EF Processes
Modern day neuropsychological measures are founded on traditional
psychometric theory. The traditional model often compares an overall raw score of an
individual on a cognitive task to norm referenced scores of the standardized sample
(McGrew & Flanagan, 1998). This comparison is hypothesized to allow inference
regarding individual performance to a control group. Ideally, this approach provides a fair
assessment of current cognitive function (Lezak, Howieson, Loring, Hannay, & Fischer,
2004). As noted previously, similarities between the norm group and the individual may
influence performance on a measure (Johnson, 2006). Most commonly, cognitive
performance evidenced by classic cognitive tests such as the WISC are evaluated using
this method. This has sometimes been described as an “achievement” approach to test
evaluation because it reflects the person’s capability (or lack of capability), but often
provides little information about why or how the person achieved a particular score.
A theoretical alternative to the traditional model for identifying
neuropsychological ability is the subtractive factors method. Donders (1868/1869)
developed a reaction time methodological paradigm to evaluate the time involved in a set
of specific sequences between the presentation of a stimulus event and the initiation of
response (Schweickert, 1978). The subtractive factors approach hypothesizes that the
time it takes to complete a particular process can be estimated by adding that process to a
task and taking the difference in reaction time between the two tasks (Donders, 1969).
This method has three components and has been used for recognition, discrimination, and
response selection measurement (Gottsdanker & Shragg, 1985). Critics of this theory
challenged the central underlying assumption that one mental process can be added to a
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task without affecting the time to complete other mental processes (Ulrich, Mattes, &
Miller, 1999). Currently the empirical research of Cattell support this criticism,
nevertheless Cattell did not analyze this hypothesis within Donder’s formal model
(Cattell, 1886; 1888; 1947). Thus, although the subtractive factors approach may not
work with all cognitive tasks, it represents a potentially powerful method to assess
component skills that make up a more complex task. This approach may be well suited
to the measurement of EF, as we may be interested in both overall performance level as
well as measuring discrete cognitive skills. Subtractive factors methods have recently
been applied to norm referenced cognitive ability measures such as Delis–Kaplan
Executive Function System (D–KEFS), NEPSY - Second Edition (NEPSY–II),
California Verbal Learning Test (CVLT–II) and Wide Range Assessment of. Memory
and Learning - Second Edition (WRAML).
Another alternative is the additive factors approach. The additive factors method
is an additional psychometric approach for the isolation of cognitive processes
(Sternberg, 1969). Sternberg further developed Donder’s theoretical paradigm to create
this model. Sternberg’s additive factors logic interpretation of reaction time pattern does
not require the assumption of discrete stages, like subtractive factors, as long as it is
assumed that the final output of a stage does not vary as a function of the manipulations.
The central assumption of the additive factors method is the processing sequence between
stimulus and response that consists in a series of discrete stages. It has been shown to be
a powerful tool for studying reading process models (Raake, 2006; Massaro, 1975).
However, the additive factors approach is currently not used in any norm-referenced
tests. This is likely because the method requires a thorough measurement of at least two
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factors over multiple levels of those factors, including their interaction. Thus, an additive
factors approach would add to the length and burden of many tasks. It is therefore best
suited to narrow assessment of a few discrete areas cognitive ability as opposed to the
broader assessment strategy used in most clinical contexts.
EF Psychometrics
There are several different types of test validity and reliability essential to the
psychometric properties of psychological tests. Assessment tools designed to report the
objective performance of an individual’s neuropsychological functioning have
traditionally been more useful to treatment research than subjective observations and
interviews due to their greater sensitivity to change (Groth-Marnat, 1999). Once a test has
been shown to maintain similar performance between testing sessions, additional
psychometric qualities such as reliability and validity should be evaluated.
Reliability assesses the extent to which a construct is consistently measured
within individuals (Loevinger, 1957; Clark & Watson, 1995). There are several common
classes of reliability which include inter-rater, intra-rater, test-retest, and internal
consistency (Groth-Marnat, 1990). For the purposes of this review, test retest and internal
consistency reliabilities will be described for EF measures utilized in pediatric SCD
literature. Test retest reliability is determined by administrating the test and then
repeating test administration during another testing session. The second testing session
must occur soon enough that changes in the underlying construct would not be expected
(Meeker and Escobar, 1998). The test retest coefficient is calculated by a correlation of
two different scores, on two different occasions, by the same individual (Cortina, 1993;
Iacobucci & Duhachek, 2003). When the purpose of the measure is to make predictions
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and ensure that stable constructs do not fluctuate highly, the evaluation of test retest
reliability is recommended (Groth-Marnet, 1990). If test retest reliability is not known
prior to administration of the measure, unreliable results could be obtained and false
inferences could be made when the measure is administered before and after treatment of
SCD.
Alternatively, internal consistency assesses the uniformity of test items across the
measure and is the correlation between different items on the same test (Cortina, 1993).
The identification of internal consistency is valuable on measures with longer formats
and various subtests or sub scales (Groth-Marnet, 1990). These forms of reliability were
chosen because they are the best forms of reliability to understand both the nature of the
EF and to inform treatment evaluation. Internal consistency is essential to the analysis of
measures in the pediatric SCD population because brief measures may be chosen due to
neurologic effects of the disease (e.g. decreased sustained attention). However, the
shorter format may not adequately represent the EF construct of interest.
Validity is one of the most critical factors in psychometric test construction.
Validity refers to the amount of which psychological tools assess the construct that they
purport to measure (Guion, 1980). Content, criterion, and construct validity are the broad
categories of test validity.
Content validity requires a degree of agreement to define a particular construct.
The meaning used to assess performance can affect the inferences that may be drawn
from the obtained data (Groth-Marnet, 1990). Depending on the definition utilized, it
may over or under represent, omit facets, or reflect factors on the periphery of the EF
construct (Haynes et al., 1995).
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The criterion validity of EF measures used in the pediatric SCD population was
evaluated for this review. This factor was chosen because EF is a complex multidimensional construct and opinions about its characterization and evaluation are often
subjective and divergent. Criterion validity is the degree to which a test performs as
expected based on an external standard (or criterion). In many instances researchers use
another established assessment test which shares a similar theoretical orientation as a
criterion measure (similar to convergent validity). This psychometric was chosen as an
appropriate representation of validity for measures used in this population. The simplest
way to understand criterion validity is to compare a psychological measure it to a gold
standard test which measures the same construct. Sensitivity and specificity for clinical
outcomes also inform whether a measure is highly validated or not and is sometimes used
as an external criterion measure (White et al., 2006). In this context, sensitivity illustrates
the accurate identification of children with known neurologic disease or suspected to be
at high risk for neurologic disease within the SCD population. In contrast, specificity
demonstrates the accuracy involved in correctly identifying children without neurologic
disease.
Construct validity is based on the extent to which the measure correlates
(positively or negatively) with other measures as expected from one’s theoretical model
or known empirical relationships. Thus, a measure of working memory should correlate
with other measures of working memory, other tasks known to be associated with
working memory ability, but not with unrelated constructs (e.g., positive affect). In
batteries of tasks, the correlation coefficient is calculated for each measure and sub
scales. Inter-correlations are then determined and compared to estimate the degree to
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which the two measures relate to each other. Comparisons among neuropsychological
tests, which measure EF, are informative to the evaluation of cognitive performance
across measures. These comparisons are also used in the identification of the most
appropriate measures to use for individuals diagnosed with pediatric SCD. Another
approach to construct validity is to use factor analytic methods to determine how well the
measure conforms to the theory or framework used to develop the measure. Traditionally,
construct validity has received the most attention in the development of norm referenced
measures and test developers can demonstrate at least moderate to high construct validity.
Thus, though construct validity is critical, criterion validity is the more neglected type of
validity and the type of validity that maps on better to clinical decision making.
Summary
Quality procedures for the selection of psychometric measures should be
conducted in general, however they should be especially considered when administering
these measures to a chronically ill pediatric population. Method of test interpretation,
normative sample quality, reliability, and validity all influence the appropriateness of
cognitive measures selected for use in pediatric SCD. The educational level, manner in
which the test is administered, social-interactional context, and length of assessment have
all been shown to impact the performance of individuals on a measure (Groth-Marnet,
1990). Psychometricians should demonstrate culturally sensitive behaviors, during test
administration, towards the reduction of possible contextual effects. Additionally, brief
tests with lower reading levels given in a standardized manner are well suited for this
population given their neurologic considerations.
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Similarity between the norm group and the individual may also affect the choice
of assessment test. Dissimilarity between norm group and examinee has been shown to
impact the examinee’s performance reported by a neuropsychological measure (Johnson,
2006). The norm sample used in a neuropsychological assessment for the purposes of
comparing children with SCD should include a stratified sample. This sample should
contain a census or over representation of African Americans children with varied
general health status. Additionally, the subtractive factors approach to isolating specific
abilities may be best suited for use with pediatric SCD. This approach may be superior
due to the within subject methodology versus drawing inferences for the comparison of a
dissimilar normative group (Gottsdanker & Shragg, 1985). Furthermore, the reliability
and validity of a neuropsychological measure should be evaluated prior to use (GrothMarnet, 2000). In particular the level of test retest reliability, internal consistency, and
criterion validity should be evaluated and well understood when used with children
diagnosed with SCD.
Criticisms of Cognitive Measurement
There are several different criticisms for the use of EF measures in specialized
populations. One criticism to utilizing these measures in treatment outcomes is the lack of
information published regarding practice effects (Filskov & Boll, 1981). Practice effects
take place when a child performs a task and then performs it again on another occasion.
They are recognized to exist for neuropsychological tests, but the magnitude of these
effects is not well known for specific measures (Strauss, Sherman, & Spreen, 2006). In
treatment studies with pre-post only designs, this can pose problems for data
interpretation. Difficulties can occur such as the child’s scores during the second
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administration improve due to previous exposure to the test, not to the treatment therapy.
Although the magnitude of practice effects are not well understood; thoughtful review of
the type of measure, test retest reliability, age range, and characteristics of the subjects
can greatly reduce the error variability associated with cognitive measurement (Dikmen
et al., 2000).
Another critique for the use of neuropsychological measures in treatment studies
is the association between cognitive measures and actual daily functioning. A strong
correlation between the test scores and functioning is preferred because it validates the
use of the test as a predictor of behavior. Hairman (1991) found results that indicate a
modest degree of association between cognitive effects and functional effects in children
with SCD and stroke. However, the Hairman (1991) study included only children with
stroke and may have suffered of a restriction of range for functional behavioral outcomes.
Data has demonstrated, more with adults than children, that cognitive performance on
neuropsychological measures is moderate in relation to measures of activities of daily
living (Farias, Harrell, Neumann, & Houtz, 2003; Carter, Oliviera, Duponte, & Lynch,
1988). In contrast, cognitive measures have shown large effect sizes for academic
achievement and educational attainment in the pediatric SCD literature (Schatz 2004,
Schatz et al., 2001; Nettles, 1994).
There are also critiques of neuropsychological assessment which relate directly to
the multifaceted risk factors often found in SCD. Criticisms include the lack of cognitive
score interpretation in light of broader psychosocial factors (Strauss, Sherman, & Spreen,
2006). In particular, factors such as parent-family factors, educational experiences, and
motivational factors for test performance may all be relevant to test outcomes (Thompson
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et al., 2004). In terms of social and family factors, Thompson and colleagues (2004)
found results that indicate one fourth of the parents of a child with SCD experienced
clinically significant levels of psychological distress and poorer parent adjustment
evidenced high levels of daily stress, less knowledge about child development, and lower
expectations of efficacy. In addition they found results which indicated that poorer
cognitive functioning was associated with the learned-helplessness attributional style for
parents of children with SCD. This psychosocial interaction may pose a problem for
isolating disease-specific effects or treatment-specific effects (Hertzog & Nesselroade,
2003). Interpretation of cognitive scores in view of the psychosocial factors is best
practices for psychological assessment and should be utilized with the pediatric SCD
population (Sue et al., 1985).
Specific issues in the selection of measures for the SCD population also include
test fairness for African Americans and lower SES children (Schatz et al., 2004). The
SCD population is the US contains an overrepresentation of African Americans (Wang et
al., 2001). The ethnic minority composition of the SCD population should be considered
prior to test selection. Examination of the cognitive performance for African Americans
has been conducted extensively and recommendations have been suggested which
promote fairness in neuropsychological testing (Unversagt, et al., 1996; Diehr, Heaton,
Miller, & Grant, 1998; Gladsjo et al., 1999). An example of recommendations that have
been made for the construction of culturally fair neuropsychological test are is
examination of “cultural contamination” prior to making predictive conclusions about the
examinee (Helms, 2002; Darlington, 1971). Helms (2002) describe cultural
contamination as a significant correlation between a test score and a total score on a
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racial identity questionnaire after controlling for the criterion variable. Relatively few
neuropsychological measures utilize this recommendation, and there are no measures
identified in the pediatric SCD literature which follow this guideline.
To address concerns regarding minority performance on psychological measures,
the Standards for Educational and Psychological Testing, published jointly by the
American Educational Research Association, the American Psychological Association,
and the National Council on Measurement in Education (AERA & APA) in1999
recommend evaluating neuropsychological measures in terms of fairness. Fairness is
estimated by four principal methods which include instrument bias, equitable treatment,
measurement equivalence, and diagnostic validity (AERA & APA, 1999). To date only
one measure, D–KEFS, has been found to adhere to fairness standards in the pediatric
neuropsychological SCD literature. Selection of neuropsychological measures which
have been evaluated by the fairness guidelines may help to ensure psychological
measurement equity across culture for African American children which are diagnosed
with SCD.
Understanding the multifaceted nature of SCD is vital to the selection of
neuropsychological tests that are most appropriate for this population. SCD affects the
general health as well as the neurologic condition of children with SCD. Issues such as
such as fatigue from anemia, CVA, silent cerebral infarct, increased blood flow velocities
may pose a significant confound for test score interpretation (Palermo, Schwartz, Drotar,
& McGowan, 2002). When evaluating measurement tools for use with the pediatric SCD
population, health effects may impact performance unrelated to the cognitive instrument.
For example, children with SCD are often in pain related to vasoocculsive crisis that do
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not require hospitalization (Platt, Thorington, Brambilla, et al. 1991; Vichinsky, Johnson,
Lubin, 1982; Shapiro, Dinges, Carota-Orne, Ohene-Frempong, Orne, 1990). An examiner
unfamiliar to the effects of pediatric SCD may not inquire as to the child’s current pain
level. The absence of the information may lead to inaccurate results which are associated
with pain instead of cognition. Therefore, administering a neuropsychological test to a
child suffering from an unreported low level pain crisis may increase measurement error
in the cognitive score. It is important to comprehend all of the properties related to a
psychological measure that are not the target of study, but nonetheless result in group
differences in test scores. Individual conditions such as health status may impact the
fairness of administration (Van de Vijver and Poortinga, 2005).
Summary
The advantages associated with the administration of neuropsychological
assessments for children with SCD are noteworthy. Strengths associated with cognitive
measurement for pediatric SCD include the identification of specific cognitive abilities in
SCD treatment studies. Likewise, a more thorough understanding of brain mechanisms
which affect cognitive processes can be discovered for individuals with pediatric SCD.
The addition of neuropsychological measures to the existing body of literature will help
to propel SCD treatment to a greater comprehensive knowledge base regarding both
treatment and disease related effects.
Disadvantages related to using cognitive measures with this population are
various. Practice effects are an instance of one such difficulty. The magnitude of practice
effect for specific measures is unknown (Strauss, Sherman, Spreen, 2006). Additionally,
the degree of association between cognition and functional living, primarily with adults,
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has also been a critique of including cognitive measures to treatment studies (Hairman,
1991). Furthermore, psychosocial factors which influence disease-specific or treatmentspecific effects may impact performance on neuropsychological measures (Hertzog &
Nesselroade, 2003). Generally neuropsychological measures have been criticized for their
fairness and disparate impact on African Americans which is salient due to the
composition of the SCD community (Wang et al., 2001). Finally, the health related
morbidity for children with SCD may impact performance unrelated to cognitive scores
(Platt, Thorington, Brambilla, et al. 1991). Given the appropriate considerations, each of
these potential confounds can be mitigated thereby allowing for the correct interpretation
of EF performance.
Section III: Existing Literature on Cognition in Pediatric SCD
A review of the pediatric SCD literature revealed a total of 40 studies which
contained cognitive measures to assess neuropsychological functioning, see Table 1.1.
This table demonstrates the wide variation of neuropsychology measures that are used
across the pediatric SCD literature. This lack in consistency has contributed to the
complexities associated with understanding the cognitive profile of children with SCD.
Additionally, this disparity in the literature has indirectly promoted the lack of narrow EF
measurement in the treatment literature. These tests were selected by researchers to
identify cognitive abilities in the pediatric SCD literature. The measurement batteries
include six versions of the Wechsler Intelligence, three editions of the Woodcock
Johnson Cognitive tests, DAS, Kaufman Assessment Battery for Children (KABC), D–
KEFS, Denver Developmental Screening Test, Developmental Neuropsychological
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Assessment, Luria-Nebraska Neuropsychological Battery, Stanford-Binet, and the
Behavior Rating Inventory of Executive Function (BRIEF).
Among the 18 neuropsychological batteries utilized; the Wechsler, Woodcock
Johnson, and the DAS scales emerged as the most commonly administered in the
pediatric SCD population. Many of these studies analyzed various facets of cognitive
ability with the Wechsler Scales. Although this measure is commonly used in the
literature, Wechsler (1991) reports that these scales measure only a few factors of
cognition among the numerous that have been proposed within the Cattell-Horn-Carroll
(CHC) theory. The CHC theory identifies 10 broad and over 70 narrow abilities to inform
a distinct EF profile (Flanagan & Harrison, 2005). The use of this scale may therefore
reveal an incomplete picture of cognition for this population. In contrast to the Wechsler
scales, the WJ-III is reported to measure a multitude of factors within the CHC
framework and was selected for use in 12 pediatric SCD studies (Woodcock, McGrew, &
Mather, 2001). The DAS was also used, in six studies, to further understand EF in this
population. This cognitive battery was not developed from any single theory of cognitive
ability but instead derives from sophisticated statistical procedures. Additionally, various
neuropsychological measures designed to specifically evaluate narrow aspects of EF were
also used to comprehend the nature of cognition in children diagnosed with SCD. Table
1.1 reveals the administration of 58 different cognitive tests for an analysis of EF to the
pediatric SCD population. These cognitive measures are assorted for 2 primary reasons:
(1) the multifaceted definition of EF and (2) the lack of standard assessment guidelines
for this population.

33

General descriptive information for the selected studies was also examined, see
Table 1.2. The average number of participants within the 30 studies included in this
review was 163.8 (SD = 423.9) participants with a mean age of 10.6 (SD = 2.4) years.
However, this statistic is misleading because 84% of the studies had samples less than
100. By excluding Steen and colleagues (2005), which had an outlier sample of 2254, the
mean participant pool was 82.5 (SD = 71.9) with a mean age of 10.8 (SD = 2.3). Sickle
Cell Anemia (HbSS) was the predominant subtype of SCD in most studies. Moreover,
this table clearly reveals the varied age range (1 year 8 months – 16 years nine months)
and dissimilar methodological considerations in the pediatric SCD literature. An
illustration of this these practices is evidenced when analyzing the use of the Wide Range
Achievement Test (WRAT) in pediatric SCD studies. The WRAT was used in 3 research
studies (Cohen et al., 1994; Wasserman et al., 1991; Fowler & Whitt, 1988). Although
this measure was used to investigate academic achievement in children with SCD, only 2
of the 3 studies were similar to one another in age and sample group characteristics.
Children, mean age 9 years and 9 months, with SCD were grouped according to left
versus right silent cerebral infarct in the Cohen and colleagues (1994) article. In contrast,
Wasserman and colleagues (1991) compared children, with a mean age 11 years 5
months, with SCD and no stroke to siblings. Likewise, Fowler & Whitt (1998) also
investigated children with SCD and no stroke compared to healthy peers, mean age 12
and 11 months. Comparing children of different age ranges, across the literature, may be
problematic as this assumes any cognitive deficits are constant across different ages.
There are also potential issues with cohort effects as the quality of medical care has
changed over time.
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It is also unmistakable that norm referenced assessment practices are varied
across pediatric SCD studies. The psychometric norm characteristics for each
neuropsychological measure in this literature were either compared to a standard or local
normative group of children. As shown in Table 1.2, an estimated forty percent of
pediatric SCD studies selected a combination of measures which include both local and
standard norms to assess EF. Stewart and Kaminski (2002) suggested that local norms
provide an increased advantage of providing meaningful information regarding
performance for a particular demographic on psychological measures. These authors also
report that local norms decrease the likelihood of bias because a child’s test performance
is compared to other children whose demographic factors are similar. Furthermore, they
also demonstrate that local norms are useful in facilitating the identification of strengths
and weaknesses. The majority of studies within pediatric SCD did not utilize measures
which included local norms. However contrasting the cognitive results of individual
children with SCD tested within these research studies to one another or similar group of
children with SCD seems more informative than to a healthy group of nationallyrepresentative children. Increased use of measures which include a normative sample
more appropriate for children with SCD can help to reveal a more accurate picture of
cognition is pediatric SCD.
The psychometric properties of 30 identified neuropsychological measures and
relevant subtests; when reported in the pediatric SCD literature, was reviewed. Age range
and method of test interpretation were included as an evaluation technique to understand
the psychometric properties of each measure. Additionally, test retest and internal
consistency were analyzed to understand the psychometric reliability of each measure.
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Also, convergent validity was examined to assess psychometric validity across
neuropsychological measures. The quality of the normative sample was reviewed with
seven different criteria (see Table 1.4). The selected psychometric factors were reviewed
to inform the appropriateness of test selection for children with SCD.
Neuropsychological measures administered for this population encompass several
different age ranges. Overall, the age ranges of neuropsychological measures were
appropriate chosen for the study samples. However the Wechsler Memory Scales (WMS)
were utilized outside of the intended psychometric age range by Watkins and colleagues
(1989). The WMS suggested for use with individuals age 16-89, nevertheless the authors
utilized this measure to understand memory functions in a sample of children with SCD
mean age 10 years 6 months. Results reported that are associated with this measure
should be interpreted with caution due to the age range guidelines suggested with this
instrument.
The method of test interpretation within neuropsychological measures for
pediatric SCD is limited to the traditional and subtractive factors measurement
approaches. As described earlier, subtractive factors may be the more potent method of
test interpretation for children with SCD due to within subject comparison. However, it
appears that only eight cognitive measures utilize this method of interpreting examinee
performance among pediatric SCD studies (see Table 1.3). Specifically, use of these
measures is generally accepted in research contexts; however due to their “experimental”
nature, most data regarding psychometric properties is not published. It is clear that
measures which utilize the traditional “achievement” approach of understanding
cognition have dominated the pediatric SCD literature.
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There was extreme variability in reliabilities evaluated within and across the 30
measures selected for use with the pediatric SCD population. Several works were
consulted to describe statistically adequate measurement practices. Ultimately reliability
evidence was determined by recommendations by Strauss and colleagues (2006). Test
retest reliability coefficients were determined as: “Very High (≥.90), High (.80-.89),
Adequate (.70-.79), Marginal (.60-.69), Low (.50-.59), Extremely Low (≤.49).’’
Additionally, internal consistency reliabilities were set as: Excellent (α ≥ .9), Good (.9 >
α ≥ .8), Acceptable (.8 > α ≥ .7), Questionable (.7 > α ≥ .6), Unacceptable (.5 > α). In
general reliability coefficients ranged within measures from extremely low to high,
depending on the subscale of interest. For instance, The Self Ordered Pointing Test
reliability associated with test retest was adequate, whereas the internal consistency was
high. Additionally the CVLT–II, long delay recall subtest has marginal test retest
reliability but excellent internal consistency. On average, when reported, test retest
reliability for the selected measures across the studies is adequate and internal
consistency is high. However, it should be noted, data was missing for many of the
subscales utilized to asses cognitive functioning. An example of this missingness is
evident in the Detroit Test Learning Aptitude 2nd ed. Reported test retest reliability varied
from adequate to very high and internal consistency from acceptable to excellent on this
instrument. However, specific subtest reliability coefficients for the measures shown to
be sensitive to SCD could not be obtained. Ideally, reporting of reliabilities would be
readily available and consistent with one another, such as in the case of the Decision
Speed subtest of the WJ-III. The test retest reliability is high and the internal consistency
is excellent.
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Overall measures in this literature demonstrated a strong relationship to other
cognitive measures which measure the same features of EF (see Table 1.3). The
following convergent validity correlations established by Strauss et al. 2006 were utilized
for this review: Strong (.50 to 1.0), Moderate (.30 to .49), Low (.10 to .29). A few
neuropsychological measures diverge from the overall prevalence strong associations in
the research literature. For instance, measures such as CVLT–II, Gordon Continuous
Performance Task, Kagan Matching Familiar Figures Test, and Self Ordered Pointing
Test indicated moderate associated with similar tests of cognition (see Table 1.3). These
modest relationships are not surprising due to the nature of EF and measurement
practices. Additionally, the Tower of Hanoi and Wisconsin Card Sorting Test have low
associations, at best, with other measures of cognition.
Normative sample characteristics were evaluated by several factors to develop a
general set of quality guidelines (see Table 1.4). The guidelines created for this review
originated from recommendations for normative samples by Mitrushina and associates
(2005). The 10 criteria chosen describe the degree of support for the normative samples
utilized by each neuropsychological measure. Additionally, these guidelines include
cultural considerations indicated by Suzuki and Ponterotto (2008) relevant to the SCD
populations. Notably, evaluation of the quality criteria requires an extent of subjectivity
in judging psychometric standards. Norm quality consists of an analysis of: sample size,
representativeness of United States (US) census data, stratification, etlhnicity by
stratification, geographic diversity, African American cultural effects, health condition,
special education inclusion, and exclusion/inclusion criteria. An analysis of these factors
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resulted in a categorization of deficits on the following continuum “excellent ≥ 8 factors,
adequate ≥ 6 factors, good ≥ 4 factors, and poor ≤ 3.”
Normative samples from 13 of the 30 articles analyzed were reviewed to be of
“poor” quality (see Table 1.3). This status was the result of a combination of factors such
as small sample size, no representativeness from US census data, no stratification, limited
geographic diversity, strong African American cultural effects, etc. An example of a
neuropsychological measure with a designation of “poor” for the normative sample is the
Connors’s Continuous Performance Test. The clinical sample was comprised of 670
individuals who were stratified by eight age bands. This sample was not representative of
the US census and subjects were only selected from five US states and a province in
Southern Ontario. The general health condition of the sample was not indicated and
children receiving special education were excluded from the sample. However, the
mental health status of the sample was reported and no ethnic/racial effects were reported
as well. This sample lacks the necessary properties to appropriately compare the
performance of children with SCD. A more appropriate measure, with a description of
“excellent” for the test norms is the WJ-III. The sample size is large, consisting of 5972
children stratified by both individual and community socioeconomic variables.
Additionally, the validation sample is geographically diverse, with individuals selected
from over 100 geographic regions within 27 US states. Similarly, comparable scores have
been evidenced for African American children when compared to their Caucasian peers.
Albeit, it is significant to mention the general health conditions of the sample were not
reported, the only exclusion criteria were less than one year of fluent English speaking.
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Despite this, the test norms represent an acceptable comparative sample for children with
SCD, which provide a more accurate representation of cognitive performance.
Norms, Measurement Approach, and Reliability of Cognitive Measures Used to Date
The psychometric properties of 30 identified neuropsychological measures and
relevant subtests, when reported, in the pediatric SCD literature indicate many measures
used to date have been lacking in one or more key dimensions. Age range was included
in this range because it is desirable for many clinical studies to be able to include a wide
range of ages. Method of test interpretation were included as an evaluation technique to
understand the whether the measure allows for more fine-grained analysis of cognitive
skills. Additionally, test retest and internal consistency were analyzed to understand the
psychometric reliability of each measure. Convergent validity was examined to assess
psychometric validity across neuropsychological measures. The quality of the normative
sample was reviewed with ten different criteria. The selected psychometric factors were
reviewed to inform the appropriateness of test selection for children with SCD (see Table
1.4).
Neuropsychological measures administered for this population encompass several
different age ranges. Overall, the age ranges of neuropsychological measures were
appropriate chosen for the study samples. However the WMS were utilized outside of the
intended psychometric age range by Watkins and colleagues (1989). The WMS suggested
for use with individuals age 16-89, nevertheless the authors utilized this measure to
understand memory functions in a sample of children with SCD mean age 10 years 6
months. Results reported that are associated with this measure should be interpreted with
caution due to the age range guidelines suggested with this instrument.
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The method of test interpretation within neuropsychological measures for
pediatric SCD is limited to the traditional and subtractive factors measurement
approaches. As described earlier, subtractive factors may be the more ideal method of
test interpretation for children with SCD due to within subject comparison to isolate
specific skills. However, it appears that only eight cognitive measures utilize this method
of interpreting examinee performance among pediatric SCD studies (see Table 1.4). For
some of these measures using subtractive factors were “experimental” (not normreferenced measures designed for individual-level interpretation in clinical contexts).
Specifically, use of these measures is accepted in the study contexts; however due to their
“experimental” nature most data regarding psychometric properties is not published. On
the contrary, it is clear that measures which utilize the traditional “achievement”
approach of understanding cognition have dominated the pediatric SCD literature.
There was extreme variability in reliabilities evaluated within and across the 30
measures selected for use with the pediatric SCD population. Several works were
consulted to describe statistically adequate measurement practices. Ultimately reliability
evidence was determined by recommendations by Strauss and colleagues (2006). Test
retest reliability coefficients were determined as: “Very High (≥.90), High (.80-.89),
Adequate (.70-.79), Marginal (.60-.69), Low (.50-.59), Extremely Low (≤.49).’’
Additionally, internal consistency reliabilities were set as: Excellent (α ≥ .9), Good (.9 >
α ≥ .8), Acceptable (.8 > α ≥ .7), Questionable (.7 > α ≥ .6), Unacceptable (.5 > α). In
general reliability coefficients ranged within measures from extremely low to high,
depending on the subscale of interest. For instance, The Self Ordered Pointing Test
reliability associated with test retest was adequate, whereas the internal consistency was
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high. Additionally the CVLT–II, long delay recall subtest has marginal test retest
reliability but excellent internal consistency. On average, when reported, test retest
reliability for the selected measures across the studies is adequate and internal
consistency is high. However, it should be noted, data was missing for many of the
subscales utilized to asses cognitive functioning. An example of this missingness is
evident in the Detroit Test Learning Aptitude 2nd ed. Reported test retest reliability varied
from adequate to very high and internal consistency from acceptable to excellent on this
instrument. However, specific subtest reliability coefficients for the measures shown to
be sensitive to SCD could not be obtained. Ideally, reporting of reliabilities would be
readily available and consistent with one another, such as in the case of the Decision
Speed subtest of the WJ-III. The test retest reliability is high and the internal consistency
is excellent.
Overall measures in this literature demonstrated a strong relationship to other
cognitive measures which measure the same features of EF (see Table 1.3). The
following convergent validity correlations established by Strauss et al. 2006 were utilized
for this review: Strong (.50 to 1.0), Moderate (.30 to .49), Low (.10 to .29). A few
neuropsychological measures diverge from the overall prevalence strong associations in
the research literature. For instance, measures such as CVLT–II, Gordon Continuous
Performance Task, Kagan Matching Familiar Figures Test, and Self Ordered Pointing
Test indicated moderate associated with similar tests of cognition. These modest
relationships are not surprising due to the nature of EF and measurement practices.
Additionally, the Tower of Hanoi and Wisconsin Card Sorting Test have low
associations, at best, with other measures of cognition. This finding is also not surprising
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given the concurrent and complex cognitive functions that are necessary to complete
these tasks.
Normative sample characteristics were evaluated by several factors to develop a
general set of quality guidelines (see Table 1.4). The guidelines created for this review
originated from recommendations for normative samples by Mitrushina and associates
(2005). The 10 criteria chosen describe the degree of support for the normative samples
utilized by each neuropsychological measure. Additionally, these guidelines include
cultural considerations indicated by Suzuki and Ponterotto (2008) relevant to the SCD
populations. Notably, evaluation of the quality criteria requires an extent of subjectivity
in judging psychometric standards. Norm quality consists of an analysis of: sample size,
representativeness of United States (US) census data, stratification, ethnicity by
stratification, geographic diversity, African American cultural effects, health condition,
special education inclusion, and exclusion/inclusion criteria. An analysis of these factors
resulted in a categorization of deficits on the following continuum “excellent ≥ 8 factors,
good ≥ 6 factors, adequate ≥ 4 factors, and poor ≤ 3.”
Normative samples from 13 of 25 test analyzed were reviewed to be of “poor”
quality (see Table 1.4). This status was the result of a combination of factors such as
small sample size, no representativeness from US census data, no stratification, limited
geographic diversity, strong African American cultural effects, etc. An example of a
neuropsychological measure with a designation of “poor” for the normative sample is the
Connors’s Continuous Performance Test. The clinical sample was comprised of 670
individuals who were stratified by eight age bands. This sample was not representative of
the US census and subjects were only selected from five US states and a province in
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Southern Ontario. The general health condition of the sample was not indicated and
children receiving special education were excluded from the sample. However, the
mental health status of the sample was reported and no ethnic/racial effects were reported
as well. This sample lacks the necessary properties to appropriately compare the
performance of children with SCD. A more appropriate measure, with a description of
“excellent” for the test norms is the WJ-III. The sample size is large, consisting of 5972
children stratified by both individual and community socioeconomic variables.
Additionally, the validation sample is geographically diverse, with individuals selected
from over 100 geographic regions within 27 US states. Similarly, comparable scores have
been evidenced for African American children when compared to their Caucasian peers.
Albeit, it is significant to mention the general health conditions of the sample were not
reported, the only exclusion criteria were less than one year of fluent English speaking.
Despite this, the test norms represent an acceptable comparative sample for children with
SCD, which provide a more accurate representation of cognitive performance.
Cognitive Measures and SCD Morbidity (Criterion Validity)
Neurologic damage caused from SCD related mechanisms often result in stroke,
silent infarcts, and cerebral blood flow abnormalities. In addition, general disease severity
factors such as anemia may also be related to brain health. Data were reviewed to identify
neuropsychological test sensitivity associated with different types of SCD disease effects.
The Stroke Prevention Trial in Sickle Cell Anemia identified the importance of
TCD intervention for children identified at high stroke risk. Three research studies have
been identified that address neuropsychological sensitivity for elevated TCD velocities
and performance on the Wechsler scales (Bernaudin et al., 2000; Kral et al., 2003; Kral &
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Brown, 2004). Bernaudin and collegues (2000) conducted an investigation which
examined the first study evidencing an effect of thrombocytosis and revealing that silent
stroke alone is not a factor of cognitive deficit when not associated with low hematocrit
or thrombocytosis. Results indicated cognitive deficits were observed in SCD patients
with a history of overt stroke and that cognitive deficits are apparent for children with
SCD and silent stroke evidenced by infarcts on MRI, severe chronic anemia, and elevated
TCD values. Another research team found that children diagnosed with SCD and
abnormal TCD values evidenced greater executive dysfunction than children with SCD
and conditional TCD values (Kral et al., 2003). It also appears that children with
abnormal TCD values and SCD performed differentially worse than children with
conditional and normal TCD values (Kral & Brown, 2004). Results from these studies
suggest that Wechsler scales are sensitive to cognitive deficits in children with SCD and
elevated TCD values.
Similarly, SCD researchers have begun to investigate the utility of the BRIEF in
evaluating cognitive functioning behaviors and SCD related neural mechanisms in the
pediatric SCD population. An early investigation of pediatric SCD and TCD revealed that
children diagnosed with SCD with normal TCD findings demonstrated better executive
functioning than children with SCD and conditional or abnormal TCD values (Kral,
Brown, Nietert, Abboud, Jackson, and Hynd, 2003). Kral and colleagues (2004) also
found that teacher ratings of children with SCD and abnormal TCD demonstrate poorer
cognitive functioning than children with SCD and conditional or normal TCD values.
More recently, Berg (2012) published findings which suggest that children with SCD
scored significantly lower than matched controls on the Metacognitive Index and Global
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Executive Composite scales of the BRIEF. Due to the low number of studies revealing
findings associated with neurologic test sensitivity and SCD morbidity, more research is
needed to understand the utility of the BRIEF in assessing pediatric SCD morbidity.
Six research studies indicated that the Wechsler Intelligence Scales, Woodcock
Johnson Cognitive Abilities, and D–KEFS were sensitive to the effects of pediatric SCD
severity. This was demonstrated by the measures showing decreased performance
associated with disease severity in comparison to healthy peers (Bernaudin, Verlhac,
Freard, Roudot-Thoraval, Benkerrou, et al., 2000, Schatz, 2004; Schatz et al., 2004;
Schatz et al, 2007; Kral, Brown, Nietert, Abboud, Jackson, MD*; and Hynd, 2003; Berg,
Edwards, and King, 2012). Among this small group of measures the WJ-III were shown
to have the strongest psychometric properties related to pediatric SCD, as reviewed above
(see Table 1.4).
It was also shown that the D–KEFS and WJ-III indicated decreased cognitive
performance associated with SCD status alone in five research studies (Goonan et al.,
1994; Puffer, Schatz, Roberts, 2007; 2010; Schatz et al., 2005). These findings are
believed to reflect disease-related neurologic problems that do not reveal themselves with
current clinical neuroimaging methods. As the D–KEFS is the only measure within this
body of literature to reflect the fairness guidelines for test practices, it is notable that
results converge for both the WJ-III and this measure. Additionally, the Wechsler Scales,
WJ-III, CVLT–II, and Wisconsin Card Sorting Test demonstrated test sensitivity for
children with SCD and evidence of CVA within 13 research studies. Children with SCD
and CVA evidenced greater deficits than healthy peers and children with SCD and silent
infarct on these measures. However, as demonstrated by table 1.4 and 1.5, the Wisconsin
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Card Sorting Task psychometrics was found to be low as well as the norm sample “poor.”
Consequently test use for SCD and CVA is not recommended for this measure.
Approximately a third of the research articles (n = 10) provided results which
indicate children with SCD and silent infarct demonstrated cognitive performance which
was sensitive to detection on the Wechsler Scales, WJ-III, CVLT–II, and the Children’s
Memory Scale. Children with SCD and silent infarct performed poorer than age-matched
peers and better than children with SCD and stroke on these neuropsychological
measures. Evaluation of the psychometrics and norm quality revealed that use of these
tests is supported for all three of these measures however; the WJ-III might be preferred
due to a better quality normative sample.
Additionally, across 19 studies, children with SCD and no abnormalities on MRI
revealed cognitive dysfunction which could be demonstrated on the following scales:
Wechsler Scales, WJ-III, Test, CVLT–II, Wisconsin Card Sorting Test, Trail Making
Test, KABC, D–KEFS, and the Children’s Memory Scales. With the exception of the
Trail Making Test, each of these measures is supported for use with children diagnosed
with SCD and cognitive deficits having normal MRI results. The exclusion of this
measure is based on the psychometric properties for the Trail Making Test. They were
revealed as adequate, but the normative sample was categorized as “poor” (see Table
1.4).
Neuropsychological measurement in pediatric SCD has limitations and strengths
associated with the potential use of particular measures. Limitations such as those
associated with utilizing tests such as Wisconsin Card Sorting and Trail Making Test
with this population are based on limitations in the test development, such as norm
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quality. The norm group for both measures is “poor,” which suggests that comparisons
made to these groups could result in inaccurate measurement of cognitive performance,
particularly for clinical decision making at the individual level. Additionally, the
psychometric properties reviewed only reached a threshold of adequate for these
measures. Acceptable reliability and validity does not promote recommendation for use
in the population when measures that achieved higher levels of reliability and validity are
available.
Across studies which address morbidity associated with pediatric SCD the WJ-III
and Wechsler Scales demonstrate the most consistent measurement sensitivity. However,
the psychometric and normative sample quality of the WJ-III surpasses the Wechsler
Scales for use with the pediatric SCD population (see Tables 4 and 5). Additionally,
when selected for use, the D–KEFS was found to detect SCD related morbidity at the
same rate as the WJ-III; however, the WJ-III is appropriate for a wider age range of
children (preschool through older adults) whereas the Delis Kaplan Executive Function
System is normed beginning at age eight years. The overall implication of this review of
psychometrics is that among measures used to date, the WJ-III excels in all areas except
in its use of a traditional, achievement approach to ability measurement.
Summary
The cognitive measurement practices for pediatric SCD studies and the
examination of psychometric properties for these cognitive measures associated with
pediatric SCD was identified. The purpose of these goals was to inform recommendations
for neuropsychological assessment batteries to use in future SCD research and treatment
studies. An examination of psychometric properties provided strong support for the
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assertion that the WJ-III was the most appropriate of the current cognitive assessment
batteries for use with pediatric SCD.
The most prominent theme demonstrated was the considerable inconsistencies in
tests use for neuropsychological assessment of children with SCD. Use of varied
cognitive measurement instruments has impacted the assessment of EF within both
research and treatment methodological designs. Table 1.1 revealed that 57 different
psychological measures have been used to better understand cognition in this special
population. Due to the wide range of instruments in the pediatric SCD research literature,
treatment research has been uninformed regarding the most appropriate cognitive
construct to focus on and which instruments should be used to measure the construct. The
use of many of these neuropsychological instruments in making clinical decisions would
be substandard scientific practices. Review of any psychometric tool prior to
administration is best practices for test administration (Groth-Marnat, 2003). It is
imperative that future research related to this body of literature utilize standard
instruments with more regularity to assess cognitive functioning the for pediatric SCD
population. This uniformity will promote a better understanding of cognition in pediatric
SCD.
It is also essential that treatment studies diverge from the common practice of
utilizing global IQ scores to assess cognitive performance in pediatric SCD. Future SCD
research efforts should take steps towards formulating a more comprehensive
understanding of both the broad and narrow abilities associated with EF. This transition is
important because children with SCD may demonstrate equivalent full scale IQ scores
pre/post treatment yet still have deficits in narrow abilities (Schatz et al., 2002). Left un-
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rehabilitated neurologic complications associated with pediatric SCD, have been shown
to impact educational attainment (King et al., 2006). Additionally, use of measurement
tools which assess a more complete picture of EF may further understanding of the
cognitive profile for these children.
Among the identified measures within the pediatric SCD literature, three
cognitive measurement batteries were utilized most often to evaluate neuropsychological
ability: The Wechsler scales, WJ-III, and the Differential Ability Scales (DAS)
assessment tools were shown to measure different components of cognition. These
neuropsychological tools focus on different factors related to cognitive theory and diverse
statistical practices to assess cognition. The WJ-III however, was the only theoretically
driven assessment tool which was designed to measures discrete cognitive abilities. The
other tools were largely developed to measure overall IQ with later delineation of narrow
abilities that might be assessed with the subtests. Therefore, the theoretical orientation
and capacity to measure various cognitive domains makes it a superior measurement
battery in comparison to the Wechsler Scales and the DAS. Furthermore, the WJ-III is a
good neuropsychological test to measure cognitive outcomes in treatment-focused
pediatric SCD studies. The WJ-III recommendation is due to relatively easy
administration procedures, better norms, and psychometrics for use with children who are
ethnic minority or from lower income backgrounds (two demographic factors
overrepresented in the SCD population). Thus, this cognitive battery should be utilized
as the standard of comparison for neuropsychological measurement in the pediatric SCD
field.
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Future directions for neuropsychological measurement in pediatric SCD field
include improvement in four areas. The first suggestion is that WJ-III should be
administered as the best available measure to assess cognition in pediatric SCD research
and treatment studies. Given the superior psychometric properties and excellent norm
sample quality, this measure could further understanding of cognition in pediatric SCD.
Secondly, measurement of narrow cognitive abilities should be included as outcomes for
research and treatment studies instead of broad level IQ scores. This shift from global to
specific measurement of cognition might help clinicians to glean a greater understanding
of cognition for children with pediatric SCD and may better delineate treatment benefits.
Finally, more sophisticated neuropsychological measurement tools should be developed
to assess cognition for children with SCD. For example, a limitation of the WJ-III is that
the underlying theory does not incorporate current knowledge of neuroscience and the
constructs used may not map well onto populations with neurologic deficits and therefore
may not be well suited to measuring specific changes in brain function (e.g., in treatment
studies). A useful approach may be to compare the WJ-III to experimental measures of
EF that have well known neural correlates. Comparative analysis of experimental
measures to this “standard” will help the field develop more accurate measurement for
children with pediatric SCD. The purpose of the present research study is to address
afore mentioned suggestions.
An experimental EF assessment tool, the “EXAMINER” will be utilized to
compare sensitivity and specificity relative to the WJ-III, measure cognitive narrow
abilities, and asses its appropriateness for use with the pediatric SCD population. More
specifically, this new EF battery will be psychometrically evaluated, assessment of its
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differential sensitivity compared with the WJ-III, and the cultural validity of this
instrument will be investigated for the measurement of cognitive deficits associated with
pediatric SCD.
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Table 1.1
Overview of Executive Function Measures Included in Sickle Cell Disease Literature
Reference

Neuropsychological Test

Acronyms

EF Domain

Thompson et al., 2002

Bayley Scales of Infant
Development III

BSID-II

Mental, Motor, and Behavioral
Development

Puffer et al., 2010
Brown et al., 2000
Cohen et al., 1994
Brown et al., 1993
Swift et al., 1989

Beery-Buktenica Developmental
Test of Visual-Motor Integration

B-VMI

Visual-Motor Deficits

Schatz et al., 2004
Schatz et al., 2001
Schatz et al., 1999
DeBaun et al., 1998

Benton Judgment of Line
Orientation

BJLO

Visuospatial Judgment

Craft et al., 1993

Benton Visual Retention Test

BVRT

Visual Perception, Visual
Memory, Visuoconstructive
Abilities

Craft et al., 1993

Benton Word Fluency Test

BWF

Speed and Ease of Verbal
Production

Brown et al., 2000
Schatz et al., 2001
Cohen et al., 1994

Boston Naming Test

BNT

Word Retrieval Performance

Berg et al., 2012
Kral et al., 2003
Kral et al., 2004

Behavior Rating Inventory of
Executive Function

White et al., 2006
Brandling-Bennett et
al., 2003
Schatz et al., 2001
Schatz et al., 1999
DeBaun et al., 1998
Schatz et al., 2001
Brown et al., 2000

California Verbal Learning Test –
Children

Schatz et al., 1999
Craft et al., 1993

Children’s Auditory Verbal
Learning Test

CAVLT

Verbal Learning and Memory

Berg et al., 2012

Children’s Kitchen Task
Assessment

CKTA

Executive Functioning

Kral et al., 2003
White et al., 2006
Brandling-Bennett et
al., 2003
Brown et al., 1993

Children’s Memory Scale

CMS

Learning and Memory

Conner’s Continuous
Performance Task

CPT

Attention and Impulsivity

i

BRIEFParent Form

Cancellation of A’s Task

CVLT-C

CAT
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Parent Observation of Executive
Function Behaviors

Verbal Learning and Memory

Visuospatial Function and
Attention

Reference

Neuropsychological Test

Acronyms

EF Domain

Kral et al., 2003

Conner’s Continuous
Performance Task II

CPT-II

Craft et al., 1994

Covert Orienting Task

COT

Sustained Visual Task

Schatz et al., 2007

Delayed Response Task

DRT

Spatial Working Memory and
Inhibition Processes

Berg et al., 2012
Puffer et al., 2007
Schatz et al., 2006
Schatz et al., 2005
ii
Schatz et al., 2004
Schatz, 2004
Cohen et al., 1994
Swift et al., 1989

Delis-Kaplan Executive Function
System

DKFS

Higher Level Cognitive Functions

Detroit Test of Learning
Aptitude II

DTLA-II

Specific Mental Abilities

Schatz et al., 2007

Denver Developmental
Screening Test II

DDST-II

Cognitive and Behavioral
Problems

Tarazi et al., 2007

Developmental
NeuroPsychological Assessment

NEPSY

Neuropsychological
Development

Steen et al., 2002

Developing Skills Checklist

DSC

Wide Range of Skills

Tarazi et al., 2007
a
Schatz et al., 2004
Schatz et al., 2002
Schatz et al., 2001
Schatz et al., 1999
DeBaun et al., 1998
a
Schatz et al., 2004

Differential Ability Scales

DAS

Variety of Cognitive Abilities

Divided Hierarchical Attention
Task

DHAT

Attention and Impulsivity

Divided Attention

Brown et al., 1993

Expressive One Word
Vocabulary Test

Cohen et al., 1994
Craft et al., 1993

Finger Tapping

Cohen et al., 1994

Finger Tip Number Writing

Cohen et al., 1994

Gray Oral Reading Test –
Revised

Brown et al., 1993
Fowler et al., 1988

Kagan Matching Familiar Figures
Test

MFFT

Attention and Impulse Control
(Cognitive Tempo)

Goonan et al., 1994

Gordon’s Continuous
Performance Task

GCPT

Selective Attention and
Impulsivity

Puffer et al., 2010
Brown et al., 2000
Cohen et al., 1994
Brown et al., 1993
Swift et al., 1989

Kaufman Assessment Battery for
nd
Children 2 ed.

KABC-II

Cognitive Development

Koenig, Reiss, and Kosslyn’s
Categorical and Coordinate
Spatial Judgment Task

KRKCSI

Categorical and Coordinate
Spatial Judgment

Schatz et al., 2004

a

EVT

Oral Language

FT

Motor Speed

FTNW

GORT=R
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Complex Tactile Perception and
Concentration
Oral Reading Growth and
Difficulties

Reference

Neuropsychological Test

Acronyms

Bernaudin et al., 2000

l’Alourette French Reading Test

LFMT

Reading Achievement

Wasserman et al.,
1991

Luria-Nebraska
Neuropsychological Battery

LNNB

Neuropsychological Impairment

Schatz et al., 2007

MacArthur Communication
Development Inventory

CDI

Language and Communication
Skills

White et al., 2000

Memory Span

MS

Short Term Memory

Mini Mental Status Examination

MMSE

Mental Impairment

Schatz et al., 2004
Schatz et al., 2001
Brown et al., 1993
Schatz et al., 1999
DeBaun et al., 1998
Brown et al., 1993

Peabody Picture Vocabulary
Test Revised

PPVT-R

Receptive Language

Tarazi et al., 2007
Bernaudin et al., 2000
Brown et al., 2000
Armstrong et al., 1996
Cohen et al., 1994

Purdue Pegboard Test

PPT

Fine and Gross Motor Dexterity
and Coordination

Schatz et al., 2001
Brown et al., 2000

Rapid Automatized Naming

RAN

Ability to Read, Phonological
Awareness, and Verbal IQ,

Schatz et al., 2006
Schatz et al., 2005

Self-Ordered Pointing Test

SOPT

Behavior by Using Plans and
Strategies

Craft et al., 1993
a

a

EF Domain

Schatz et al., 2004
DeBaun et al., 1998

Simple Reaction Time

Brown et al., 1993

Stanford Binet IV

Schatz et al., 2001
Schatz et al., 1999
DeBaun et al., 1998

Test of Variables of Attention

Cohen et al., 1994

Test of Visual Perceptual Skills

Puffer et al., 2010

Test of Language Development –
rd
Primary Version, 3 ed.

Cohen et al., 1994

Test of Visual-Perceptual Skills

TVPS

Visual Perceptual Strengths and
Weaknesses

Schatz et al., 1999

Tower of Hanoi

TOH

Problem Solving, Executive
Function Deficits

Kral et al., 2003

Trail Making Test

TMT

Visual Attention and Task
Switching

SRT
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Motor Skills

SB-IV

Cognitive Ability

TOVA

Attention Disorders

TVPS

Visual Perceptual Strengths and
Weaknesses

TOLD III

Language Development

Reference

Neuropsychological Test

Acronyms

EF Domain

Puffer et al., 2007
Schatz et al., 2006
Steen et al., 2005
Schatz et al., 2005
Schatz, 2004
b
Schatz et al., 2004
Steen et al., 2003
Boni et al., 2001
Schatz et al., 2001
Wang et al., 2001
Bernaudin et al., 2000
Brown et al., 2000
Steen et al., 1999
Steen et al., 1998
Watkins et al., 1998
Berg et al., 2012

Wechsler Intelligence Scale for
rd
Children 3 ed.

WISC-III

Cognitive Ability

Wechsler Intelligence Scale for
th
Children 4 ed.

WISC-IV

Cognitive Ability

Steen et al., 2003
Wang et al., 2001
Steen et al., 1998
Armstrong et al., 1996
Knight et al., 1995
Cohen et al., 1994
Craft et al., 1993
Wasserman et al.,
1991
Swift et al., 1989

Wechsler Intelligence Scale for
Children Revised

WISC-R

Cognitive Ability

Watkins et al., 1998

Wechsler Memory Scale

Watkins et al., 1998

Wechsler Preschool and Primary
Scale of Intelligence Revised

WPPSI-R

Cognitive Ability

Tarazi et al., 2007

Wechsler Preschool and Primary
rd
Scale of Intelligence 3 ed.

WPPSI-III

Cognitive Ability

Kral et al., 2003
Kral et al.,2004
White et al., 2006
Schatz et al., 2002
Knight et al., 1995

Wechsler Abbreviated Scale of
Intelligence

WAIS

Cognitive Ability

White et al., 2006

Wechsler Individual
Achievement Test

WIAT

Academic Strengths and
Weaknesses

Cohen et al., 1994

Wepman Auditory
Discrimination Test

WADT

Auditory Discrimination

Schatz et al., 2004

Puffer et al., 2010

b

WMS

Woodcock-Johnson
Psychoeducational Test Battery
Woodcock-Johnson
Psychoeducational Test
Battery III

WJ

WJ-III
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Memory Functions

Cognitive Abilities, Scholastic
Aptitude, and Academic
Achievement
Cognitive Abilities, Scholastic
Aptitude, and Academic
Achievement

Reference

Neuropsychological Test

Acronyms

Kral et al., 2003
Puffer et al., 2007
Schatz et al., 2005
Schatz, 2004
a
Schatz et al., 2004
Wang et al., 2001
Schatz et al., 2001
Brown et al., 2000
Schatz et al., 1999
DeBaun et al., 1998
Armstrong et al., 1996
Craft et al., 1993
Swift et al., 1989

Woodcock-Johnson
Psychoeducational Test Battery
Revised

WJR

EF Domain

Cohen et al., 1994
Wasserman et al.,
1991
Fowler et al., 1988

Wide Range Achievement Test
Revised

WRAT-R

Achievement Test

Schatz et al., 2001

Wide Range Assessment of
Memory and Learning

WRAML

Memory Functions

Schatz et al., 2001
Schatz et al., 1999
DeBaun et al., 1998

Wisconsin Card Sorting Test

WCST

Ability to Display Flexibility in
the Face of Changing Schedules
of Reinforcement

Berg et al., 2012

Children's Kitchen Task
Assessment

CKTA

Initiation, Sequencing, Safety
Judgment, Organization,
Working Memory

Cognitive Abilities, Scholastic
Aptitude, and Academic
Achievement

Cognitive tests utilized for analysis of Executive Functioning across pediatric SCD literature.
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Table 1.2.
Descriptive Table of Pediatric Sickle Cell Disease Studies with Executive Function
Measures
Norms: Participant
Group
Characteristics

Age
SCD
(mean)

n
SCD

n
Control
s

Reference

Measure

Armstrong
et al., 1996

Purdue Pegboard Test
Wechsler Intelligence Scale for Children
Revised
Woodcock Johnson Revised

Std Norms: SCD –
Normal MRI vs.
Silent Infarct vs.
CVA

6.1

n=
194

n/a

Berg et. al.,
2012

Delis-Kaplan Executive Function System
Wechsler Intelligence Scale for Children
IV
Behavior Rating Inventory of Executive
Function
Children’s Kitchen Task Assessment
144: French Memory Scale

Local/Std Norms:
SCD – Normal

10.2

n=
22

n = 22

Bernaudin
et al., 2000

Batterie d'Efficience Mnesique
l’Alourette French Reading Test
Purdue Pegboard Test
Wechsler Intelligence Scale for Children
III

Local/Std Norms:
SCD –
Abnormal MRI vs.
Abnormal TCD vs.
Low Hematocrit
vs. Siblings

10.2

n=
173

n = 76

Boni et al.,
2001

Wechsler Intelligence Scale for Children
III

Std Norms: SCD –
CVA and HbSS vs.
Normal MRI and
HbSS vs. Normal
MRI and HbSC

11.4

n=
52

n/a

BrandlingBennett et
al., 2003

California Verbal Learning Test for
Children – Children’s Version
Children’s Memory Scale

Std Norms: SCD Abnormal MRI vs.
Normal MRI

12.9

n=
83

n/a

Brown et
al., 2000

Cancellation A’s Task
Trails Making Test (B)
Wechsler Intelligence Scale for Children
III
Woodcock Johnson Revised

Local/ Std Norms:
SCD - CVA vs.
Silent stroke vs.
Normal MRI

9.8

n=
63

n/a
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Reference

Measure

Norms: Participant
Group
Characteristics
Local/ Std Norms:
SCD vs. Siblings

Age
SCD
(mean)
10.4

n
SCD

Brown et
al., 1993

Beery-Buktenica Developmental Test of
Visual-Motor Integration
Continuous Performance Task
Expressive One Word Vocabulary Test
Kagan Matching Familiar Figures Test
Kaufman Assessment Battery for
Children 2nd ed.
Peabody Picture Vocabulary Test
Revised
Picture Vocabulary Test
Stanford Binet IV

Cohen et
al., 1994

Beery-Buktenica Developmental Test of
Visual-Motor Integration
Boston Naming Test
Finger Tapping
Finger Tip Number Writing
Kaufman Assessment Battery for
Children 2nd ed
Purdue Pegboard Test
Test of Visual-Perceptual Skills
Wechsler Intelligence Scale for Children
Revised
Wepman Auditory Discrimination Test
Wide Range Achievement Test Revised

Local/ Std Norms:
SCD - Left
Cerebral Infarct vs.
Right Cerebral
Infarct

9.96
years

n=
10

n/a

Craft et al.,
1994

Covert Orienting Task

Local: SCD - no
CVA vs. Bifrontal
Lesions vs. Diffuse
Lesions vs. Siblings

10.7

n=
29

n = 20

Craft et al.,
1993

Benton Verbal Fluency Test
Benton Visual Retention Test
Children’s Auditory Verbal Learning Test
Finger Tapping
Mini Mental Status Examination
Wechsler Intelligence Scale for Children
Revised
Woodcock Johnson Revised

Local/Std Norms:
SCD – CVA with
Anterior Lesions
vs. CVA with
Diffuse Lesions vs.
CVA with Normal
MRI vs. Siblings

7.51

n=
39

n = 20

DeBaun et
al., 1998

Benton Judgment of Line Orientation
Benton Visual Form
California Verbal Learning Test –
Children
Choice Reaction Time Task
Differential Ability Scales
Multilingual Aphasia Examination
Peabody Picture Vocabulary Test
Revised
Simple Reaction Time
Test of Variables of Attention
Wisconsin Card Sorting Test
Woodcock Johnson Revised
Discrimination

Local/Std Norms:
SCD – Silent Stroke
vs. Overt Stroke vs.
Siblings

11.5

n=
28

n = 17

59

n=
88

n
Control
s
n/a

Reference

Measure

Fowler et
al., 1988

Beery-Buktenica Developmental Test of
Visual-Motor Integration
Kagan Matching Familiar Figures Test
Wechsler Intelligence Scale for Children
Revised
Wide Range Achievement Test

Goonan et
al., 1994

Gordon’s Continuous Performance Task
Kagan Matching Familiar Figures Test

Knight et
al., 1995

Wechsler Intelligence Scale for Children
Revised
Wechsler Abbreviated Scale of
Intelligence

Kral et al.,
2003

Behavior Rating Inventory of Executive
Function
Children's Memory Scale
Conners’s Continuous Performance Test
II
Trail Making Test
Wechsler Abbreviated Scale of
Intelligence
Wechsler Intelligence Scale for Children
III

Kral et al.,
2004

Puffer et
al., 2010

Norms: Participant
Group
Characteristics
Std Norms: SCD –
No Stroke vs.
Healthy Peers

Age
SCD
(mean)
12.8

Local/ Std Norms:
SCD – No CVA vs.
Sibling
Std Norms: SCD vs.
Healthy Peers

11.5

n=
24

n = 11

16.85

n=
60

n = 60

10.6

n=
25

n = 35

Std Norms: SCD vs.
Normal

n
SCD
n=
28

n=0

10.1
n=
62

Std Norms: SCD –
TCD status Normal
vs. Conditional vs.
Abnormal

Woodcock-Johnson Psychoeducational
Test Battery Revised
Behavior Rating Inventory of Executive
Function: Parent/Teacher
Wechsler Abbreviated Scale of
Intelligence
Beery-Buktenica Developmental Test of
Visual-Motor Integration
Kaufman Assessment Battery for
Children 2nd ed.
Test of Language Development, 3rd. ed.
Woodcock-Johnson Psycho-educational
Test Battery III

n
Control
s
n = 28

Std Norms: SCD –
SCD vs. Healthy
Peers

6.5

n=
64

n = 81

Puffer et
al., 2007

Delis-Kaplan Executive Function System
Wechsler Intelligence Scale for Children
III
Woodcock Johnson Revised

Std Norms: SCD Hydroxyurea
Therapy vs.
Without

13.2

n=
65

n/a

Schatz,
2004

Delis-Kaplan Executive Function System
Woodcock Johnson Revised

Std Norms: SCD vs.
Healthy Peers

11.6

n=
50

n = 36

Schatz et
al., 2006

Delis-Kaplan Executive Function System
Self-Ordered Pointing Test
Wechsler Intelligence Scale for Children
III

Local/ Std Norms:
SCD - No Lesion vs.
Silent Infarct vs.
Overt Stroke vs.
Healthy Peers

12.8

n=
28

n = 16
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Reference

Measure

Schatz et
al., 2001

Benton Judgment of Line Orientation
Boston Naming Test
California Verbal Learning Test for
Children – Children’s Version
Test of Variables of Attention Wisconsin
Card Sorting Test
Cancellation A’s Task
Differential Ability Scales Peabody
Picture Vocabulary Test Revised
Rapid Automatized Naming Trail Making
Test
Wechsler Intelligence Scale for Children
III
Woodcock-Johnson Psychoeducational
Test Battery Revised

Schatz et
al., 2004iii

Benton Judgment of Line Orientation
Differential Ability Scales
Simple Reaction Time
Woodcock-Johnson Psychoeducational
Test Battery Revised
Peabody Picture Vocabulary Test
Revised
Treisman and Gelade (1980) Parallel and
Serial Visual Search Task
Koenig, Reiss, and Kosslyn’s Categorical
and Coordinate Spatial Judgment Task
Benton Judgment of Line Orientation
California Verbal Learning Test –
Children
Differential Ability Scales
Peabody Picture Vocabulary Test
Revised
Test of Variables of Attention Tower of
Hanoi
Wisconsin Card Sorting Test
Woodcock-Johnson Psychoeducational
Test Battery Revised

Schatz et
al., 1999

Norms: Participant
Group
Characteristics
Local/Std Norms:
SCD – Silent
Cerebral Infarcts
vs. Without Infarct
vs. Siblings

Age
SCD
(mean)
10.8

Local/ Std Norms:
SCD - Unilateral
Left Brain Injury vs.
Unilateral Right
Brain Injury vs.
Bilateral Brain
Injury vs. Siblings

12.8

n=
42

n = 43

Local/Std Norms:
SCD – Anterior
Cerebral Infarct vs.
Diffuse Cerebral
Infarct vs. Siblings

12.7

n=
28

n = 17

n
SCD
n=
64

n
Control
s
n = 16

Schatz et
al., 2004iv

Delis-Kaplan Executive Function System
Wechsler Intelligence Scale for Children
III
Woodcock-Johnson Psychoeducational
Test Battery Revised

Std Norms: SCD vs.
Healthy Peers

11.6

n=
50

n = 36

Schatz et
al., 2005

Delis-Kaplan Executive Function System
Self-Ordered Pointing Test
Wechsler Intelligence Scale for Children
III
Woodcock-Johnson Psychoeducational
Test Battery Revised

Local/ Std Norms:
SCD vs. Healthy
Peers

11.4

n=
25

n = 25
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Norms: Participant
Group
Characteristics
Local/ Std Norms:
SCD - High
Neurologic Risk vs.
Low Neurologic
Risk
Std Norms: SCD Silent Infarct Cases
vs. No Infarct
Cases

Age
SCD
(mean)
2.2

12

n=
25

n/a

Wechsler Intelligence Scale for Children
Revised
Wechsler Intelligence Scale for Children
III

Std Norms: SCD vs.
Healthy Peers

10.9

n=
54

n=
2200

Steen et
al., 2002

Developing Skills Checklist

Std Norms: SCD vs.
Healthy Peers

5.6

n=
34

n = 68

Steen et
al., 2003

Wechsler Intelligence Scale for Children
III
Wechsler Intelligence Scale for Children
Revised
Wechsler Intelligence Scale for Children
III
Wechsler Intelligence Scale for Children
Revised

Std Norms: SCD Abnormal MRI vs.
Normal MRI

9.5

n=
49

n/a

Std Norms: SCD –
No MRI
Abnormalities vs.
Abnormal MRI vs.
Healthy Peers

8.4

n=
30

n = 24

Reference

Measure

Schatz et
al., 2007

Delayed Response Task
Denver Developmental Screening Test II
MacArthur Communication
Development Inventory

Schatz et
al., 2002

Differential Ability Scales
Wechsler Abbreviated Scale of
Intelligence

Steen et
al., 2005

Steen et
al., 1998

n
SCD
n=
61

n
Control
s
n/a

Steen et
al., 1999

Wechsler Intelligence Scale for Children
III

Std Norms: SCD vs.
Healthy Peers

10.6

n=
50

n = 52

Swift et al.,
1989

Wechsler Intelligence Scale for Children
Revised
Woodcock-Johnson Psychoeducational
Test Battery Revised
Kaufman Assessment Battery for
Children 2nd ed.
Detroit Test of Learning Aptitude II
Beery-Buktenica Developmental Test of
Visual-Motor Integration

Std Norms: SCD
with no CVA vs.
Siblings

11.5

n=
21

n = 21

Differential Ability Scales Wechsler
Preschool and Primary Scale of
Intelligence Revised PPT
Developmental NeuroPsychological
Assessment

Std Norms: SCD –
No History of
Stroke

4.3

n=
28

n/a

Bayley Scales of Infant Development III

Std Norms: SCD –
HbSS vs.
HbSC/Other

1.8

n=
89

n/a

Tarazi et
al., 2007

Thompson
et al., 2002

62

Norms: Participant
Group
Characteristics
Std Norms: SCD Abnormal MRI vs.
Normal MRI

Age
SCD
(mean)
8.1

Luria-Nebraska Neuropsychological
Battery
Wechsler Intelligence Scale for Children
Revised
Wide Range Achievement Test Revised

Std Norms: SCD vs.
Siblings

11.5

n=
43

n = 30

Watkins et
al., 1998

Wechsler Intelligence Scale for Children
III
Wechsler Memory Scale
Wechsler Preschool and Primary Scale of
Intelligence Revised
Wisconsin Card Sorting Test

Std Norms: SCD –
CVA vs. No CVA
and Silent Infarct
vs. No CVA and
Normal MRI vs.
Siblings

10.62

n=
41

n = 15

White et
al., 2006

Wechsler Abbreviated Scale of
Intelligence
Wechsler Individual Achievement Test
California Verbal Learning Test –
Children
Children’s Memory Scale

Std Norms: SCD Abnormal MRI vs.
Normal MRI

11.95

n=
65

n/a

White et
al., 2000

Memory Span

Local: SCD:
11.7
History of Stroke
vs. No History)
Descriptive information for the selected studies utilized in the literature review.

n=
31

n/a

Reference

Measure

Wang et
al., 2001

Wechsler Intelligence Scale for Children
III
Wechsler Intelligence Scale for Children
Revised
Woodcock-Johnson Psychoeducational
Test Battery Revised

Wasserma
n et al.,
1991

63

n
SCD
n=
373

n
Control
s
n/a

Table 1.3.
Review of the Prominent Executive Function Psychometrics
Measure & Subtest

Type of Test

Age Range

Behavior Rating
Inventory of
Executive Function

Traditional

5-18 years

Test-Retest
Reliability
Good

California Verbal
Learning Test –
Children

Traditional

5-16 years

Marginal

-Long Delay Free
Recall

Convergent
Validity
Child Behavior
Checklist

California Verbal
Learning Test:
Moderate

Norm Quality
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Subtractive
Factors

Children’s Auditory
Verbal Learning Test

Traditional

7-17 years

Children’s Memory
Scale

Traditional

5-16 years

Reference

Adequate

Gioia, et al. 2000

Adequate

Diller, 1974

Excellent

Cancellation A’s
Task

-Backwards Digit
Span

Internal
Consistency
Good

Van der Elst et al., 2005

DATA NOT REPORTED

Good

Good

CVLT: Strong

Wechsler Memory Scale
III: Strong

High

High

Good

Adequate

Kennepohl et al., 2004
Schmidt, 1996
Tally, 1990
Cash, 2009
Cohen, 1997
Strauss et al., 2006

Measure & Subtest

Type of Test

Age Range

Children’s Kitchen
Task Assessment

Traditional

Choice Reaction
Time Task

Subtractive
Factors

Conner’s Continuous
Performance Task

Subtractive
Factors

6-55+ years

-II

Subtractive
Factors

6-55+ years

8-12 years

Test-Retest
Reliability
Moderate

Internal
Consistency
High

Convergent
Validity
BRIEF: Parent

Norm Quality
Poor

DATA NOT REPORTED

Adequate

Moderate

Reference
Rocke et al., 2008

Canavan et al., 1974

Not
Reported

Posner Visual Orienting
Task: Strong

Poor

Conners, 1994

Modest

Beery Test of Visual
Perception: Acceptable

Poor

Strauss, Sherman, & Spreen,
2006

65

Memory Span

Traditional

DATA NOT REPORTED

Gihooly et al., 1980

Mental Status
Examination –
Auditory Vigilance

Interview

DATA NOT REPORTED

Strub et al., 1977

Multilingual Aphasia
Examination

Traditional

6-12 and
16-97 years

DATA NOT REPORTED

Boston Naming Test
and Wechsler
Abbreviated Scale of
Intelligence Revised
– Verbal subtests:
High

Poor

Schum et al., 1989

Odd Man Out

Traditional

22-79

DATA NOT REPORTED

Cattell Culture Fair
Intelligence
Quotient: Strong

Poor

Pomati et al., 1996
Diascro et al., 1994
Frearson et al., 1986

Self-Ordered Pointing

Subtractive
Factors

5-11 years

Go-No-Go:
Moderate

Poor

Strauss et al., 2006
Archibald et al., 1999
Petrides et al., 1982
Green et al. 1990

Kaufman
Assessment Battery
for Children: Strong

Good

Thorndike et al., 1986

Stanford Binet IV

Traditional

2-23 years

Adequate

High

Measure & Subtest
Test of Variable of
Attention

Type of Test

Age Range

Traditional

4-19 years

-Reaction Time
Tower of Hanoi

Trail Making Test

Internal
Consistency
Moderate to
High

Convergent
Validity
Criteria for ADHD in
the Diagnostic and
Statistical Manual of
Mental Disorders
th
4 : Strong

Norm Quality
Poor

Reference
Riccio et al., 2001
Dupuy Cenedela, 2000
McCarney et al., 1990

Very High
Puzzle

7+

Subtractive
Factors

9-14 and
15-89 years

66

-B

Wechsler Abbreviated
Scale of Intelligence

Test-Retest
Reliability

Traditional

6-89 years

Low

Unacceptable

Tower of London:
Low

Moderate to
High

Digit Modality Test:
Moderate

Adequate

Acceptable

Wisconsin Card
Sorting Test and
Visual Search and
Attention and Test:
Strong

Good

Good

Kaufman Brief
Intelligence Test:
Strong

Not Reported

Bishop et al., 2001
Welsh et al., 2000
Klahr et al., 1981

Poor

Strauss et al., 2006
Lucas et al., 2005
Kennepohl et al., 2004
Lee et al., 2000

Adequate

Wechsler, 1999

Measure & Subtest

Type of Test

Age Range

Wechsler Intelligence
rd
Scale for Children 3
ed.

Traditional

6-16 years

-Digit Span Backwards

Test-Retest
Reliability

Internal
Consistency

High

Acceptable

-Coding

Adequate

Excellent

-Picture Arrangement

Adequate

Questionable

Convergent
Validity
WPPSI-R, WISC-R,
WAIS-R, Differential
Ability Scales: Very
Strong

Norm Quality
Adequate

Reference
Canivez et al., 1999
Wechsler, 1997

-Symbol Search
Adequate

Moderate

-Freedom from
Distractibility

Adequate

Adequate

-Processing Speed

Adequate

Adequate

Adequate

Good

Adequate

Good

Good

Good
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Traditional

6-16

th

-4 edition
Traditional

-Digit Span Backwards
-Digit Span Forwards

WPPSI-III, WISC-III,
WAIS-III,: Very Strong

Good

Wechsler, 2003

Stanford-Binet:
Moderate

Poor

Woodcock, et al., 1977

3-80 years

Test-Retest
Reliability

Internal
Consistency

Convergent
Validity

-Visual Matching

Adequate

Moderate

Wechsler Intelligence
Scale for Children

-Spatial Relations

High

Moderate

Revised: Strong

-Category Fluency

Adequate

Moderate

-Digit Span
Test:
Woodcock Johnson
Psycho-Educational
Battery III

Marginal

Moderate

Measure & Subtest

Type of Test

Age Range

Norm Quality

Reference

Woodcock Johnson
Psycho-Educational
Battery

Traditional

2-90 years

68

Standford Binet IV &
Kaufman Adolescent
and Adult Intelligence
Test: Strong

-Decision Speed
-Memory for Words
Woodcock Johnson
Psycho-Educational
Battery Revised

Traditional

High

Excellent

Adequate

Good

2-90 years

Assessment Battery
and Wide Range
Achievement Test:
Strong

Sub-Tests:
-Visual Matching

Adequate

Excellent

-Processing Speed

Adequate

Excellent

-Spatial Relations
Test:
Wisconsin Card
Sorting Test

High

Good

Low to
Marginal

DATA NOT
REPORTED

Traditional

5-89 years

Woodcock, et al., 2001
Excellent

Trails Making Test B:
Marginal

Woodcock, et al., 1989

Poor

Boone, 1999
Ariffa et al., 1998
Boone et al., 1993
Axelrod et al., 1992

Notes: Test Retest Reliability Coefficients: Very High (≥.90), High (.80-.89), Adequate (.70-.79), Marginal (.60-.69), Low (.50-.59), Extremely Low (≤.49)
Internal Consistency: Excellent (α ≥ .9), Good (.9 > α ≥ .8), Acceptable (.8 > α ≥ .7), Questionable (.7 > α ≥ .6), Unacceptable (.5 > α)
Convergent Validity Correlations: Strong (.50 to 1.0), Moderate (.30 to .49), Low (.10 to .29)
Norm Quality: Sample descriptive: number, age, geographic location, gender, race/ethnicity, education (parental), inclusion criteria (special education, gifted): high, adequate,
poor

Psychometric properties of neuropsychological measures included in literature review.
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Table 1.4.
Complete Normative Sample Psychometric Considerations

Measure
&
Reference

Pediatric
Sample
Size

Sample
Representative
of US Census

Behavior
Rating
Inventory of
Executive
Function

n = 1,419

Yes

Age
Bands

No

Males
generally
higher
ratings for
Inhibition

Yes

Random
Age,
Location,
Parent
Educatio
n,
Gender,
Race/
Ethnicity

No

Minimal,
overall
females
outperform
males

Sample
Stratified

Ethnicity
Stratified
by SES

Gender
Effects

Gioia, et al.,
2000
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African
American
Cultural
Effects

Sample
General
Health
Condition
Reported

Children
Receiving
Special
Education
Included

Maryland
public and
private
schools
26.5%
urban, 59%
suburban,
14.5% rural

Unknown

Yes

No

Public and
Private
Schools in
Western,
North,
Central,
Northeast,
Southern US

Unknown

No

Yes

Sample
Geographic
Diversity

Sample Criteria

Exclusion: Special
Education or
Psychotropic
Medication

n = 920
California
Verbal
Learning
Test –
Children
Delis et al.,
1994
Cancellation
A’s Task
Diller, 1974

DATA NOT REPORTED

Exclusion: English
Fluency

Measure
&
Reference
Children’s
Auditory
Verbal
Learning
Test

Pediatric
Sample
Size

Sample
Representative
of US Census

Sample
Stratified

MetaNorms:
Children
n = 80900

Yes

Age
Bands

n = 1000

Yes

Age
Bands

Ethnicity
Stratified
by SES
No

Van der
Elst et al.,
2005

71

Children’s
Memory
Scale

No

Gender
Effects

Sample
Geographic
Diversity

Canavan
et al., 1974

Sample
General
Health
Condition
Reported

Children
Receiving
Special
Education
Included

Sample Criteria

A female
Advantage
has been
Shown in
Recall and
Recognition
Trials

International

Lower Levels
of
Acculturation
are Linked to
Lower Scores

Yes

No

Exclusion:
Learning
Disabilities,
Attention
Disorders,
Special
Academic
Assistance, Very
High or Low
Academic
Performance

Not Reported

National

Minimal if
Parent
Education is
Controlled

No

No

Exclusion:
Below grade
level reading,
grade
repetition,
special
education,
neurologic
disorder, and
head injury

Strauss et
al., 2006

Choice
Reaction
Time Task

African
American
Cultural
Effects

DATA NOT REPORTED

Measure
&
Reference
Conner’s
Continuous
Performan
ce Task
Conners ,
1994
Controlled
Oral Word
Association
Test

Pediatric
Sample
Size
n=
1190

Sample
Representative
of US Census

Sample
Stratified

Ethnicity
Stratified
by SES

Sample
General
Health
Condition
Reported

Children
Receiving
Special
Education
Included
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No

Not
Reported

5 states and
Southern
Ontario

Not Reported

No

No

Exclusion:
“Outliers” on
Attentional
Diagnoses and
those Taking
Psychotropic
Medication

No

Age
Bands

No

Overall
Females
Shown to
Outperform
Males

Melbourne
Australia

Scores shown
to be less than
Caucasian
Peers

No

No

Exclusion:
English as
Second
Language,
History of
Neurological,
Sensory,
Developmental
Disorders

Not Reported

No

No

Sensory
Limitations,
Substance
Abuse, Medical,
Psychiatric, or
Motor
Condition

Note:
Clinical
n = 670
n = 422

Sample Criteria

8 Age
Bands

Note: Age
Bands 14
and 15
contain
less than
20
children

Delayed
Response

Delis et al.,
2001

African
American
Cultural
Effects

No

Anderson
et al., 1997

DelisKaplan
Executive
Function
System

Gender
Effects

Sample
Geographic
Diversity

DATA NOT REPORTED

n = 750

Yes

Random
Age,
Gender,
Race/
Ethnicity,
Education
Level

No

Not
Reported

38 States

Measure
&
Reference
Detroit Test
of Learning
nd
Aptitude 2
Edition

Pediatric
Sample
Size
n=
1532

Sample
Representative
of US Census
No

Hammill et
al., 1985

Sample
Stratified

Missing
Information
for Sample
Ethnicity,
Age,
Education of
parents

Ethnicity
Stratified
by SES
No

73

Divided
Hierarchical
Attention
Task
Robertson et
al., 1993
Gordon’s
Continuous
Performance
Task
Gordon et
al., 1988

Gender
Effects

No

Sample
Geographic
Diversity
30 states

African
American
Cultural
Effects

Sample
General
Health
Condition
Reported

Children
Receiving
Special
Education
Included

Sample Criteria

Unknown:Black
and White
Ethnicity is
Reported
Together as
“Other” (92%
of sample)

Not
Reported

No

Not Reported

Not
Reported

No

No

Exclusion: ADD
or ADD/H,
Special
Classroom
Placement,
Learning
disability, IQ <
70,
Major
Neurological
Impairment,
Psychotropic
Medication,
Psychotherapy,
Grade
Retention,
Emotional
Disturbance

DATA NOT REPORTED

n=
1300

Not Reported

Age
Bands

Not
Reported

Not Found

Syracuse, New
York
Charlottesville
Virginia

Measure
&
Reference

Pediatric
Sample
Size

Sample
Representative
of US Census

Sample
Stratified

Ethnicity
Stratified
by SES

Gender
Effects

74

Kaufman
Assessment
Battery for
nd
Children, 2
ed.
Kaufman et
al., 2004

n=
3025

Yes

Random
Age,
Gender,
Ethnicity,
Parental
Education,
Geographic
Region

Yes

Not Found

Kagan
Matching
Familiar
Figures Test

n=
5000

No

Age Bands

No

Female
Scores
Correlated
with Verbal
Intelligence

Salkind, et
al., 1978

Memory
Span

Note:
2,676
Ameri
can

Sample
Geographic
Diversity

Sample
General
Health
Condition
Reported

Children
Receiving
Special
Education
Included

Sample Criteria

39 States and
DC

Scores
shown to be
less than
Caucasian
Peers

No

Yes

Inclusion:
Learning
Disability,
Speech
Language
Impairment,
Mental
Retardation,
Emotional/Beha
vioral
Disturbance,
ADHD, Gifted

International

Not
Reported

No

No

Inclusion:
Normal
Intelligence,
Middle-Class
SES

DATA NOT REPORTED

Gilhooly et
al., 1980
Mental
Status
Examination
Strub et al.,
1977

African
American
Cultural
Effects

DATA NOT REPORTED

Measure
&
Reference
Multilingual
Aphasia
Examination

Pediatric
Sample
Size

Sample
Representative
of US Census

Sample
Stratified

n=
229

Yes

Age Bands

n = 89

Yes

Age Bands

Ethnicity
Stratified
by SES
No

Gender
Effects

Not
Found

Sample
Geographic
Diversity

No

Not Found

75

Petrides et
al., 1982
Stanford
Binet IV
Thorndike et
al., 1986
Greene et
al., 1990

n=
5013

Yes

Random
Geographic
Region,
Community
Size, Ethnic
Group, Age,
Gender,
Socioeconomic
Status

No

Not
Reported

Sample
General
Health
Condition
Reported

Children
Receiving
Special
Education
Included

Iowa

Black, Urban,
Inner City
Culture and
Lower Levels
Acculturation
have been
Linked to
Lower Scores

No

Greater
Victoria
School
District in
Canada

Not Reported

No

No

National

Found to be
Valid for
Exceptional
Black Male
Students but
not Learning
Disabled

No

Yes

Schum et al.,
1989

Self-Ordered
Pointing Test

African
American
Cultural
Effects

No

Note: Race/
Ethnicity Not
Reported

Sample Criteria

Inclusion:
Children with
Scores of 80120 on the
Peabody
Picture
Vocabulary
Test -Revised
included
Exclusion:
Significant
Neurological,
Psychiatric,
Developmental
Difficulties
Exclusion:
Severe Medical
Conditions,
Communication
Deficits, Severe
Behavior/
Emotional
Disturbances

Measure
&
Reference
Test of
Variables of
Attention

Pediatric
Sample
Size
n = 2551

Sample
Representative
of US Census
No

Sample
Stratified

Age and
Sex

Ethnicity
Stratified
by SES
No

Riccio et al.,
2001
Dupuy
Cenedela ,
2000

Tower of
Hanoi

n = 200300

76

Welsh, 2000
Anderson, et
al., 1996
Klahr et al.,
1981

Note:
Individual
Research
Studies

Trail Making
Test

n = 100392

Strauss et
al., 2006
Lucas et al.,
2005
Kennepohl
et al., 2004

Note:
Metanorms

Sample
Geographic
Diversity

African
American
Cultural
Effects

Males have
been
evidenced
to have
Faster
Reaction
Times and
Errors in
Scores for
Subtests

Minneapolis
Minnesota

Not
Reported

Gender
Effects

Sample
General
Health
Condition
Reported

Children
Receiving
Special
Education
Included

Sample Criteria

No

No

Exclusion:
Significant
Neurological,
Psychiatric,
Developmental,
or Learning
Difficulties

Note:
Race/
Ethnicity of
Sample: 99%
Caucasian,
1% Other

Varied

Age
Bands

No

Males
Shown to
Complete
Task
Quicker
than
Females

Varied

Not Reported

No

No

Exclusion:
Varied

Yes

Age
Bands

No

Females
Shown to
have
Minimal
Advantage

Internation
al

Lower Overall
Scores are
Associated
with Black
English
Speakers

No

Yes

Exclusion:
Neurological,
Developmental,
or Psychiatric
Disorders

Measure
&
Reference

Pediatric
Sample
Size

Sample
Representative
of US Census

Sample
Stratified

Ethnicity
Stratified
by SES

Gender
Effects

Sample
Geographic
Diversity

African
American
Cultural
Effects

Sample
General
Health
Condition
Reported

Children
Receiving
Special
Education
Included

Sample Criteria

Wechsler
Abbreviated
Intelligence
Scale ADD
INFO
Wechsler
Intelligence
Scale for
rd
Children 3
Edition

n = 2200

Yes

Random
Gender,
Age,
Parent
Education

No

77

Canivez et
al., 1999
Wechsler ,
1997
Wechsler
Intelligence
Scale for
rd
Children 4
Edition

Kaufman, et
al., (2006)

Female scores
higher for Full
Scale, Verbal,
Performance

31 states

Black
Scores
shown to
be less
than
Caucasian
Peers

No

No

Exclusion:
(Special Group)
Gifted, and
Mental
Retardation,
Reading

4
geographical
areas
covering
United States
and Hawaii

Black
Scores
shown to
be less
than
Caucasian
Peers

No

No

Disability,
Reading and
Written
Expression
Disorder,
Learning
Disorder, ADD,
ADHD,
Expressive
Language
Disorder, Head
Injury, Autistic
Disorder, Motor
Impairment:

FSIQ,
Processing
Speed

n = 2,200

Yes

Random,
Stratified

Yes

Females
scored higher
on Coding
Males
Scored higher
on
Information
and
Arithmetic
No significant
differences in
FSIQ

Measure
&
Reference
Wechsler
Memory
Scale

Pediatric
Sample
Size

Sample
Representative
of US Census

Sample
Stratified

Ethnicity
Stratified
by SES

Gender
Effects

Sample
Geographic
Diversity

African
American
Cultural
Effects

Sample
General
Health
Condition
Reported

Children
Receiving
Special
Education
Included

Sample Criteria

n = 200
(adults)

No

Age Bands

No

Not Found

Bellevue
Hospital, NY

Not
Reported

No

No

Inclusion:
“Normal” Adults

n = 3935

Yes

Age Bands

No

Females Out
Preformed
Males on
Subtests
Related to
Verbal
Performance

National

Scores
shown to
be less
than
Caucasian
Peers

No

No

Exclusion: Not
Reported

Scores
have been
Shown to
have
Comparab
le
meaning
for African
American
and
Caucasian
groups

No

No

Exclusion: Less
than One Year
Experience
English Speaking
Classes

Wechsler,
1945
Woodcock
Johnson
PsychoEducational
Battery

78

Woodcock
et al., 1977
Woodcock
Johnson
PsychoEducational
Battery III
Woodcock
et al., 2001

n = 5972

Yes

Random
Community,
and Individual
Variables
Note: Variables
-Census
Region,
Community
size, Sex, Race,
Hispanic, Type
of school,
Adult
Education,
Occupation &
Status

No

Not Reported

Note: Rural N.
Easterners
and
Southerners
Underrepresented
100
Geographic
Regions in 27
States

Measure
&
Reference

Pediatric
Sample
Size

Sample
Representative
of US Census

Sample
Stratified

Ethnicity
Stratified
by SES

Gender
Effects

Sample
Geographic
Diversity

African
American
Cultural
Effects

Sample
General
Health
Condition
Reported

Children
Receiving
Special
Education
Included

Sample Criteria

79

Woodcock
Johnson
Psycho
Educational
Battery
Revised
Woodcock
et al., 1989

n = 4359

Yes

Age, Gender,
Region,
Community
Size, and Race

No

Not Reported

Communities
Selected by
Socioeconomic
Variables in
US

Not Found

No

Yes

Inclusion:
Mainstreamed,
Special
Education,
Handicapped

Wisconsin
Card Sorting
Test

n = 459

No

Age Bands

No

Not Reported

National

Not
Reported

No

No

Exclusion:
Neurological
Dysfunction,
Learning
Disability,
Emotional and,
Attention
Disorders

Heaton et
al., 1993

Note: Larger
Number of
Males (58%)

Criteria used to evaluate the quality of the normative sample for executive function measure used to measure cognition in Pediatric SCD literature.

Table 1.5.
Studies by Type of SCD Morbidity
Study
Authors

SCD Morbidity
Disease
Severity

Normal
MRI

Berg et
al.,2012

SCD
Status

Silent
Infarcts

Cerebral
Vascular
Accident

X

X

X

Abnormal
TCD

Results
Children with SCD earned lower
scores in the domains of
metacognition and global
executive function on the BRIEF
compared to healthy
demographically matched
controls.
Children with SCD performed w,
initiation, organization, and
completion on the CKTA.
Children with SCD revealed
signiﬁcant time differences for
the Color-Word Interference
test for all conditions except on
DKFS except Naming Colors and
the Sorting test.

Bernaudin
et al., 2000

X

X

X

X

X

Children with SCD performed
more poorly than siblings overall
on WISC III Verbal IQ
(Similarities, Comprehension,
Digit Span), Performance IQ
(Coding, Symbols), Processing
Speed, and Full IQ.
Children with SCD and overt
stroke evidenced significant
impairment on WISC III
Performance IQ and Full Scale IQ
compared to SCD with no
history of stroke.
Children with SCD and silent
stroke performed poorer than
children with no history of silent
stroke for WISC III Similarities,
Vocabulary, and Verbal
Comprehension.
Children with severely low
hematocrit and those with
thrombocytosis infarcts on
magnetic resonance imaging
evidenced poor scores on WISC
III Verbal IQ, Performance IQ,
and Full Scale IQ

80

Study
Authors

SCD Morbidity
Disease
Severity

BrandlingBennett et
al., 2003

Normal
MRI
X

SCD
Status

Silent
Infarcts

Cerebral
Vascular
Accident

X

Abnormal
TCD

Results
Children with SCD and frontal
infarcts performed more poorly
on learning and free recall tasks
of the CVLT-C.
Children with SCD and frontal
infarcts revealed lower
performance on Children’s
Memory Scale Backward Digit
Span.

Brown et
al., 2000

X

X

X

Children with SCD and no
central nervous system
pathology evidenced greater
general performance than the
SCD group with Silent Infarcts.
Children with SCD and no
history of central nervous
system pathology evidenced less
omission errors and data
suggest there is a commission
error trend on the Cancellations
of As task.
Children with SCD and localized
frontal lobe lesions made
significantly more omission and
commission errors on the
Cancellations of A’s task.

Brown et
al., 1993

X

Children with SCD evidenced
greater errors on CPT than
siblings.
Children with SCD performed
more poorly on K-ABC Reading
Decoding and Bead Memory
subtests than siblings.
Older children with SCD
performed worse B-VMI and
MMFT than younger children
with SCD.

Cohen et
al., 1994

X

Children with SCD and left
cerebral infarcts showed greater
impairment on the Full Scale IQ,
VIQ, and PIQ of the WISC-R than
children with SCD and right
cerebral infarcts.
Children with SCD and left
cerebral infarct showed global
impairment on WRAT and
GORT, Wepman, and KABC
Number Recall when compared
to children with SCD and right
cerebral infarcts.
Children with SCD and left
cerebral infarct demonstrated
impairment on Picture Naming
for the Boston Naming Test.

81

Study
Authors

SCD Morbidity
Disease
Severity

Craft et al.,
1994

Normal
MRI
X

SCD
Status

Silent
Infarcts

Cerebral
Vascular
Accident

X

X

Abnormal
TCD

Results
Children with SCD and bi-frontal
lesions evidenced quick
disengagement at brief cue
intervals and slower
disengagement for lower
intervals on the Covert
Orienting Task.
Children with diffuse lesions
showed no lateralized effects
and greater reaction time at
brief cue delays on the Covert
Orienting Task.

Craft et al.,
1993

X

X

X

Children with SCD and diffuse
cortical strokes performed more
poorly on WISC-R Block Design,
Benton Visual Retention, and
WJR Spatial Relations than both
children with SCD and anterior
stroke group and siblings.
Children with SCD and anterior
lesions had greater intrusions
during list recall on the CAVLT
than both children with SCD and
diffuse stroke and siblings.
There were no significant
differences between children
with diffuse or anterior lesions
and siblings on Finger Tapping,
WISC- R Vocabulary, and CAVLT.

DeBaun et
al., 1998

X

X

TOVA, Wisconsin Card Sorting
Test, and the CVLT identified
children with SCD and Silent
Cerebral Infarct.
TOVA (95%) evidenced greater
sensitivity (86%) and specificity
(81%) ratings than all other
measures (≥ 60%).
TOVA also demonstrated great
sensitivity (95%) for children
with SCD and overt stroke

Fowler et
al., 1988

X

Children with SCD and no CVA
evidenced no group differences
for VIQ, PIQ, and Full Scale IQ
from healthy peers on WISC-R.
Children with SCD and no CVA
demonstrated significant poorer
performance than healthy peers
on WISC-R Coding subtest.
Children with SCD and no CVA
performed more poorly on
MFFT than healthy peers.

82

Study
Authors

SCD Morbidity
Disease
Severity

Goonan et
al., 1994

Normal
MRI

SCD
Status

Silent
Infarcts

Cerebral
Vascular
Accident

Abnormal
TCD

X

Results
Children’s age contributed the
greatest significance to
predicted variance on CPT and
MFFT performance.
Younger children with SCD and
no CVA showed poorer
sustained attention on CPT and
greater impulsivity on MFFT
than older children with SCD
and siblings.

Kral et. al.,
2004

X

Children in the abnormal TCD
group demonstrated greater
deficits in the areas of inhibitory
control, problem-solving
ﬂexibility, and modulation of
emotional responses when
compared to the conditional
group, by parent observation
(not significant).
Teachers rated poorer
performance for children with
abnormal TCD findings in their
ability to solve problems in
working memory, plan and
organize, as well as self-monitor.

Kral et. al.,
2003

Puffer et al.
2010

X

X

Children with abnormal TCD
values evidenced lower
performance than children with
conditional TCD values in areas
of verbal intelligence and
executive function.
Height for age in children with
SCD was shown to partially
account for poor cognitive
performance on the TOLD III
Spoken Language Quotient, BDTVMI, KABC Hand Movements,
WJ-III Decision Speed, Memory
for Words, Letter Word
Identification, and Applied
Problems.
Children with SCD and a greater
body-mass-index performed
significantly better on B-DTVMI
and WJ-III Letter Word
Identification and Applied
Problems than children with
SCD and smaller Body-massindex. This result was not
evidenced in healthy peers.

83

Study
Authors

SCD Morbidity
Disease
Severity

Schatz,
2004

Normal
MRI

SCD
Status

Silent
Infarcts

Cerebral
Vascular
Accident

X

Abnormal
TCD

Results
Children with SCD had greater
difficulties with WRAT-3 SingleWord Reading ability and
Written Calculations than
healthy peers.
DKFS Digit Span–backward,
WRAT-3 Single-Word Reading
ability, and Written Calculations
were valid predictors of
functional education outcomes
for children with SCD.
Overall performance on
cognitive measures was found
to be a strong predictor for
WRAT-3 Single-Word Reading
ability and Written Calculations
for children with SCD.
Academic attainment was
predicted by school absences
related to SCD; however,
academic achievement was not
a significant predictor for illness
related absences.

Schatz et
al., 2001

X

X

Children with SCD and silent
cerebral infarcts demonstrated
a greater incidence of being
retained a grade level in school
or receiving special academic
services, having cognitive
deficits and frontal lobe injuries
than children with SCD without
infarcts.
Language: Differential Abilities
Scales Word Definitions, Word
Fluency, WJ-R Picture
Vocabulary, Peabody Picture
Vocabulary Test, or Rapid
Automatized Naming, and
Boston Naming Test.
Visual-spatial/visual-motor:
Differential Abilities Scales
Pattern Construction, Judgment
of Line Orientation, and WJ-R
Visual Closure, or Wechsler
Block Design and Purdue
Pegboard.
Memory: CVLT-C or WRAML
Attention and Executive
Functioning: Test of Variables of
Attention, Wisconsin Card
Sorting Task, and Perseveration
and Intrusion errors on the
CVLT-C, or Cancellation of A’s
and the Trail Making Test.

84

Study
Authors

SCD Morbidity
Disease
Severity

Schatz et
al., 2007

Normal
MRI

SCD
Status

Silent
Infarcts

Cerebral
Vascular
Accident

X

Abnormal
TCD

Results
Older children with SCD showed
poorer performance in language
skills on the Denver-II, VABS
Communication, CDI Vocabulary
and on the fine motor scales of
the Denver-II and VABS Motor.
Working memory performance
on the Delayed Response was
poorer in children with higher
risk SCD when compared to
lower risk SCD.

Schatz et
al., 2006

X

The corpus callosum of children
with SCD and silent infarcts or
overt stroke was smaller than
children with SCD and no visible
infarct or healthy peers.
Lesion volume was a found to
be a predictor of WISC-III Full
Scale IQ, Verbal Comprehension,
Perceptual Organization,
Freedom from Distractibility,
Processing Speed, DKFS Verbal
Fluency, and Self-Ordered
Pointing Test
The corpus callosum rostral
body size demonstrated robust
prediction of performance on
measures of WISC-III Processing
Speed factor, DKFS Verbal
Fluency, and the SOPT.

Schatz et
al., 2005

X

Children with SCD demonstrated
poorer performance for WJ-R
Oral Vocabulary, Incomplete
Words, Visual Matching and
Digit Span-Backward on the
WISC than healthy peers.
Children with SCD demonstrated
deficits in auditory processing,
on the WJ-R Incomplete Words,
suggesting relation to WISC Digit
Span-Backward performance.

85

Study
Authors

SCD Morbidity
Disease
Severity

Schatz et
al., 2004

Normal
MRI

SCD
Status

Silent
Infarcts

Cerebral
Vascular
Accident

X

Abnormal
TCD

Results
Children with SCD and greater
anemia severity performed
poorer on DKEFS Category and
Verbal Fluency, WISC III Full IQ,
WJ-R Digit Span Backwards,
Spatial Relations, and Visual
Matching.
Anemia severity was shown to
predict overall cognitive ability,
crystallized ability, and
processing speed for children
with SCD.
A bio-psychosocial interaction of
anemia severity and SES was
found to predict general
cognitive ability and short-term
memory performance.

Schatz et
al. 2004

X

X

Children with SCD and
independent left or right
cerebral injury demonstrate less
efficient visual search for the
contra-lateral visual field.
Deficits in global-level
processing measured by a task
of divided hierarchical attention
and coordinating spatial
judgments assessed with
Koenig, Reiss, and Kosslyn’s Task
were associated with righthemisphere injury for children
with SCD.
Children with SCD and bilateral
injury showed deficits in globallevel processing and coordinate
spatial judgments as well
however they also evidenced a
disruption of visual search
across visual fields.

86

Study
Authors

SCD Morbidity
Disease
Severity

Normal
MRI

Schatz et
al. 1999

X

Steen et al.,
2005

X

SCD
Status

Silent
Infarcts

Cerebral
Vascular
Accident

X

Abnormal
TCD

Results
Children with SCD and anterior
cerebral infarcts, diffuse
cerebral infarct, and siblings
preformed significantly worse,
respectively, on TOVA, Tower
of Hanoi, Wisconsin Card Sorting
Test, DAS Position, Visual Form,
Shape Discrimination, Pattern
Construction; Judgment of Line
Orientation, and WJ-R Visual
Closure.
Children with SCD had generally
lower scores on the Tower of
Hanoi and TOVA compared to
siblings.
Volume of cerebral lesion was
significantly related to
performance on TOVA, Tower of
Hanoi, WCST, CVLT-C, PPVT-R,
and WJ-R Picture Vocabulary for
children with SCD and anterior
cerebral infarct.
Children with SCD and normal
MRI showed significant deficits
in WISC III Full-Scale IQ, VIQ,
PIQ, Verbal Comprehension,
Perceptual Organization,
Freedom from Distraction, and
Processing Speed compared
with healthy peers.
The performance of children
with SCD and normal MRI
decreased as a function of age
for the WISC III Full Scale IQ,
Verbal IQ, Verbal
Comprehension, and Perceptual
Organization.

Steen et al.,
2003

X

X

Children with SCD and MRI
abnormalities showed greater
cognitive impairment than
children with SCD and normal
MRI in VIQ and Verbal
Comprehension on WISC III.
Children SCD and low
hematocrit demonstrated
greater impairment than
children with SCD and higher
hematocrit on Full Scale IQ,
Verbal Comprehension, and
Freedom from Distractibility.

87

Study
Authors

SCD Morbidity
Disease
Severity

Steen et al.,
1999

Normal
MRI

SCD
Status

Silent
Infarcts

Cerebral
Vascular
Accident

X

Abnormal
TCD

Results
Children with SCD and no CVA
were found to be at a 23 fold
increased risk of mild mental
deficiency.
Hematocrit of more than 27% in
children with SCD was positively
correlated with Full Scale IQ,
Verbal Comprehension,
Perceptual Organization,
Freedom From Distractibility,
and Processing Speed scores on
WISC III.
Hemtocrit of less than 27% was
correlated with lower WISC III
scores as well as T1 grey matter
reductions in the caudate,
putamen, and cortex regions of
the brain.

Swift et al.,
1989

X

Children with SCD and no CVA
performed significantly poorer
on DTLA-2 Memory for Words
and Designs, WJ Math and
Reading, and WISC-R VIQ, PIQ,
Full Scale IQ.
Children with SCD and no CVA
along with healthy peers
demonstrated that their WJ
Math and Reading scores were
commiserating with their WISCR VIQ, PIQ, and Full Scale IQ
performance.

Wang et
al., 2001

X

X

X

Children with SCD and normal
MRI had significantly higher
scores on WISC III Full Scale IQ,
VIQ, PIQ, Digit Span, Coding and
WJ-R Math/Reading compared
to children with SCD with Silent
Infarcts or Stroke.
Children with SCD and Silent
Infarct performed significantly
better than children with SCD
and Stroke on WISC III Full Scale
IQ, VIQ, PIQ, Digit Span, Coding
and WJ-R Math/Reading.
WISC III Verbal IQ, WJ-R Math
Achievement, and WISC III
Coding scores demonstrated
decline with increasing age of
the child with SCD.

88

Study
Authors

SCD Morbidity
Disease
Severity

Watkins et
al., 1998

Normal
MRI
X

SCD
Status

Silent
Infarcts

Cerebral
Vascular
Accident

X

X

Abnormal
TCD

Results
Children with SCD and normal
MRI demonstrated higher FSIQ,
Digit Span, Coding, Picture
Arrangement, and Symbol
Search scores on WISC-III.
A trend was evident for children
with SCD and normal MRI
suggesting greater performance
on VIQ, PIQ, and FSIQ than SCD
and CVA.
Children with SCD and CVA
demonstrated poorer
performance overall on WISC-III
compared to SCD and normal
MRI and siblings.
Children with SCD and CVA
generated more perseverative
errors on Wisconsin Card
Sorting Test and had poorer
performance on WMS Logical
Memory, Visual Memory, and
Paired Association Learning.

White et
al., 2006

X

X

CVLT-C List A recall over 5
presentations was the most
robust predictor for
discriminating between children
with SCD and silent infarct vs. no
history of infarct.
Block Design from the WAIS was
the second best predictor of
silent infarct in children with
SCD.
Together CVLT-C and Block
Design from the WAIS
demonstrated 75%, 75%
sensitivity and 76% specificity
for identifying children with SCD
and silent infarct from children
with SCD without silent infarct.

Schatz J, Craft S, Koby M, et al. (2004). Asymmetries in visual-spatial processing following childhood stroke. Neuropsychology, 18, 340–352.
Schatz, J., Finke, R.L.,Roberts, C.W. (2004). Interactions among biomedical and environmental factors in cognitive development: A preliminary study of
sickle cell disease. Journal of Developmental and Behavioral Pediatrics, 25, 303–310.
Schatz J, Craft S, Koby M, et al. (2004). Asymmetries in visual-spatial processing following childhood stroke. Neuropsychology, 18, 340–352.
Schatz, J., Finke, R.L., Kellett, J.M., & Kramer, J.H. (2002). Cognitive functioning in children with sickle cell disease: A metaanalysis. Journal of
Pediatric Psychology, 8, 739–748.
Schatz J, Craft S, Koby M, et al. (2004). Asymmetries in visual-spatial processing following childhood stroke. Neuropsychology, 18, 340–352
b
Schatz, J., Finke, R.L.,& Roberts, C.W. (2004). Interactions among biomedical and environmental factors in cognitive development: A preliminary
study of sickle cell disease. Journal of Developmental and Behavioral Pediatrics, 25, 303–310.

Note: Research studies which utilize cognitive measure that evidence measurement sensitivity to
neurologic damage associate with pediatric SCD.
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CHAPTER II
RESEARCH QUESTIONS AND HYPOTHESES
The development of the EXAMINER, a neuropsychological assessment battery
that intended to supplant established cognitive measures such as the WJ-III and the
BRIEF, is potentially important for more accurate EF assessment of children with SCD.
Similar to the WJ-III, this newly developed measure includes subtests which evaluate the
narrow domains of ability. However, these measures have been chosen to represent well
established measures of EF, with known neural underpinnings and often used subtractive
factors logic so that both overall performance and narrower abilities can be identified.
Similar to the BRIEF, component tests can be combined to assess broader cognitive
domains. As a new battery, it is not expected that the EXAMINER can match the WJ-III
or the BRIEF in the area of a large, representative normative sample; however, if other
features of the battery are shown to be promising, this expensive process could be
implemented at a later point in time.
Three specific research questions will be addressed in this study: (1) Will the
psychometric qualities of the EXAMINER meet or exceed the WJ-III standards based on:
the structure of the test, target age range, reliability (internal consistency), size of
normative sample, and quality of normative sample for children with SCD? (2) What is
the extent of cross-cultural validity for the EXAMINER? (3) Does the EXAMINER
demonstrate similar criterion validity as other well-established measures, such as the WJIII, to detect Sickle Cell related cognitive deficits?
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Study Hypotheses
Goal 1: Evaluate traditional psychometric properties of the EXAMINER relative
to the WJ-III.
Hypothesis 1: The reliability (internal consistency) of the EXAMINER will be
equivalent to the WJ-III for use in pediatric SCD, including the reliability for youth tested
across multiple sites, local demographic controls, and youth with SCD.
The EXAMINER will be administered to a heterogeneous sample of children
across multiple sites, a local demographic comparison group for our SCD sample, and a
group of children with SCD in conjunction with selected measures from the WJ-III. The
purpose of this comparison is to evaluate the reliability for the EXAMINER battery. It is
hypothesized that the EXAMINER will be equivalent to the WJ-III on the demonstration
of high internal consistency. The EXAMINER will also demonstrate better
appropriateness for this population due to its inclusion of a special developmental sample
of children with SCD (from this proposed study) supporting reliability within this clinical
group.
Goal 2: Evaluate evidence of the cultural validity of the EXAMINER for AfricanAmericans with SCD by comparing African-American youth relative to White youth on
measures of convergent validity.
Hypothesis 2A: The strength of association between EXAMINER scores and VIQ
from the WJ-III will be similar for African American and White children.
Hypothesis 2B: The strength of the association between the validity coefficient for
the BRIEF Behavioral Regulation, Metacognition, and Global Executive Composite and
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the EXAMINER executive composite, working memory factor, cognitive control factor,
and fluency factor scores will be similar for African American and White children.
It is plausible that the EXAMINER will demonstrate similar or greater cultural
validity for the WJ-III and BRIEF. The developers of the EXAMINER selected,
developed, and piloted methods of assessment including neuropsychological tests,
computer-administered tasks, and behavioral observation techniques with an a priori goal
to develop measures that could be applied widely to individuals across ages and
ethnicities. In addition, tasks were designed to minimize the need for specific cultural
knowledge or specific linguistic knowledge that often is a source of bias in cognitive
testing. Furthermore, the developers of the EXAMINER appropriately field tested and
modified forms of tests and administration procedures for test takers. These modifications
were made as developers received feedback from the national field testing sites that
accommodations were necessary for standardization.
Goal 3: Establish the sensitivity (criterion validity) of the EXAMINER to SCDrelated cognitive deficits.
Hypothesis 3A: Children with SCD at high risk for disease-related cognitive
effects will show significantly poorer performance on the EXAMINER than
demographically matched control children without SCD. The effect size of these
differences will be compared to the magnitude of group differences on selected WJ-III.
Hypothesis 3B: The EXAMINER will show at least as high of sensitivity and
specificity in identifying high risk children with sickle-cell disease as the selected
measures from the WJ-III relative to the local, demographically matched comparison
group.
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It is believed that the degree of differences for the effect sizes of the
EXAMINER, when compared with that found for established measures of cognitive
functioning such as the WJ-III, will be similar or greater. With comparable criterion
validity, the EXAMINER could be a preferred measure for clinical outcome studies
(particularly treatment studies) given that the measures are based on well-established
brain-behavior relationships, allows for both narrow and broad cognitive abilities to be
measured, and specifically measures EF, a construct rooted in measuring higher-level
cognitive skills that are essential for adaptive functioning.

93

CHAPTER III
METHODS
Participants
Clinical research participants were children who voluntarily took part in the
EXAMINER national project (Kramer, Mungas, Possin, Rankin, Boxer, Rosen,
Widmeyer, 2014). Overall, 396 children without a known neurologic condition (8 to 18
years of age) completed the study. One hundred and seventeen of these children, SCD
and demographically matched controls, were recruited from a local catchment area
surrounding Columbia, South Carolina. The overall sample for the multisite study
contained 279 youth identifying as White who matched the age range of the local
African-American children without known neurologic conditions. At the University of
South Carolina site, 32 children diagnosed with SCD participated in the investigation.
The 85 control participants were demographically matched on race and age for children
for the SCD sample who voluntarily participated in the study from after school, summer,
church, and community programs in the Columbia, SC area.
SCD subjects were a group of children diagnosed with high risk SCD (HbSS or
HBSβ0). Children with known neurologic histories were included given the purpose of
the study, though participants with severe sensory or motor deficits as judged by the
treating hematologist were not recruited. Of the total SCD participants (n = 32), 56.3%
were male (n = 18) and 43.8% were female (n = 14). The mean age of the SCD sample
was 12.7 years (SD = 3.2). All local respondents self-identified as African American
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ethnicity (N = 85), mean age 12.8 years (SD = 2.53). The local control sample was also
relatively equally balanced for gender, 46.3% were male (n = 39) and 53.7% were female
(n = 46). The multi-site sample (N = 279), contained participants which self-identified as
White, mean age 11.2 years (SD = 2.9). Similar to the SCD and local control samples, the
non-neurologic sample was comprised of 47.0% male (n = 133) and 53.0% female (n =
146). Fisher’s Exact test indicated no differences across race/ethnicity groups for gender
(p = .804). Socioeconomic (determined by parent age, education, income, number of
children and adults in the home) information was also obtained for the University of
South Carolina site participants. Unfortunately, this data was to have been collected from
children at other sites, but was missing as described below.
General Inclusion/Exclusion Criteria
For the overall EXAMINER project there were a set inclusion/exclusion criteria
across sites. Most of these criteria; however, were more relevant to adult neurologic
conditions. General systemic medical conditions were exclusionary only if additional
medical conditions were present besides the target condition, as with SCD. Participants
had to be between 3-90 years old and speak fluent English and/or Spanish. Subjects who
were unable to consent for themselves required an informant to consent for them.
General exclusion criteria were current alcohol abuse or dependence, current drug abuse,
psychiatric disorder (apart from those specified in diagnostic groups of interest),
B12 deficiency or other metabolic syndrome, hypothyroidism (i.e. TSH>150% of
normal), known HIV, renal failure, respiratory failure (i.e. requiring oxygen), significant
systemic medical illnesses (e.g. deteriorating cardiovascular disease), or current
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medication likely to affect CNS functions (e.g. benzodiazepines, antidepressants, lithium,
and/or neuroleptics in the phenothiazine and haloperidol families).
Procedure
All procedures were approved by university and hospital institutional review
boards and by the administrations of the schools and programs involved. Informed
consent and assent were obtained from caregivers and children. The children diagnosed
with SCD were recruited from Palmetto Health Children’s Center for Cancer and Blood
Disorders. Scheduling conflicts were most often cited as the reason for participation
refusal. Children diagnosed with SCD with history of stroke or major developmental
disabilities were excluded from analyses based on medical record review. Children
experiencing any acute SCD complications did not participate in the investigation and
were rescheduled at their next routine visit.
Neuropsychological assessment was conducted by a graduate student or trained
undergraduate student under the psychologist’s supervision. The data were collected via
questionnaires with parents and one-on-one testing with the child. Parent questionnaires
and BRIEF-Parent Form were collected and EXAMINERs were stationed nearby to
address any parent questions or available to help the parent if questions arose. Children
diagnosed with SCD were typically assessed after their routine care from the
hematologist. Order of test administration was in a fixed order across the study.
EXAMINERs were blind at the time of testing to disease-related measures (e.g., extent of
SCD complications) and socioeconomic status, but not group diagnostic group (SCD vs.
without SCD). Each child completed the EXAMINER and WJ-II administered in a
single, 90- to 120-minute session. Compensation for participation involved the families
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receiving monetary compensation (both parent and child) and SCD participants’ data for
clinically informative cognitive measures was shared with the hematologist.
The comparison group was recruited from the same general community to match
the sample with SCD in terms of age, gender distribution, ethnicity, and SES. Caregivers
were asked to enroll children in the study through telecommunications, electronic
correspondence, and face to face contact at program sites. These sites consisted of local
schools, after-school, summer, community, and church programs providing academic
enrichment and leisure activities for children. Children with chronic health conditions or
developmental disabilities were excluded from participation (based on parent report on a
demographic survey). Demographically matched children also did not participate in the
investigation during a time when they were experiencing acute illness.
Children without SCD were assessed at the end of their school day when the
academic year was in session and various times of day during breaks from school. These
participants were also assessed in a fixed order across the study. Parent report measures
were completed by caregivers prior to study participation. Standardized procedures were
utilized as described in the EXAMINER training manual.
Measures
Medical History
Medical chart reviews were conducted for all children with SCD to collect disease
subtype. In addition, history of SCD complication (e.g. stroke, splenic sequestration) was
reviewed to asses’ inclusion/exclusion criteria for this study.
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Socioeconomic Status
At our local site, demographic information was collected pertaining to age,
gender, ethnicity, and the presence or absence of medical/psychiatric illness, or learning
disability from participant’s caregivers. Descriptive informative was also collected
regarding age, gender, ethnicity, education, yearly household income, and household size
from parents of participants. Household income data were collected in the following
manner: less than $10,000 was recorded as Level One, $10,000 - $20,000 was recorded
as Level Two, $20,000 - $30,000 was recorded as Level Three, $30,000 - $40,000 was
recorded as Level Four, and more than $40,000 was recorded as Level Five. Parental
education was recorded according to years of education and categorized: less than ninth
grade recorded as Level One, ninth through eleventh grade recorded as Level Two, high
school diploma/GED recorded as Level Three, Some college/Associates degree recorded
as Level Four, and college degree/Bachelors or higher recorded as Level Five.
Unfortunately, detailed demographic information was not collected at all sites in the
overall study. It was intended for each of the 11 sites to collect parent education
information for child participants. However, due to investigator error, education was only
collected for adult participants. Therefore, we had access to information about age,
gender, and race for children entered at other sites
Neuropsychological Assessment Tools
An experimental cognitive measurement test, the EXAMINER, WJ-III, and
BRIEF-Parent Form were selected for use in this study to best capture EF in children
with SCD.
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Brief-Parent Form
The BRIEF-Parent Form is a parent questionnaire, created to measure the
expression of the child’s behaviors related to executive function. More specifically, it was
included in this study to assess the observed cognitive abilities for a broad range of
children ages 5–18 in the school and home environments. It was normed on the child
ratings from 1,419 parents and has Eight theoretically derived clinical scales: Inhibit,
Shift, Emotional Control, Initiate, Working Memory, Plan/Organize, Organization of
Materials, and Monitor. These scales form two broader Indexes: Behavioral Regulation
and Metacognition were reviewed. An overall Global Executive Composite score, which
depicts overall executive function, was also calculated from the clinical scales to provide
a greater understanding of cognitive abilities for this population. Two validity scales:
Inconsistency and Negativity were evaluated for each respondent. Gioia, Isquith, Guy,
and Kenworthy (2000) reported high internal consistency (alphas = .80-.98) and testretest reliability (rs = .82) for this measure.
Parents of participants were asked to complete an 86 items paper and pencil form.
Each parent was asked to indicate if the behavior described in each item was never a
problem, sometimes a problem, or often a problem for the child.
EXAMINER
The EXAMINER is a newly developed neuropsychological test battery that
purports to reliably and validly assess domains of EF, across a wide range of disorders
which impact cognition (Kramer et al., 2014). The test was designed largely using
Miyake’s unity and diversity model of EF with the expectation of capturing a global
measure of executive function and more discrete component measures. A combination if
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Item Response Theory (IRT) and factor analytic methods were used to extract useful
factor scores from a set of well-established EF measures used in non-clinical contexts.
This novel neuropsychological battery has components specifically designed to measure
narrow domains of EF (e.g., attention, set shifting, inhibition, fluency, planning, problem
solving, and abstract reasoning). Normative data has been derived from national
standardization, involving children and adults between the ages of 5 and 89 years of age,
including subjects with clinical syndromes known to impact cognition. Theoretically
derived tasks were designed to measure narrow domains of EF; which include attention,
set shifting, inhibition, fluency, planning, problem solving, and abstract reasoning.
Performance on the EXAMINER tasks is used to inform fluency, cognitive control, and
working memory factor scores, as well as an overall composite score. The fluency factor
score is constructed from the total correct responses for 2 trials of Phonemic Fluency and
2 trials of Category Fluency tasks. The cognitive control factor score is comprised of the
total Flanker score, total Set Shifting score, anti-saccade total, and total dysexecutive
errors on the Continuous Performance Task. The Working Memory factor is comprised
of total correct responses for the Dot Counting task along with the total correct and dprime scores for the n-back task. Each task of EF includes aspects from multiple
domains however for the purposes of illustrating the experimental procedures; the tasks
are categorized accordingly below.
Fluency Tasks
Fluency refers to the ability to avoid response repetition while using strategies
that maximize the formation of responses (Ruff, Allen et al. 1994).
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Verbal Response Set
Verbal – Phonemic: Participants were instructed to say as many words as possible
from a category in a given time (60 seconds). This category included 2 phonemic tasks,
such as words that begin with letter L. Number of correct responses, repetitions, and rule
violations were recorded.
Category – Animals: Participants were instructed to say as many words as
possible from a category in a given time (60 seconds). This category included 2 semantic
tasks, such as animals. Number of correct responses, repetitions, and rule violations were
recorded.
Attention Tasks
Random Number: Participants were instructed to say numbers randomly from 0-9
until they reached 100 numbers. Total number of errors, strategies utilized, and prompts
for randomness were recorded. This task was later dropped from the final battery for
psychometric reasons.
Paper and Pencil Response Set
Design – Empty Dots: Participants were instructed to draw as many designs as
possible with 4 straight lines, connecting empty dots only. They were told to complete
this task as fast as they could, without touching any filled dots. The given time was 60
seconds. Rules for the second task were then modified such that participants were
instructed to draw as many designs as possible alternating between connecting empty and
filled dots in 60 seconds. They were also told to complete this task as fast as they could,
without touching any filled or unfilled dots outside their designs. This task was dropped
later from the final battery for psychometric reasons.
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Planning, Problem Solving, and Abstract Reasoning Task
Planning is the ability to divide an objective into the individual components
necessary to achieve the goal (Lezak, Howieson et al. 2004). Therefore effective planning
requires a multitude of simultaneous processes, including sustained attention, abstract
thinking, temporal sequencing, problem solving and reasoning (Norman and Shallice,
1986).
Unstructured Task: Participants were given 6 minutes to earn as many points as
possible by accurately completing puzzles. Each puzzle was worth a specific amount of
points, which was randomly associated with difficulty levels. They were given 3 booklets
of puzzles and each booklet contained an equal sum of points. The number of high and
low value puzzles that were accurately completed and the total number of points earned
was recorded. This task was later dropped from the final battery for psychometric
reasons.
Computer Response Set
Working Memory and Inhibition Tasks
Working memory is the ability to actively hold numerous pieces of information,
for the execution of both verbal and nonverbal tasks, and subsequently retrieve them for
further information-processing (Becker & Morris, 1999). On the other hand, inhibition is
the ability to deny a response or suppress irrelevant or intrusive stimuli. Inhibition has
been shown to have both "cognitive" and "behavioral" components (Chamberlain,
Blackwell et al. 2005).
Flanker: Participants were shown a series of arrows, pointing to the left or right.
They were instructed to press the left arrow key if the central arrow points to the left and
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press the right arrow key if the central arrow pointed to the right. The target was flanked
by arrows which correspond either to the same directional response as the target or to the
opposite response. Response times for congruent and incongruent stimuli are recorded.
Dot Counting: Participants were shown a series of images containing blue circles,
green circles, and blue squares. They were instructed to count the number of blue circles
out loud on each screen, repeat the final number out loud, and remember that number.
After a number of displays they were presented with screen containing question marks
and expected to repeat the final numbers counted for each screen.
Set Shifting
Set shifting is the ability to concurrently or alternately engage in two different
tasks (Crossley, Hiscock et al. 2004).
Set Shifting Task: Participants were shown a picture in the middle of the screen,
and a word at the bottom of the screen. They were instructed to match the picture by
shape or color with the objects in the corners of the screen. The word at the bottom of the
screen told the subjects how to match the picture in the middle of the screen. When they
matched the picture by color, they were instructed to push the left arrow key. When they
matched the picture by shape they were instructed to push the right arrow key. Response
times for accurate and inaccurate responses were recorded.
Attention
Attention is the ability to process selected information to the exclusion of others,
in the service of achieving a goal. (Cohen, 2004)
Continuous Performance Task/Go-No-Go: Participants were presented with a
number of shapes on the screen, one at a time. If a 5 pointed star appeared, they were
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instructed to press the left arrow key. If any other shape appeared, they were instructed to
not press any key. Response times for accurate and inaccurate responses were recorded.
1-Back: Participants were instructed to remember the location of the square that
appeared on the screen, so that they could compare that location with the location of the
next square that appeared on the screen. If the location was the same as the square before,
they were told to push the left arrow key. If the location was different than the location of
the square before, they were told to press the right arrow key. Response times for
accurate and inaccurate responses were recorded.
Saccades (Go-No-Go): Participants were instructed to look at the center of the
computer screen. They were instructed to move only their eyes in the direction that the
dot moves on the screen or the opposite direction that the dot moves on the screen,
depending on the trial. The total correct initial eye movements were recorded.
Final EXAMINER Scores
Using a combination of IRT methods and confirmatory factor analytic methods
the final EXAMINER structure yielded both a one-factor and a three-factor organization
that both showed strong support from factor analysis (Kramer et al., 2014). Eleven key
variables from the battery (only 10 of these were used for children) were used to generate
an overall Executive Function Composite score based on all of these variables and three
specific factors: Fluency (based on total scores for Verbal Fluency and Category Fluency
tests), Cognitive Control (based on four scores from the Flanker Test, Set Shifting test,
anti-saccade test, and total dysexecutive errors), and Working Memory (based on four
scores from N-back tests and the Dot Counting test in adults and three scores in children
due to difficulties with 2-back version of the N-back test).
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Given the use of IRT to measure factors with fewer items, test-retest reliability
was chosen as the primary measure of reliability in the initial test development. The
more traditional approach of internal consistency, assessed with Chronbach’s alpha, is
highly sensitive to the number of items in the scale. Therefore, test-retest reliability was
assessed in 122 normal adult controls at an average interval of 25 days. The Executive
Composite factor showed a test-retest reliability of r = .93. For the Fluency, Cognitive
Control, and Working Memory factors the test-retest reliability was .88, .88, and .78,
respectively.
The EXAMINER factor and composite scores represent the sums of weighted
scores from the variables and are on an equal-interval scale. Each unit represents equal
changes in ability across the scale. Scores are not age corrected.
Woodcock Johnson Tests of Cognitive Abilities 3rd edition
The WJ-III is designed to assess the CHC factors. It was normed on national
sample of 4,783 children and 4,035 adults. The WJ-III was included in this investigation
to assess verbal comprehension and knowledge, processing speed, and working memory
as these measures have shown the most consistent and robust effects for SCD-related
deficits. Picture Vocabulary, Synonyms, Antonyms, and Verbal Analogies are
components within the Verbal Comprehension subtest. This subtest provides an
assessment of comprehensive-knowledge. This subtest requires an individual to identify
objects, provide knowledge of antonyms, and complete verbal analogies. Visual
Matching is a subtest which provides a greater understanding of processing speed.
Rapidly locating and circling identical numbers from a defined set of numbers, within a
predetermined amount of time (3 min), is necessary for completion of this task. The
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primary broad factor assessed by the Numbers Reversed subtest is Short Term Memory.
The subject is instructed to hold a span of numbers in immediate awareness while
verbally reversing the sequence. These subtests were given to create a greater
understanding of the specific cognitive abilities for this population. The processing speed
and short-term memory subtests are components of cognitive efficiency. Reliability
coefficients indicate adequate to high reliability (.78 to .90) with children for all 3
subtests,
WJ-III tasks were scored according to the test manual. WJ-III raw scores and ageadjusted standard scores were mathematically transformed using the W scale, which is a
data transformation used in clinical research and practice. The W scale score was created
by converting raw scores such that they representing ability level with a center on a value
of 500, which is set approximately at the average performance of children 10.0 years of
age analysis (Woodcock et al., 2001). Each unit is meant to represent a similar change in
ability level across the scale. The W metric from the WJ-III is most similar to the scaling
of the EXAMINER factor scores and permitted the most direct comparison of both
cognitive measures.
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CHAPTER IV
STATISTICAL ANALYSIS PLAN

Hypothesis 1: The reliability (internal consistency) of the composite scores for
EXAMINER will be equivalent to the WJ-III for use in pediatric SCD, including the
reliability for youth tested across multiple sites, local demographic controls, and youth
with SCD.
Internal consistency scores for the EXAMINER variables will be compared to the
WJ-III measures by assessing the magnitude of difference between the two correlation
values (Papoulis, 1990). WJ-III internal consistency scores will be for the 8-18 year olds
in the normative sample who endorsed race as White or African American. Due to the
construction of the final EXAMINER, the Executive Composite was used as the primary
measure to examine the internal consistency of the measure across White and AfricanAmerican participants. Due to differences in the age distribution between these two
groups, twenty eight- or nine-year-old children were dropped from the White sample to
create a better match of the two age distributions. The cases excluded were chosen at
random using an on-line software program to select twenty cases from the total number
of cases in this age range. In addition, there was 3.4% missing data for children included
in the final analyses. I used mean substitution for missing data to allow for more cases to
influence the reliability estimates. Imputation procedures are preferred in most cases for
addressing missing data; however, in this context imputation would artificially increase
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the internal consistency scores. All variables were centered with a mean of zero and
standard deviation of one before computing internal consistency.
In the comparison of the internal consistency scores, the alpha value (which is
essentially an intraclass correlation value among items) was compared using methods that
compare two correlation values from separate samples. The two correlation coefficients
are transformed with the Fisher r-to-z-transform and the probability for the magnitude of
the difference between these two values can be computed (Lowry, 1998).
There are potential concerns about what is an adequate sample size for computing
a stable internal consistency score. Many experts have recommended sample sizes of
200-300 as a minimal requirement (Peterson, 1994; Kline, 1986; Nunnally and Bernstein,
1994; Segall, 1994; Charter, 1999). Recent literature has indicated that the sample size
needed for a stable measure of internal consistency is dependent on how unidimensional
the items are in the scale (Yurdugul, 2008). This work provides estimates of sample sizes
needed for stable measurement of alpha based on the magnitude of the first eigen value
from principle components analysis of the scale items. Therefore, a principle component
analysis was run with the healthy control sample to determine the first eigen value for the
ten items used to compute the EXAMINER factor scores.
Hypothesis 2A: The strength of association between EXAMINER executive
composite, working memory factor, cognitive control factor, and fluency factor and VIQ
from the WJ-III will be similar for African American and White children.
Hypothesis 2B: The validity coefficient for the BRIEF Behavioral Regulation,
Metacognition, and Global Executive Composite and the EXAMINER executive
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composite, working memory factor, cognitive control factor, and fluency factor scores
will be similar for African American and White children.
These hypotheses test the similarity in convergent validity across the two samples.
The statistical tests will be calculated by comparing the magnitude of the two correlation
values as described with Hypothesis 1, above.
Hypothesis 3A: Children with SCD at high risk for disease-related cognitive
effects will show significantly poorer performance on the EXAMINER than
demographically matched control children without SCD. The effect size of these
differences will be compared to the magnitude of group differences on selected WJ-III.
Hypothesis 3B: The EXAMINER executive composite, working memory factor,
cognitive control factor, and fluency factor will show at least as high of sensitivity and
specificity in identifying high risk children with sickle-cell disease as the selected
measures from the WJ-III relative to the local, demographically matched comparison
group.
This aim will be evaluated by comparing the area under the curve using receiver
operating characteristic (ROC) curves for each of the EXAMINER and WJ-III variables
using the Statistical Package for Social Sciences software, version 22 (SPS-22). In
previous work in SCD and other clinical conditions, sensitivity and specificity of
measures has often been evaluated with cut-off scores that mimic the process often used
in clinical practice, such as setting rules for the number of tests and the magnitude of
difference (often 1.5 or 2.0 standard deviation units from age expectation) for indicating a
positive test. However, I decided that this type of approach would be premature in
working with the current version of the EXAMINER. The current EXAMINER version
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does not contain age-adjusted scores and typically a large normative database would be
used for establishing cut-off scores.
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CHAPTER V
RESULTS
Hypothesis One: The reliability (internal consistency) of the EXAMINER will be
equivalent to the WJ-III for use in pediatric SCD, including the reliability for youth tested
across multiple sites, local demographic controls, and youth with SCD.
Descriptive Statistics
Prior to performing the statistical analyses, data were analyzed by SPSS-22 to
detect the presence of outliers and the possible influence over variable relationships.
Examination of histograms, independent samples t-tests, and chi-square analyses were
performed to examine whether there were significant differences between the study
groups. Normality was tested using the Shapiro – Wilk test. Overall, these procedures
revealed no significant violations of normality, however a significant statistical age
difference was found between the SCD group with White comparison in the final sample
used, t(362) = 4.94, p < .001. The mean age of the SCD group (M = 12.8, SD = 2.5) was
higher than White comparison group (M = 11.2, SD= 2.9), see Table 5.1. However, the
overall age distribution (8-18 years), variance in age, and shapes of the distribution were
highly similar across the two groups. Dropping additional cases to create a closer mean
age was viewed as throwing away data and decreasing the reliability of the internal
consistency estimates.
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Internal Consistency
The reliability literature suggests that sample sizes should range from 200-500 to
calculate a more precise estimate of coefficient alpha (Peterson, 1994; Kline, 1986;
Nunnally and Bernstein, 1994; Segall, 1994; Charter, 1999). However, a recent
investigation reveals that a sample size of 100 is adequate to produce a sufficiently
unbiased estimator of coefficient alpha if the first eigenvalue is between 3.00 and 6.00 of
the sample data set (Yurdugul, 2008). The principle components analysis of the 10
EXAMINER variables yielded an eigen value of 4.1 for the one-factor model, indicating
the sample sizes in this study were likely to yield moderately to highly stable internal
consistency estimates for this measure in the White and African-American samples.
Using standard eigen value and scree plot rules, the principle components analysis also
indicated a three-factor solution is appropriate, as found in the overall development of the
EXAMINER battery, which used both exploratory and confirmatory factor analytic
methods. The second and third factors had eigen values above 1 (1.3 and 1.2) and the
scree plot showed a natural break in the curve with a relatively flat (horizontal) line after
plotting the third factor.
Internal consistency of the EXAMINER and WJ-III were evaluated for
Cronbach's alpha to assess the magnitude of difference between SCD and comparison
groups. Internal consistency reliability values for 10 EXAMINER tasks were calculated
to identify a consistent response pattern across the tasks, see Table 5.2. Although the
EXAMINER contains 11 cognitive tests, the 2-back task was not relevant for this
analysis. This sub-test of the N-back was only administered to the adult norming group.
Results revealed the following Cronbach’s alpha scores for the EXAMINER: White
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control group, α = .84 (n = 279), African American comparison group, α = .81 (n = 85),
SCD group, α = .84 (n = 32). Reliability coefficient data for the WJ-III was obtained
from Woodcock et al., (2001) using the mean internal consistency score: Verbal
Comprehension, α = 0.91 (n = 3549, SEM = 4.40), Visual Matching, α = 0.88 (n = 3719,
SEM = 5.15), and Numbers Reversed, α = 0.86 (n = 3337, SEM = 5.53).
Significance of Difference between Cronbach’s Alpha Coefficients
Analyses were conducted to assess the significance of the difference between
internal consistency coefficients. Chronbach’s alpha scores for the SCD and comparison
groups were then transformed into Fisher Z scores and the probability for the magnitude
of the difference between the values was computed, with a two-sided test. These findings
suggest statistically significant differences between reliability coefficients for the
EXAMINER Composite values for White and Black youth on the WJ-III verbal
comprehension and visual matching measures, see Table 5.3. Comparing reliability
values from the EXAMINER to the WJ-III, for the White sample, reveal the following
findings: verbal comprehension, (z = -4.9, p = .00), visual matching, (z = -2.48, p = .01),
numbers reversed, (z = -1.15, p = -.25). Results for the WJ-III reliability scores compared
to the EXAMINER composite, for the African-American sample, were as follows: verbal
comprehension, (z = -3.59, p = .00), visual matching, (z = -2.23, p = .03), numbers
reversed, (z = -1.49, p =.14). In addition, analyses of the alpha reliability data between
EXAMINER composite and WJ-III reliability coefficients for the SCD group reveal no
significant differences between values: verbal comprehension, (z = -1.64, p = .10), visual
matching, (z = -0.83, p =.41), numbers reversed, (z = -0.39, p =.70).
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For descriptive purposes, internal consistency scores were also computed for the
specific EXAMINER factors, which indicated a generally similar pattern. There were not
significant differences evident across race/ethnicity groups, as a test of potential cultural
differences in the validity of the measures. However, the internal consistency values were
lower than found for the WJ-III. The EXAMINER Fluency factor is based on the two
fluency scores found in the EXAMINER composite variable. The alpha coefficient was
.61 for the White sample, .65 for the African-American sample, and .68 for the SCD
sample. The Working Memory factor was based on the variables from the Dot Counting
and N-back tests (n = 3 variables) and showed an alpha of .76 for the White -sample, .72
for the African-American sample, and .63 for the SCD sample. Finally, the remaining
variables are part of the EXAMINER Cognitive Control factor (n = 5 variables) and
showed an alpha of .80 for the White sample, .78 for the African-American sample, and
.71 for the SCD sample.
Hypothesis 2A: The strength of association between EXAMINER executive
composite, working memory factor, cognitive control factor, and fluency factor and VIQ
from the WJ-III will be similar for African American and White children.
Correlation Analysis
Partial correlations, controlling for age, were conducted to examine construct
validity for EXAMINER in relation to verbal ability. Data were computed with pairwise
exclusion for missing values to maximize the sample size for each validity coefficient
The verbal ability construct is represented by both the WRAT-IV reading T score
and WJ-III verbal comprehension standard score. As mentioned above, the WJ-III was
not administered to the White comparison group. For that reason, reading performance on
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the WRAT-IV was included in these analyses. Inclusion of this sub-test is
psychometrically suitable because the WRAT-IV reading score and WJ-III verbal
comprehension have been shown to demonstrate a moderate-to-large (r = .48) Pearson
correlation, at the p > .05 significance level (Woodcock et al., 2001).
Partial correlations were computed among the four scores of the EXAMINER and
verbal ability, holding age constant. The results of these correlational analyses indicated
that the EXAMINER executive composite, fluency factor, cognitive control factor, and
working memory scores were positively correlated with verbal ability standard scores,
see Table 5.4. These partial correlation values also revealed generally similar associations
across the two groups, with a trend toward higher convergent validity for the AfricanAmerican control sample as compared to the White control sample. The relationship
between the EXAMINER composite scores and verbal ability for the White comparison
group were small-to-medium in size (r = .29 to .42, p < .05). Similarly, the strength of the
association between the EXAMINER and verbal ability for the African American
comparison group were medium-to-large associations (r = .28 to .50, p < .05).
Descriptive terms are based on those used by Cohen (1988).
Significance of Difference between Correlation Coefficients
Fisher r-to-z transformations were conducted, across the two samples, to assess
the significance of the difference between partial correlation coefficients which evaluated
construct validity for the EXAMINER. Partial correlation scores for the cognitive
performance, controlling for age, of the African American control and White comparison
groups were transformed into Fisher Z scores and the probability for the magnitude of the
difference between the values was computed, with a two-sided test. The strength of
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association between the EXAMINER executive composite (z = -.72, p < .05), fluency
factor (z = -.44, p < .05), cognitive control (z = -.38, p < .05), and working memory (z = .01, p < .05) and verbal ability was not statistically significant for African American and
White samples.
Hypothesis 2B: The validity coefficient for the BRIEF Behavioral Regulation,
Metacognition, and Global Executive Composite and the EXAMINER executive
composite, working memory factor, cognitive control factor, and fluency factor scores
will be similar for African American and White children.
Correlation Analysis
Partial correlations were computed to examine construct validity for EXAMINER
compared to the BRIEF, controlling for age. To maximize sample size for each reliability
coefficient, data were computed with pairwise exclusion for missing values.
The degree of association between EXAMINER executive composite, fluency
factor, cognitive control, and working memory scores and the BRIEF Metacognition,
Behavioral Regulation, and Executive Composite scales was examined. Results of these
correlational analyses indicated that all EXAMINER variables were correlated in the
expected direction with each of the BRIEF indices, see Table 5.4. For the EXAMINER
composite, fluency, and working memory factors higher scores mean better performance.
For the EXAMINER cognitive control factor higher scores mean more difficulties with
cognitive control tasks. These partial correlation values also suggested a trend of higher
validity coefficients for the African-American control sample as compared to the White
control sample for the EXAMINER. The relationship between the EXAMINER scores
and BRIEF Metacognitive Index, controlling for age, were small for the White
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comparison group (r = -.14 to -.21, p < .05) and small-to-medium in size for the African
American control group (r = -.18 to -.30, p < .05). The relationship between the
EXAMINER scores and BRIEF Behavioral Regulation Index, holding age constant, also
ranged from very small-to-medium range for the White comparison group (r = -.01 to .21, p < .06) yet the range of scores for the African American control group were smallto-medium in size (r = -.18 to -.30, p < .05). Finally, the relationship between the
EXAMINER scores and BRIEF Executive Composite Index, holding age constant, were
small for the White comparison group (r = -.12 to -.17, p < .05) but medium-to-large in
the African American control group (r = -.25 to -.32, p < .05).
Significance of Difference between Correlation Coefficients
Fisher r-to-z transformations were conducted to assess the significance of the
difference between partial correlation coefficients utilized in EXAMINER construct
validity evaluation. Partial correlation scores assessing the cognitive performance of
African American control and White comparison groups between BRIEF and
EXAMINER factors were transformed into Fisher Z scores.
The probability for the magnitude of the difference between these values was
computed across the two samples, with a two-sided test. Ten calculations for the test of
the difference between EXAMINER and BRIEF scores were found to be statistically
non-significant, see Table 5.4. The strength of association between EXAMINER
executive composite (z = -.62, p < .05), fluency factor (z = .83, p < .05), cognitive control
(z = -.02, p < .05), and working memory factor (z = .86, p < .05) and the BRIEF
Metacognition Index was not statistically significant between the African American and
White samples. The strength of association between EXAMINER fluency factor (z =
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1.57, p < .05) and working memory factor (z = 1.27, p < .05) and the BRIEF Behavioral
Regulation Index was not statistically significant between the African American and
White samples. Conversely, the strength of association between EXAMINER executive
composite (z = 2.36, p < .05) and cognitive control factor (z = 2.61, p < .01) in relation to
the BRIEF Metacognition were significantly larger for the African American than the
White sample. The strength of association between EXAMINER executive composite (z
= 1.16, p < .05), fluency factor (z = 1.11, p < .05), cognitive control (z = -.89, p < .05),
and working memory factor (z = .86, p < .05) and the BRIEF Executive Composite Index
was not statistically significant between the African American and White samples.
Hypothesis 3A: Children with SCD at high risk for disease-related cognitive
effects will show significantly poorer performance on the EXAMINER than
demographically matched control children without SCD. The effect size of these
differences will be compared to the magnitude of group differences on selected WJ-III.
Descriptive Statistics
Prior to performing the statistical analyses, data were analyzed by SPSS-22 for
the presence of outliers and the possible influence over variable relationships.
Examination of histograms and a series of independent sample t-tests were performed to
examine whether there were significant differences between the age ranges of SCD and
comparison study group. Normality was tested using the Shapiro – Wilk test. Overall,
these procedures revealed no significant violations of normality. These procedures
revealed no significant statistical difference in age between the SCD group (M = 12.72,
SD = 3.16) and the African American comparison group (M = 12.87, SD= 2.53), see
Table 5.1.
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Analysis of Variance Analyses
An ANOVA analysis revealed a statistically significant difference between the
parental income levels of the SCD group and the African American comparison group, at
the p<.05 level [F (21.110) = 20.33, p = .00, η² = .01]. The mean level of parental income
for the African American sample was (M = 2.92, SD= 1.22) was higher than the mean
level of parental income for the SCD group (M = 1.74, SD= 1.40). Therefore income was
added to the statistical models to control for this variance.
A series of two-way analysis of variance analyses were conducted to examine
whether there were statistically significant differences among children with SCD and the
non-neurologic control group, in relation to performance on the EXAMINER.
ANOVA results revealed a main effect between the SCD group and African
American comparison group on the executive composite score, at the p<.05 level [F (1,
111) = 12.86, p = .00, η² = .13]. The main effect of income was non-significant at the
p<.05 level [F (4, 111) = 1.37, p = .25, η² = .05]. The average executive composite score
was significantly higher for African American control children (M = -.18, SE = .08) than
the SCD group (M = -.72, SE = .10) composite scores, see Figure 5.1. This evidence
suggests that children diagnosed with SCD have poorer performance on the EXAMINER
when compared to demographically matched peers.
ANOVA results also reveal that the main effect of the SCD group and the African
American comparison group, in relation to the cognitive control factor, was statistically
significant, controlling for family income levels, at the p < .05 level [F (1, 111) = 12.66,
p = .00, η² = .11]. The main effect of income was non-significant at the p<.05 level [F (4,
107) = 1.26, p = .29, η² = .04]. The mean composite cognitive control scores for the SCD
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group (M = -.60, SE = .14) were significantly lower than the Black comparison group (M
= .06, SE = .11) cognitive control scores, see Figure 5.2. Results suggest that children
with SCD exhibit poorer cognitive control than Black peers.
ANOVA analysis also examined the presence of statistically significant
differences among children, controlling for family income levels, diagnosed with SCD
and a demographically matched comparison group related to their performance on the
EXAMINER fluency factor score. Results revealed statistically significant differences
among the groups, at the p < .05 level [F (2, 393) =8.08, p = .00, η² = .04]. The main
effect of income was non-significant at the p<.05 level [F (4, 105) = .47, p = .76, η² =
.02]. The mean fluency scores of the SCD group (M = -.68, SE = .10) were statistically
lower than those of the demographically matched control group (M = -.20, SE = .08), see
Figure 5.3. Findings indicate that African American children with no neurologic
condition performed significantly higher compared to children diagnosed with SCD on
the mean fluency composite score.
ANOVA findings also demonstrate a significant main effect between SCD group
status and the African American comparison group on the EXAMINER working memory
composite score, at the p<.05 level [F (1, 92) = 7.18, p = .01, η² = .17]. The main effect
of income was non-significant at the p < .05 level [F (4, 92) = 1.28, p = .28, η² = .05].The
mean score for the African American comparison group (M = -.21, SE = .09) was
significantly different than the SCD group (M = -.64, SD = .13), see Figure 5.4. Results
suggest that African American children with no neurologic condition performed better
than children diagnosed with SCD on the working memory factor score, η² = .17].
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Similarly, ANOVA results revealed statistically significant differences between
the SCD group and the demographically matched control group, across income levels, on
the W scores calculated from the WJ-III. Results revealed that the verbal comprehension
scores for the SCD group and the African American comparison group were statistically
different, at the p<.05 level [F (1, 111) = 7.12, p = .01, η² = .07]. The main effect of
income was non-significant at the p<.05 level [F (4, 111) = .84, p = .50, η² = .03].Verbal
comprehension scores for the SCD group (M = 495.60, SE = 2.59) was significantly
lower than the Black comparison group (M = 504.94, SE = 2.01) verbal comprehension
scores, see Figure 5.5. This evidence suggests that children diagnosed with SCD have
poorer verbal comprehension on the WJ-III when compared to demographically matched
peers.
In addition, ANOVA analysis examined the presence of statistically significant
differences among children with SCD and a demographically matched comparison group
in relation to their performance on WJ-III visual matching score, across all income levels.
Results revealed a statistically significant main effect among the groups, at the p<.05
level [F (1, 111) = 14.35, p = .00, η² = .12]. The main effect of income was nonsignificant at the p<.05 level [F (4, 111) = .89, p = .47, η² = .03]. There were statistically
significant differences between the SCD group (M = 495.88, SE = 2.75), and those of the
demographically matched control group (M = 509.38, SE = 2.13), see Figure 5.6.
Findings indicate that African American children with no neurologic condition performed
significantly higher compared to children diagnosed with SCD for visual matching on the
WJ-III.
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ANOVA results also revealed a significant main effect of SCD group status on
WJ-III numbers reversed W score across income levels, at the p<.05 level [F (1, 111) =
7.21, p = .00, η² = .06]. The main effect of income was non-significant at the p<.05 level
[F (4, 111) = 1.09, p = .37, η² = .04]. The mean score for the African American
comparison group (M = 504.49, SE = 3.67) was significantly different than the SCD
group (M = 487.99, SD = 4.73), see Figure 5.7. Results suggest that African American
children with no neurologic condition performed better than children diagnosed with
SCD, on the WJ-III numbers reversed task.
The eta-squared values for the EXAMINER scores ranged from small-to-large,
.04 to .17 with a median of .12, whereas for the WJ-III the effect sizes were medium, .06
to .12 with a median of .07. Comparison of the magnitude of the observed effects across
the EXAMINER and WJ-III W scale measures might suggest a slight trend toward larger
effects for the EXAMINER, though overall the values were comparable (Cohen, 1988).
Overall, children with SCD showed significantly poorer performance on the
EXAMINER than demographically matched control children without SCD, Table 5.5.
Therefore, hypothesis 3A was supported. These results further support the conclusion that
children with SCD evidence disease-related cognitive effects.

Hypothesis 3B: The EXAMINER executive composite, working memory factor, cognitive
control factor, and fluency factor will show at least as high of sensitivity and specificity
in identifying high risk children with sickle-cell disease as the selected measures from the
WJ-III relative to the local, demographically matched comparison group.
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Descriptive Statistics
Prior to performing the statistical analyses, SPSS-22 was utilized to conduct a
subgroup analysis of African American comparison group. This procedure was
performed to provide balance in parental income between groups. A targeted selection of
cases was performed from the African American comparison group, with the intent of
exclude cases more than 1 SD away from mean income level of the SCD group (M =
1.73, SD = 1.74). A random sub-group (n = 51) was then generated with a lower mean
parental income level (M = 1.39, SD = .73). Normality was tested using the Shapiro–
Wilk test. Analyses revealed no significant violations of normality or significant
statistical difference between the SCD group (M = 12.72, SD = 3.16) with skewness of
0.8 (SE = 0.41) and kurtosis of -1.2 (SE = 0.8) and the African American comparison
group (M = 12.64, SD= 2.77) with skewness of 0.01 (SE = .44) and kurtosis of -0.88 (SE
= 0.86). An independent samples t-test revealed no statistical significance between the
income range of the SCD and African American comparison groups (t = 9.99, df = 27, p
< .73). ROC Curves were constructed based upon the sensitivity and specificity of the
EXAMINER and WJ-III scores.
Receiver Operating Characteristic Curve Analysis
ROC Curve analyses were conducted to evaluate the performance of multiple
curves in order to compare the EXAMINER and WJ-II neuropsychological measures.
Results indicated that the EXAMINER scores were statistically significance (p = .05) in
differentiating between the SCD and demographically matched comparison groups. The
balance between sensitivity and false positive rate is shown in Figure 5.8. The WJ-III
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scores were also statistically significance (p = .05) for differentiating between study
groups. The balance between sensitivity and false positive rate is shown in Figure 5.9.
ROC Curves in Figure 5.8 and Figure 5.9 can be expressed numerically as area
under the curve values, which indicate the likelihood that a randomly selected case will
perform more poorly than a randomly selected control. The area under the curves for the
EXAMINER scores were: executive composite (.79), fluency factor (.74), cognitive
control factor (.77), working memory factor (.74) and these values appear to be similar to
the WJ-III: verbal comprehension, (.72), visual matching (.76), numbers reversed (.70).
More specifically, for discriminating no SCD status from SCD diagnosis among all
subjects, the areas under the ROC curves for the EXAMINER and WJ-III evidence
moderate accuracy by Swets’s (1988) criteria, see Table 5.6.
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Table 5.1.
Descriptive Information for Study Groups

Variable
Age (M ± SD; range)
Gender (n)

High Risk
SCD
(n-32)

AA
Comparison
Group Without
SCD (n-85)

12.7 ± 3.2

12.8 ± 2.5

White
Comparison
Group
Without
SCD (n-279)
11.2 ± 2.9

Males

14 (43.8%)

39 (46.3%)

133 (47.0%)

Females

18 (56.3%)

46 (59.7%)

146 (53.0%)

African-American

32

80 (94.5)

n/a

Hispanic and African American

0

5 (0.6%)

n/a

Statistic
t(362) = 4.94, p < .001

Race/Ethnicity

Parent Education
9-11 years

3 (3.2%)

4 (3.0%)

n/a

High School

4 (13.3%)

19 (16.2%)

n/a

Some College

9 (28.8%)

20 (17.0%)

n/a

College Degree

16 (51.2%)

42 (35.7%)

n/a

Family Income (n)

F(21.110) = 20.33, p =
.001

< $10,000/year

9 (28.8%)

3 (3.5%)

n/a

$10-20,000/year

5 (15.6%)

9 (10.6%

n/a

$20-30,000/year

8 (25.0%)

15 (17.6%)

n/a

$30-40,000/year

5 (15.6%)

18 (21.2%)

n/a

> $40.000/year

5 (15.6%)

40 (47.1%)

n/a

Adults in the home (M ± SD)

1.6 ± 0.5

1.8 ± 0.6

n/a

Age of Primary Caregiver (M ±
SD)
Current Therapy (n)

37.4 ± 9.0

37.0 ± 9.0

n/a

Hydroxyurea

2

n/a

n/a

Chronic therapy

1

n/a

n/a

Bone Marrow therapy

0

n/a

n/a

White cells (K/ul)

13.1 ± 3.1

n/a

n/a

Hemoglobin (g/dL)

8.6 ± 1.3

n/a

n/a

Platelets (K/uL)

466 ± 129

n/a

n/a

Routine CBC Values

SCD=sickle cell disease
*p<0.05; **p<0.01
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Table 5.2.
Overview of Internal Consistency for EXAMINER and WJ-III

Test
Examiner Battery
Composite Score
Woodcock-Johnson III
Verbal
Comprehension
Visual Matching
Numbers Reversed

African
American
Comparison
Group

Study Groups
White
Comparison
Group

SCD Group

WJ-III
Normative
Sample

.81 (n = 85)

.84 (n = 279)

.84 (n = 32)

-

-

-

.91 (n = 3549)

-

-

-

.88 (n = 3719)
.86 (n = 3337)

Note: Internal consistency reliability values, Chronbach’s alpha, for 10 EXAMINER tasks and Woodcock-Johnson
Tests of Cognitive Abilities, 3rd edition mean internal consistency scores for children 8-18 of age; *p<.05; **p<.01,2tailed test.
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Table 5.3.
Fisher r-to-z transformation scores used to assess the significance of the difference
between EXAMINER composite scores and WJ-III tests.
WJ-III Subscales

African
American
-3.59**

Sickle Cell
Disease
-1.64

-4.9**

Visual Matching

-2.23*

-0.83

-2.48**

Numbers Reversed

-1.49

-0.39

-1.15

Verbal
Comprehension

White

Notes: Z-scores test the difference in the magnitude of the correlation between the Woodcock-Johnson Tests of
Cognitive Abilites, 3rd edition Verbal Comprehension, Visual Matching, and Numbers Reversed scales and the
EXAMINER Composite scores for the African-American, SCD, and White samples; *p<.05; p<.01, 2-tailed test.
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Table 5.4.
Partial correlations (controlling for age) assessing construct validity for EXAMINER
Battery factor scores. Twelve of sixteen coefficients were in the direction of higher
convergent validity for the African-American sample as compared to the White sample.

Measure

Group

Executive

Fluency

Composite
Verbal Ability –

W

Age Adjusted
Score

BRIEF - Meta-

A-A

W

cognitive Index
A-A

BRIEF -

W

Behavioral
Regulation Index

BRIEF –

A-A

W

Executive
Composite Index

A-A

Cognitive

Working

Control

Memory

.421

.293

-.380

.279

(n = 231)

(n = 232)

(n = 231)

(n = 218)

.495

.345

-.339

.280

(n = 82)

(n = 82)

(n = 79)

(n = 73)

z = -0.72

z = -0.44

z = 0.36

z = -0.01

-.212

-.142

.187

-.180

(n = 246)

(n = 246)

(n = 246)

(n = 231)

-.291

-.250

-.184

-.297

(n = 72)

(n = 73)

(n = 70)

(n = 64)

z = 0.62

z = 0.83

z = -0.02

z = 0.86

-.054

-.059

.006

-0.153

(n = 246)

(n = 246)

(n = 246)

(n = 231)

-.352

-.261

.344

-.228

(n = 77)

(n = 77)

(n = 74)

(n = 68)

z = 2.36*

z = 1.57

z = 2.61**

z = 1.27

-.170

-.123

.130

-.145

(n = 244)

(n = 244)

(n = 244)

(n = 229)

-.318

-.269

.249

-.273

(n = 72)

(n = 72)

(n = 69)

(n = 63)

z = 1.16

z = 1.11

z = 0.89

z = 0.92

Notes: Verbal Ability was estimated from either the Woodcock-Johnson Tests of Cognitive Abilities, 3rd edition Verbal
Comprehension scale or the Wide Range Achievement Test, 4th edition Reading Score; BRIEF=Behavioral Rating
Inventory of Executive Function; Z-scores test the difference in magnitude of the correlation between the White and
African-American samples; *p<.05; **p<.01; data were computed with pairwise exclusion for missing values to
maximize the sample size for each validity coefficient.
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Table 5.5.
Mean Score for African American and SCD study groups on EXAMINER Z scores and
WJ-III W Scores
Study Groups
African American
SCD Group
Comparison Group
Test
Examiner Battery
Composite Factor Score
Cognitive Control Factor Score
Fluency Factor Score
Working Memory Factor Score
Woodcock-Johnson III
Verbal Comprehension
Visual Matching
Numbers Reversed

-0.18 (SE = .08)
-0.60 (SE = .14)
-0.20 (SE = .08)
-0.21 (SE = .09)

-0.72 (SE = .10)
0.06 (SE = .11)
-0.68 (SE = .10)
-0.64 (SE = .13)

504.94 (SE = 2.01)
509.38 (SE = 2.13)
504.49 (SE = 3.67)

495.60 (SE = 2.59)
495.88 (SE = 2.75)
487.99 (SE = 4.73)

Note: Internal consistency reliability values, Chronbach’s alpha, for 10 EXAMINER tasks and Wookcock-Johnson
Tests of Cognitive Abilities, 3rd edition mean internal consistency scores and standard error scores for children 8-18,
*p<.05; **p<.01, 2-tailed test.
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Table 5.6
Area under ROC curve for EXAMINER and WJ-III
Area Under the
Curve (95% CI)

Standard
Error

EXAMINER
Composite Factor Score
Cognitive Control Factor Score
Fluency Factor Score
Working Memory Factor Score

.79* (.67-.90)
.77* (.66-.88)
.74* (.62-.86)
.74* (.63-.86)

.06
.06
.06
.06

Woodcock-Johnson III
Verbal Comprehension W Score
Visual Matching W Score
Numbers Reversed W Score

.72* (.61-.82)
.76* (.65-.87)
.70* (.59-.80)-

.06
.06
.05

Note: Null hypothesis: true area = 0.5
*. Significant at the 0.05 level (2-tailed).
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Figure 5.1. Mean EXAMINER Composite Scores for SCD and AA Comparison Group
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Figure 5.2. Mean EXAMINER Cognitive Control Scores for SCD and AA Comparison
Group
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Table 5.3. Mean EXAMINER Fluency Scores for SCD and AA Comparison Group
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Figure 5.4. Mean EXAMINER Working Memory Scores for SCD and AA Comparison
Group
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Figure 5.5. Mean WJ-III Verbal Comprehension Scores for SCD and AA Comparison
Group
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Figure 6.6. Mean WJ-III Visual Matching Scores for SCD and AA Comparison Group
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Figure 5.7. Mean WJ-III Numbers Reversed Scores for SCD and AA Comparison Group
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Figure 5.8. Hypothesis 3B - Receiver-Operating Characteristic Curves for EXAMINER
Factor and Composite Scores

138

Figure 5.9. Hypothesis 3B - Receiver-Operating Characteristic Curves for WJ-III Verbal
Comprehension, Visual Matching, and Numbers Reversed tests
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CHAPTER VI
DISCUSSION
This study aimed to investigate the psychometric properties of a new executive
function measure, the EXAMINER, to determine its utility with the pediatric SCD
population. The psychometric properties of the EXAMINER were evaluated, relative to
the WJ-III. The WJ-III was chosen as a gold standard because this literature review
revealed that it has strong psychometric properties and cultural validity with AfricanAmerican children. Thus, the WJ-III appears to be the most appropriate measure for use
with the pediatric SCD population, in the US. In this investigation, the cultural validity of
the EXAMINER was investigated for African-Americans with SCD, by comparing the
internal consistency and convergent validity for African-American youth relative to
White youth. In addition, criterion validity was assessed for the EXAMINER to SCDrelated cognitive deficits. Overall, this study revealed three novel findings. First, the
EXAMINER demonstrated adequate reliability (internal consistency) for the Executive
Composite score. This assessment of internal consistency was based on traditional
standards. Reliability values were found to be similar across White and AfricanAmerican children. However, reliability was found to be lower for the EXAMINER,
compared to the normative sample of children in the WJ-III manual. Second, the
EXAMINER displayed acceptable cultural validity for African-Americans with SCD.
Convergent validity was evaluated by the degree to which the EXAMINER and well
established measures were related across Black the White samples. Finally, the
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children with and without neurologic morbidity and performed at least as well as an
established measure, the WJ-III.
Hypothesis 1: The reliability (internal consistency) of the EXAMINER will be
equivalent to the WJ-III for use in pediatric SCD, including the reliability for youth tested
across multiple sites, local demographic controls, and youth with SCD.
Results suggested that hypothesis one was partially supported by the findings in
this investigation. Findings revealed that the internal consistency of the EXAMINER
composite score appeared to function adequately across SCD and comparison pediatric
groups. Similar to the WJ-III, the EXAMINER composite score evidenced good internal
consistency for each study group when employing commonly accepted descriptive labels
(Cohen, 1988). More specifically, the internal consistency of the EXAMINER for each of
the study groups reached the generally accepted 0.8 Chronbach’s alpha threshold for
making interpretations and clinical predictions. There were also no significant
differences for internal reliability found between the pediatric SCD, African American,
and White comparison groups on the EXAMINER, relative to the WJ-III. Likewise, there
were no differences found within the pattern of responses between the EXAMINER and
WJ-III for children diagnosed with pediatric SCD and youth in the comparison groups for
the WJ-III working memory task. Divergent to Hypothesis 1, the magnitude of
difference between the internal consistency of the EXAMINER composite score and WJIII verbal comprehension and visual matching tests were significant for White and Black
youth, indicating higher reliability for these WJ-III measures than for the EXAMINER.
Contrary to what we originally expected, the EXAMINER showed lower
reliability than found in the WJ-III manual for the measure’s normative sample. It is
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possible that comparison between a larger and more diverse sample, matched to the U.S.
census, improved the alpha value by increasing the range of scores with greater
variability. However, the EXAMINER appeared to perform nearly as well as the WJ-III
with one-third the items. This suggests the EXAMINER items were well chosen. The
WJ-III measures typically have 30 or more items per scale, whereas the EXAMINER
composite score used 10 items derived from different tasks. Given that sensitivity of the
alpha coefficient to the number of items in the scale, it is somewhat impressive that the
EXAMINER composite score was able to achieve acceptable reliability as a clinical tool
with so few items.
These results contribute to the emerging empirical literature which suggests that
the EXAMINER may assess EF reliably across a variety of ages, ethnicities, and
disorders (Kramer, 2014; Kramer, et al., 2013). The developers of the EXAMINER
utilized IRT methods to measure factors with fewer variables. IRT is focused on
individual items; the reliability of a scale is enhanced by containing a small number of
non-redundant items that measure a very specific level of the latent variable. Therefore, it
would have been more suitable for this study to utilize the IRT method of analysis,
thereby comparing similar results with the EXAMINER manual. Future studies may
consider using more sophisticated methods of scale development, such as IRT, to
investigate the appropriateness of the EXAMINER for use with pediatric SCD. Future
researchers should also consider examining test-retest reliability, in children, with other
well established measures of EF. These values should then be used to assess crosscultural examinations for the reliability of the EXAMINER across different cultural
groups.
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Hypothesis 2A: The strength of association between EXAMINER scores and VIQ
from the WJ-III will be similar for African American and White children.
The psychometric literature reveals that there is an association between VIQ and
EF measures for pediatric populations (McCarthy, 1972; Ardila et al., 1998; Ardila et al.
2000). Findings suggest that hypothesis 2A was supported in this study. The
EXAMINER shows comparable validity across African American youth, compared to
established measures of VIQ. Results from this study reveal that the strength of
association between the EXAMINER and VIQ on WRAT and WJ-III was similar for
African American and White children, when age was held constant. In addition, three of
four partial correlation coefficients for the EXAMINER, relative to VIQ on the WRAT
and WJ-III were in the direction of higher convergent validity for the African American
sample, as compared to the White sample. This suggests that increasing sample size and
power would be unlikely to change the outcome of these analyses. Despite the fact that
the EXAMINER appeared to demonstrate higher convergent validity for the African
American group, there was also greater variability across partial correlation values for the
African American sample. However, the similar convergent validity shown between the
EXAMINER with the WJ-III and the WRAT between African American and White
samples, demonstrates acceptable cultural validity for African American children. These
findings are consistent in the multicultural assessment literature. Reynolds & Suzuki
(2012) suggest that when psychological test are developed through culturally fair
methods, they are more likely to demonstrate relatively equivalent ability levels across
ethnic groups and are also more likely correctly identify patterns of performance between
different ethnic groups.
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Hypothesis 2B: The strength of the association between the validity coefficient for
the BRIEF Behavioral Regulation, Metacognition, and Global Executive Composite and
the EXAMINER executive composite, working memory factor, cognitive control factor,
and fluency factor scores will be similar for African American and White children.
Convergent validity for the EXAMINER was also assessed with the BRIEF. The
BRIEF is a cognitive measure that was developed to examine the functional expression of
EF through parent or teacher report of day-to-day behavior (Gioia, Isquith, Guy,
Kenworthy, 2000). Findings from hypothesis 2B were supported in this study. Overall,
the EXAMINER shows similar validity across the African American and White youth,
relative to the BRIEF. Results reveal no significant differences for 10 of 12 analyses to
compare the strength of the association between the BRIEF and the EXAMINER for the
African American and White comparison groups, controlling for age. In general, these
findings suggest that partial correlation values were more variable, but in the direction of
higher convergent validity for the African American sample, as compared to the White
sample. Again, this suggests that increasing sample size and statistical power would be
unlikely to reveal a pattern of poorer convergent validity for African-American children.
The standard deviation was slightly larger for the African American comparison group on
the BRIEF. Differences in variability may have led to slightly lower coefficients for the
White sample. However, the increased variability in validity values does not appear to
detract from the moderate correlations found in the African American sample, which
support validity for this cultural group
It was reasonable to expect that results of hypothesis 2A and 2B would reveal that
the EXAMINER demonstrates similar cultural validity to well-established measures, for
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African American children. The mission of the EXAMINER test development was to
promote methods of measurement that could be useful across diverse ages and ethnicities
(Kramer, et al., 2014). Thereby, this study contributes to the emerging empirical
literature which suggests that the EXAMINER may have appropriate detection
capabilities for EF in the pediatric SCD population (Kramer, 2014; Kramer, et al., 2013).
These results are also a noteworthy first-step to understanding how the EXAMINER
performs for African Americans children when compared to White youth. Traditional
factor analysis allows for insights into the nature of multiple latent variables, however
this typically requires larger sample sizes than our study could efficiently recruit
(DeVellis, 2003). An important next step is to explore the construct validity of the
EXAMINER with confirmatory factor analysis to test whether the data fit the
hypothesized measurement model. The sample size in this study was too small to conduct
this analysis. Therefore, future investigations should consider concentrating on further
enhancing our understanding of cultural and convergent validity for the EXAMINER, by
utilizing larger sample sizes of African American children and other cultural groups.
Hypothesis 3A: Children with SCD at high risk for disease-related cognitive
effects will show significantly poorer performance on the EXAMINER than
demographically matched control children without SCD. The effect size of these
differences will be compared to the magnitude of group differences on selected WJ-III.
Overall, findings from this study suggest that Hypotheses 3A were supported. The
EXAMINER appears to evidence comparable sensitivity in detecting neurologic
decrements in the pediatric SCD population as compared to the WJ-III. Children with
SCD revealed poorer performance on the Examiner Battery compared to the African
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American comparison group, providing support for hypothesis 3A. Across all
EXAMINER scores, statistically significant findings showed that poorer executive
performance occurred for children diagnosed with SCD relative to the African American
comparison group. Similarly, results revealed statistically significant differences between
the SCD group and the demographically matched control group on each of the variables
from the WJ-III. Comparison of the magnitude of the observed effects across the
EXAMINER and WJ-III W scale measures suggest a slight trend toward larger effects for
the EXAMINER, though overall the values were comparable.
Hypothesis 3B: The EXAMINER will show at least as high of sensitivity and
specificity in identifying high risk children with sickle-cell disease as the selected
measures from the WJ-III relative to the local, demographically matched comparison
group.
The ROC sensitivity-specificity analyses showed that the EXAMINER predicted
neurologic risk/status at a comparable rate as WJ-III. These findings provide support for
hypothesis 3B. Results of the sensitivity-specificity analyses showed statistical
significance for the EXAMINER scores and WJ-III variables in the prediction of
neurologic status. The areas under the ROC curves for the EXAMINER and WJ-III
evidenced moderate accuracy utilizing Swets’s (1988) criteria. Both measures
demonstrated classification accuracy rates that were slightly lower than 80%. Given that
80% sensitivity and specificity are often used as common standards for accuracy of
psychological tools in decision making, the measures fell slightly below this standard.
However, the EXAMINER tool at this point in development does not use age-adjusted
scores, which would likely improve its ability to differentiate between groups. Likewise,
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non-age adjusted scores were used with the WJ-III to provide a more direct comparison
between measures. Thus, the EXAMINER appears to have the potential to provide
excellent criterion validity, but needs additional work, primarily in the area of collecting
of a larger sample for normative purposes.
Taken together, these results highlight the acceptable levels of criterion validity
for both the EXAMINER and WJ-III in terms of sensitivity to SCD-related cognitive
deficits though for individual-level decision making the EXAMINER is still lacking in
age-specific norms. As the WJ-III is a well-established measure for the detection of
neurologic deficits with the pediatric SCD population, these findings provide evidence
for the EXAMINER’s ability to effectively discriminate between children with and
without neurologic morbidity. Therefore, this study contributes to the developing
literature which supports the use of the EXAMINER with diverse clinical populations,
including pediatric SCD (Kramer, 2014; Kramer et al., 2013). In addition, these results
further support the assertion that cognitive testing is an efficacious and cost effective
method for identifying neurologic deficits in pediatric SCD. Future investigations should
focus efforts on further examining the EXAMINER’s ability to detect neurologic deficits
within pediatric SCD and its use in clinical trials can be justified.
Limitations
Although the EXAMINER appeared to function as well as traditional cognitive
measures for each of these analyses, there are some limitations of this study that must be
acknowledged. First, the sample sizes were relatively small for the SCD group and
African-American controls, which may account for some of the variation in findings
regarding internal consistency. Most notably, the magnitude of difference between the
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internal consistency of the EXAMINER and WJ-III verbal comprehension and visual
matching was significant for African American and White youth. One reason for higher
reliability in the WJ-III may the more limited variability of the EXAMINER sample
groups compared to the large normative sample for the WJ-III. Data collection for the
multi-site study was performed largely by psychologists, focused on collecting clinical
samples. It is likely that the neurologic study samples were in some cases collected as
samples of convenience, more so than large well-designed normative data sets.
Consequently, decreased variability within the study sample may have translated into
lower internal consistency observed for the EXAMINER, relative to the WJ-III normative
sample.
The Yurdugul, (2008) article suggests that our sample sizes were large enough to
adequately produce a sufficiently unbiased estimator of coefficient alpha for the
EXAMINER composite score, given the first eigenvalue of greater than four. However,
in detecting differences in alpha across groups one must decide what degree of
differences is likely to be meaningful. With a large enough sample, it is likely that group
differences in reliability could have been shown. Therefore the critical number of
participants may not have been large enough to detect internal consistency. Despite the
small sample sizes, results suggest that the overall internal consistency and convergent
validity for the EXAMINER evidenced acceptable levels across study groups.
Another limitation of this study concerns the lack of detailed demographics
provided for children from other sites. Due to investigator error at these sites, the level of
parent education was not provided for the children that participated at 10 sites of the
multi-site investigation. It was intended that parent education data would be included in
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the analyses, as a proxy variable to represent SES. In 2000, the US Census Bureau
reported that African Americans experience disproportionate poverty rates, compared to
White non-Latino youth. Schatz and colleagues (2004) found results which suggest that
children with SCD experience a combination of biopsychosocial risk factors related to the
neurologic factors and socioeconomic disadvantage. Failure to include a variable to
account for SES limited the ability to examine cultural differences. SES differences may
have influenced some of the comparisons of White and African American youth. It is not
clear whether the inclusion of measures for SES would have changed the results found in
these samples; future investigations should try to obtain information on these variables to
improve our understanding of the performance of African American children on the
EXAMINER.
Conclusion
As revealed in the literature review, the great variability related to
neuropsychological measures used to assess neurologic morbidity has, in part, negatively
impacted treatment outcomes for pediatric SCD. The newly developed EXAMINER was
developed with the central goal of reliably and validly assessing EF across a wide range
of ages and disorders (Kramer et al., 2012). Therefore it was important to evaluate the
psychometric properties of the EXAMINER to help determine the suitability of this tool
with children diagnosed with SCD relative to an alternate measure. In sum, this study
demonstrated the feasibility of using the EXAMINER for children with SCD as a reliable
and valid tool in clinical research and intervention trials. In conclusion, findings in this
study suggested that the internal consistency, convergent validity, cultural validity, and
sensitivity of the EXAMINER demonstrated that it is a useful neuropsychological test for
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the pediatric SCD population. It is important to note that as test development continues
for the EXAMINER, consistent evaluation of its psychometric properties should be
continued with this clinical population; due to an increased risk of subtle problems with
learning and cognition, even in the absence of an identifiable insult to the brain.(Schatz et
al., 2002).
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